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Abstract 
 
In immunology, the mouse is unquestionably the predominant model organism. 
However, an increasing number of reports suggest that mouse models do not 
always mimic human innate immunology. To better understand this discordance 
at the molecular level, we are investigating two mechanisms of gene evolution: 
positive selection and gene remodeling by introgression/domain shuffling. We 
began by creating a bioinformatic pipeline for large-scale evolutionary analyses. 
We next investigated bowhead genomic data to test our pipeline and to determine 
if there is lineage specific positive selection in particular whale lineages. Positive 
selection is a molecular signature of adaptation, and therefore, potential protein 
functional divergence. Once we had the pipeline troubleshot using the low 
quality bowhead data we moved on to test our innate immune dataset for lineage 
specific selective pressures. When possible, we applied population genomics 
theory to identify potential false-positives and date putative positive selection 
events in human. The final phase of our analysis uses network (graph) theory to 
identify genes remodeled by domain shuffling/introgression and to identify 
species-specific introgressive events. Introgressive events potentially impart 
novel function and may also alter interactions within a protein network. By 
identifying genes displaying evidence of positive selection or introgression, we 
may begin to understand the molecular underpinnings of phenotypic discordance 
between human and mouse immune systems.   
  
xxiii 
Thesis Aims 
(1) Automation of large-scale selective pressure variation – Chapter 2. 
We wished to develop a streamlined highly automated method to improve large-
scale identification of selective pressure variation and to stream line all processes 
associated with this type of analysis such as: (i) identification of gene families, 
(ii) alignment, (iii) phylogenetic reconstruction, (iv) selective pressure analyses, 
(v) LRTs, and (vi) quality control. We tested this software using novel sequence 
data from Bowhead Whale. 
 
(2) To determine if positive selection is correlated with phenotypic 
discordance using the innate immune system of vertebrates as a model – 
Chapter 3.  
We wished to determine if positive selection identified in the innate immune 
system correlates with known phenotypic discordance thereby providing a 
putative target to understand the known discordance at the molecular level. And 
from here we wished to predict sequence changes that may underpin currently 
unknown discordance cases.   
 
3) To elucidate the role of domain shuffling in the emergence of proteins in 
vertebrate evolution – Chapter 4.  
We wished to qualify and quantify gene remodeling by domain shuffling in 
vertebrate protein coding gene evolution, and to define the principles that govern 
how the domains of modular proteins combine to form functional units often in a 
species-specific manner that could lead to variation in function across species. 
  
1 
Chapter 1: Introduction 
2 
1.1 Innate Immunity 
1.1.1 General overview of the innate immune system in vertebrates 
The immune system of an organism is primarily responsible for defense against 
and resistance to pathogens. In vertebrates, immunity is divided into two distinct 
strategies: adaptive immunity and innate immunity. Adaptive immunity is unique 
to vertebrates and grants immunity from previously encountered pathogens by 
means of immunological memory [Flajnik and Kasahara, 2010]. A noteworthy 
aspect of immunological memory is that the survival advantage is confined to an 
individual [Medzhitov and Janeway, 2000]. Innate immunity evolved in the 
common ancestor of plants and animals and confers immunity to a wide range of 
pathogens by recognizing conserved characteristics or pathogen-associated 
molecular patterns (PAMPs) [Medzhitov and Janeway, 2000]. Innate immunity is 
responsible for activating multiple inflammatory responses as well as adaptive 
immunity [Janeway and Medzhitov, 2002]. In contrast with the adaptive immune 
system, the ability of the innate immune system to detect PAMPs by pattern 
recognition receptors (PRRs) is heritable.  
 
1.1.2 Major proteins categories involved in innate immunity 
Innate immunity involves a number of signaling pathways typically characterized 
by bespoke interaction networks and their proteins. Deciphering the complexities 
of these pathways (not to mention pathway-pathway interactions) begins by 
understanding the basic categories of proteins that are required in innate immune 
pathways. The protein categories that will be discussed in this section have been 
limited to those involved in intracellular pathways: PRRs, adaptor proteins, and 
transcription factors.  
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The majority of PRRs, including transmembrane and cytosolic PRRs, respond to 
pathogens by inducing the activation of transcription factors (e.g. NF-κB 
[nuclear factor kappa-light-chain-enhancer of activated B cells] and IRFs 
[interferon regulatory factors]) and can activate the adaptive immune response 
[Mogensen, 2009; Iwasaki and Medzhitov, 2010]. Typically, the response is 
dependent on the classification of the PRR in question: secreted, transmembrane, 
or cytosolic [Mogensen, 2009; Iwasaki and Medzhitov, 2010]. Secreted PRRs are 
responsible for inducing opsonization for phatgocytosis [Iwasaki and Medzhitov, 
2010] but are unable to directly activate the adaptive immune response without 
assistance.  
 
Detection of PAMPs by transmembrane and cytosolic PRRs and subsequent 
signal transduction requires various adaptor proteins to generate the required 
immunological response [Jordan et al., 2003]. In innate immunity, a number of 
adaptor proteins are responsible for encoding binding domains that recognize 
PAMP-activated PRRs [Jordan et al., 2003]. PRR-bound adaptors (i.e. activated 
adaptors) are required to facilitate the formation of a protein complex that either 
generates the required immunological response or binds and activates another 
adaptor for subsequent rounds of protein complex formation [Pawson, 2007]. It 
should be noted that many innate immune pathways require multiple rounds of 
adaptor activation to generate an immune response [Jordan et al., 2003]. 
 
Activation of adaptor proteins by transmembrane and cytosolic PRRs eventually 
forms protein complexes that are responsible for activating a variety of 
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transcription factors to induce the appropriate immunological responses. The role 
of activated transcription factors in innate immunity (such as NF-κB and IRFs) is 
typically to regulate the expression of specific proteins involved in cellular 
signaling, including the well-documented cytokines [Caamaño and Hunter, 2002; 
Tamura et al., 2008]. Activation of NF-κB for example leads to regulating the 
expression of proteins involved in: apoptosis (both inhibitors and activators), 
immune cell development and function, inflammatory response, and also triggers 
the adaptive immune system [Caamaño and Hunter, 2002].  
 
1.1.3 Central innate immune proteins and pathways 
The innate immune system incorporates a diverse collection of pathways that 
provide immunity to a range of pathogens (bacteria, parasites, and viruses). For 
the purpose of this thesis two of the pathways will be reviewed in detail here: the 
Toll-like Receptor (TLR) signaling pathways and the complement system. These 
are the two pathways that feature in Chapter 3. 
 
1.1.3.1 The TLR signaling pathways 
The TLRs are a well-studied family of hetero/homo-dimeric transmembrane 
PRRs [Moresco et al., 2011]. It is currently thought that there are eleven TLRs 
encoded in the human genome, ten of which are expressed (TLRs 1-10) (Table 
1.1). The functions of human TLR8 and 10 are still not fully understood, 
however it has been reported that TLR10 is involved in the innate immune 
response to influenza infection [Lee et al., 2014] and TLR8 is involved in 
recognizing RNA of both viral and bacterial origin [Cervantes et al., 2012]. 
Human TLR11 is not expressed due to pseudogenization [Zhang et al., 2004]. 
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Signal transduction of the TLR signaling pathway requires various adaptor 
proteins and results in the activation of specific transcription factors to activate 
the appropriate response (Figure 1.1) [Kanehisa and Goto, 2000]. Of the adaptors 
involved in the TLR signaling pathway, MyD88 (myeloid differentiation primary 
response 88) and TRIF (TIR-domain-containing adapter-inducing interferon-β) 
are of particular importance. MyD88 and TRIF are central adaptors that are 
required to activate the MyD88-dependent and MyD88-independent pathways, 
respectively. The MyD88-dependent pathway is responsible for NF-κB 
activation and inflammatory cytokine release for TLRs 5, 7, 9 and TLR2 (as a 
heterodimer with TLR1/6). The MyD88-independent pathway (TRIF) is 
responsible for NF-κB activation and cytokine release for TLR3 alone. Of 
particular note, TLR4 (which is required to form a complex with MD-2 
[Lymphocyte antigen 96] and LBP [Lipopolysaccharide binding protein] for 
activation) is unique in its ability to activate both pathways with MyD88 
responsible for cytokine release and early phase NF-κB activation and TRIF for 
late phase NF-κB activation [Kawai and Akira, 2007]. 
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Table 1.1: Properties of the functional human TLRs. 
 
The various TLR receptors of humans, the dimer type of the receptor, the cellular localization of each receptor (information from [Kawai and 
Akira, 2010; Matsumoto et al., 2011; Cervantes et al., 2012; Lee et al., 2014]), the PAMP recognized by each receptor (information from 
[Moresco et al., 2011; Cervantes et al., 2012]), the pathogen recognized by each receptor (information from [Moresco et al., 2011; Cervantes et 
al., 2012; Lee et al., 2014]), and any additional molecular ligands of the receptor (reviewed in [Moresco et al., 2011]).  
Receptor(s) Dimer Type Cellular Localization PAMP Pathogen(s) Detected Additional Ligands
TLR2/TLR1 Heterodimeric Cell Surface Lipopeptides Gram-positive bacteria and Fungi
TLR2/TLR6 Heterodimeric Cell Surface Lipopeptides Gram-positive bacteria and Fungi
TLR3 Homodimeric
Cell Surface & Intracellular 
(Endosome)
dsRNA Viruses poly I:C 
TLR4 Homodimeric Cell Surface LPS Gram-negative bacteria
TLR5 Homodimeric Cell Surface Flagellin Bacterial flagellum
TLR7 Homodimeric Intracellular (Endosome) ssRNA Viruses Resiquimod, Imiquimod, and Loxoribine
TLR8 Homodimeric Intracellular (Endosome) ssRNA Viruses & Bacteria 
TLR9 Homodimeric Intracellular (Endosome)
Unmethylated 
DNA
Bacteria CpG-oligodeoxynucleotides (CpG-ODNs)
TLR10 Homodimeric Intracellular Unknown Virus (influenza)
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Figure 1.1: Pathway map of the TLR signaling pathway 
 
Simplified pathway map of the TLR signaling pathway (adapted from the KEGG 
pathway map of the TLR signaling pathway [Kanehisa and Goto, 2000]). 
Proteins are depicted as white boxes and interactions as arrows; dashed arrows 
indicate that some interactions are not shown for legibility. The PAMPs detected 
by each TLR receptor are shown to the left of their respective receptor (obtained 
from [Moresco et al., 2011; Cervantes et al., 2012]). The pathway is divided into 
two distinct pathways: the MyD88-dependent pathway and the MyD88-
independent pathway. For example, Lipopolysaccharides (LPS) activate TLR4. 
Activated TLR4 subsequently activates: i) a complex of MyD88 and TIRAP 
(toll-interleukin 1 receptor domain containing adaptor protein) to activate the 
MyD88-dependent pathway (resulting in activation of NF-κB and IRF5) and ii) 
TRIF activates the MyD88-independent pathway (results in activation of IRF3 
and IRF7). See table of abbreviations for the name of each protein shown above.  
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1.1.3.2 Vertebrate TLR repertoires 
Drosophila Toll was the first member of the TLRs to be described and it was 
found to function in embryonic dorsoventral regulation rather than immunity. 
Later it was discovered that in the presence of the pathogen-recognition adaptor 
gene, spätzle, a potent antifungal immune response was observed [Lemaitre et 
al., 1996].  
 
Comparative studies of vertebrate TLRs have found that both the recognition of 
and response to PAMPs has remained conserved [Roach et al., 2005]. Indeed, 
evidence of functional conservation has been reported in zebrafish [Purcell et al., 
2006], highlighting the ancient and conserved function of TLRs throughout 
nearly 400 million years of vertebrate evolution [Hedges et al., 2006].  
 
In addition to this functional conservation, vertebrates exhibit numerous 
instances of clade and/or species-specific TLR family expansion/contraction. For 
example, Zebrafish encode 17 putative TLR variants, including orthologs for 
mammalian TLR2-5 and 7-9, the remaining proteins represents divergences of 
the zebrafish TLR repertoire. For example, zebrafish TLR1 and 18 are the only 
TLR homologs reported for the mammalian TLR cluster of TLR1, 6, and 10. The 
zebrafish repertoire also includes multiple duplicated TLRs (4, 5, 8, and 20) and 
a cluster of fish specific TLRs (19, 20a/b, 21, and 22) [Jault et al., 2004; Meijer 
et al., 2004]. Similar studies in chicken have revealed the presence of 10 TLRs, 
with orthologs to mammalian TLR2, 3, 4, 5, and 7 [Alcaide and Edwards, 2011]. 
Chickens encode two lineage-specific duplications, TLR2A/2B and TLR1A/1B, 
TLR2A and 2B are homologous to mammalian TLR2, however, TLR1A and 1B 
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are unique to birds. Of the remaining chicken TLRs, TLR15 is unique to birds 
and TLR21 is orthologous to zebrafish TLR21. The significance of TLR 
repertoire divergences is the potential establishment of species/clade-specific 
innate immunity such as the zebrafish-specific TLR4a/b duplicates that are 
functionally divergent to mammalian TLR4 [Sullivan et al., 2009].  
 
The Mouse genome encodes thirteen TLRs, twelve of which are functionally 
expressed: TLR1-9 and 11-13, with TLR1-9 having direct orthologs in human 
[Roach et al., 2005]. Mouse TLR11-13 do not have any human homologs, rather 
they share common ancestry with TLR21 of fish and birds. Mouse TLR10, is 
nonfunctional due to a species-specific retroviral insertion [Hasan et al., 2005].  
 
Phylogenetic reconstruction places several of the TLRs into two clusters: the 
endocellular TLR cluster (7, 8, and 9) and the heterodimeric TLR cluster (1, 2, 6, 
and 10) [Roach et al., 2005]. An additional TLR cluster (TLR11) has been 
documented but lacks a functional human homolog due to the pseudogenization 
of human TLR11 [Roach et al., 2005; Zhang et al., 2004]. Considering the 
prevalent nature of divergent TLR repertoires combined with an affinity for 
functional divergence the TLRs represent an excellent case study for those 
interested in molecular mechanisms of protein evolution. 
 
1.1.3.3 The complement system 
The complement system is a network of proteins involved in host defense and 
inflammation [Sarma and Ward, 2011]. Activation of the complement system is 
known to occur through three distinct pathways: the alternative, classical, and 
10 
lectin pathways (Figure 1.2) [Kanehisa and Goto, 2000]. The alternative pathway 
is triggered by C3b (a complex of C3 [complement component 3] and Factor B) 
binding to carbohydrates, lipids, and proteins found the surface of a variety of 
pathogens [Sarma and Ward, 2011]. The classical pathway responds to IgG- and 
IgM-containing antigen-antibody complexes via the C1 complex (C1q 
[complement component 1, q subcomponent], C1r [complement component 1, r 
subcomponent], and C1s [complement component 1, s subcomponent]) binding 
to the Fc portion of IgG and IgM [Sarma and Ward, 2011]. The lectin pathway 
activates the complement system via mannose-binding lectin (MBL) or Ficolin 
binding to the surface of pathogens [Sarma and Ward, 2011]. Each pathway 
results in the formation of the membrane attack complex (MAC) on the cellular 
surface of the pathogen. The MAC acts as a stable transmembrane pore that leads 
to lysis of the pathogen [Ehrnthaller et al., 2011]. The complement system is also 
known to induce opsonization, inflammation, and phagocyte migration, and also 
to activate the adaptive immune system [Ehrnthaller et al., 2011].  
 
1.1.4 Discordant innate immune responses 
On March 13
th
 2006, six healthy volunteers were administered TGN1412, an 
immunomodulatory drug developed by TeGenero Immuno Therapeutics for 
combating autoimmune diseases and leukaemia [Suntharalingam et al., 2006]. 
Within the next two hours, all six volunteers began to exhibit severe symptoms 
(e.g. nausea, vomiting, drop in blood pressure, etc.) and eventually multiple 
organ failure [Suntharalingam et al., 2006]. While all volunteers survived the 
ordeal, an investigation was launched to determine how the potential lethality of  
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Figure 1.2: Pathway map of the complement system  
 
Simplified pathway map of the complement system (or cascade) (adapted from 
the KEGG pathway map of the complement system [Kanehisa and Goto, 2000]). 
Proteins are depicted as white boxes and interactions as arrows; dashed arrows 
indicate that some interactions are not shown for legibility. The PAMPs detected 
by each TLR receptor are shown to the left of their respective receptor (obtained 
from [Sarma and Ward, 2011]). The pathway is divided into three distinct 
pathways: the alternative pathway, lectin pathway, and classical pathway. Each 
pathway results in activation of the membrane attack complex (MAC). For 
example, the C1 (complement component 1) complex activates the classical 
pathway in response to IgG- and IgM-containing antigen-antibody complexes. 
The activated C1 complex then leads to the activation of the MAC to combat the 
pathogen. See table of abbreviations for the name of each protein shown above. 
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TGN1412 had gone unnoticed [Attarwala, 2010]. Investigation of TGN1412 
found the drug to be superagonist that led to a rapid release of proinflammatory 
cytokines or a “cytokine storm” in human patients [Suntharalingam et al., 2006; 
Stebbings et al., 2007]. Animal trials had been completed prior to clinical trial in 
cynomolgus monkeys (crab-eating macaque) and there had been no evidence of 
superagonism or cytokine storm. It was concluded that the white blood cells of 
cynomolgus monkeys were unable to properly mimic TGN1412 response in 
humans [Stebbings et al., 2007]. 
 
TGN1412 presents a worst-case scenario for model organism discordance - a 
biological response in the model organism that does not mimic human [Mestas 
and Hughes, 2004]. Traditionally, researchers respond to discordance by 
selecting more suitable model organisms [Davis, 2008]. While such solutions 
may be required for expediting research, they ignore the underlying molecular 
cause. Only by understanding discordance will we truly understand the biology 
of model organisms.  
 
1.1.4.1 Discordance reported in TRIM5α 
TRIM5α represents one of the most prominent and frequently cited instances of 
model discordance in the innate immune system [Stremlau et al., 2004]. Initially 
characterized as conferring resistance to human immunodeficiency virus-1 (HIV-
1) in rhesus macaque, TRIM5α belongs to the TRIM family of proteins, a group 
of RING proteins containing the ubiquitin-protein isopeptide ligase RBCC motif 
[Stremlau et al., 2004; Short and Cox, 2006]. Restriction of HIV-1 by TRIM5α 
in rhesus macaque is dependent on the SPRY domain, which is capable of 
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recognizing the HIV-1 capsid protein [Sawyer et al., 2005; Stremlau et al., 2005; 
Yap et al., 2005; Pertel et al., 2011]. A comparative analysis identified two 
possible causative polymorphisms for the discordant phenotype between human 
(susceptible) and macaque (resistant), a single polymorphic residue P332R and a 
variable region of eight rhesus macaque and six human residues at position 335. 
Replacing either human variant with the rhesus macaque equivalent sequence 
conferred resistance to HIV-1 in human [Sawyer et al., 2005; Stremlau et al., 
2005; Yap et al., 2005]. 
 
1.1.4.2 Discordance reported in the Toll-like Receptors 
Since discovery of the first human TLR in 1997 [Medzhitov et al., 1997], the 
scientific literature has reported a large number of studies in which non-human 
TLRs produced unexpected phenotypic responses. Concern over these reports 
has spawned a number of review articles on the subject of unique phenotypes 
[Rehli, 2002; Mestas and Hughes, 2004; Werling, 2009]. Beyond differences in 
TLR repertoires, discordant responses have been reported in TLR2, TLR3, 
TLR4, TLR5, TLR8, and TLR9. The discordant responses of TLR5 and TLR9 
are minimal and are mostly attributed to flagellin and CpG-ODNs sequence 
prefereces respectively [Bauer et al., 2001; Rankin et al., 2001; Pontarollo et al., 
2002; Andersen-Nissen et al., 2007; Keestra et al., 2008]. Phenotypic 
discordance between human and mouse for TLR2 (as a heterodimer) is attributed 
to the unique ability of mouse TLR2 to respond to tri-lauroylated lipopeptide 
(Lau3CSK4) [Yamamoto et al., 2002; Grabiec et al., 2004]. These are the more 
mild phenotypic discordances reported, however those involving TLR8, TLR4, 
and TLR3 are more signifcant. 
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Human TLR8, but not mouse TLR8, has been reported as capable of conferring 
NF-B activation in response to RNA ligands, imidazoquinoline resiquimod 
(R848), and the immunostimulant derivatives CLO95 (imidazoquinoline 
resiquimod) and CL075 (thiazoloquinolone) in the absence of polyT-ODN [Jurk 
et al., 2002; Forsbach et al., 2008; Liu et al., 2010]. Such findings led to the 
conclusion that TLR8 was non-functional in mouse [Cervantes et al., 2012]. 
Subsequent sequence comparisons and deletion experiments identified two 
potentially causative motifs, RQSYA and PGIQ, both of which were missing in 
rodents [Liu et al., 2010]. Reports suggest that activation of mouse TLR8 by 
CL075 is possible, but requires the addition of polyT-ODNs to confer activation 
[Liu et al., 2010].  
 
TLR4 is responsible for recognition of LPS from gram-negative bacteria and was 
one of the first TLRs to be characterized in vertebrates [Medzhitov et al., 1997; 
Moresco et al., 2011]. Subsequent research identified that TLR4 is required to 
associate with the protein MD2 to recognize the hydrophobic domain of LPS (i.e. 
Lipid A) [Shimazu et al., 1999; Raetz and Whitfield, 2002]. Various LPS 
molecules have been reported to elicit discordant immune responses, a small 
number of examples are detailed here for illustrative purposes. Lipid IVA (a 
synthetic Lipid A precursor) and LpxL1 LPS of Neisseria meningitides are able 
to induce an innate immune response in mouse but not human TLR4/MD2. The 
cause of Lipid IVA discordance was determined to be mutations in both TLR4 
and MD2, whereas LpxL1 discordance was dependent on TLR4 mutations alone 
[Steeghs et al., 2008; Meng et al., 2010]. The LPS molecules of msbB (mutated 
msbB E. coli [Somerville et al., 1996]) and Porphyromonas gingivalis are also 
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documented to elicit species-specific discordance, both LPS molecules 
antagonize normal LPS based TLR4/MD2 induction in humans whereas they 
induce an immune response in mouse TLR4/MD2 [Coats et al., 2007]. Human 
TLR4 but not mouse TLR4 produces an immune response upon recognizing 
nickel (Ni
2+
), resulting in human-specific contact hypersensitivity (CHS). This 
discordant response to nickel was subsequently attributed to the histidine 
residues H456 and H458 in human TLR4 [Schmidt et al., 2010]. 
 
TLR3 is documented to localize to the cellular surface and endosomal 
compartments and is responsible for recognizing the double-stranded RNA 
(dsRNA) of viruses [Alexopoulou et al., 2001; Matsumoto et al., 2003]. 
Recognition of the immunostimulant poly(I:C) has been reported to elicit a 
discordant response, albeit minor. Mouse macrophages but not human 
macrophages have been documented to induce TNF and activate NFB and 
IRF-3 in response to poly(I:C) [Fortier et al., 2004; Lundberg et al., 2007]. 
Beyond poly(I:C) discordance, human TLR3 has been reported to exhibit a 
restricted anti-viral role in resisting herpes simplex virus encephalitis, whereas 
mouse TLR3 exhibits broad functionality [Ariffin and Sweet, 2013]. 
 
1.1.4.3 Variations reported in inflammation 
Inflammation is a critical response triggered by the innate immune system upon 
infection. The suitability of mouse as a model of inflammation has recently been 
questioned [Seok et al., 2013]. In the study by Seok et al. the gene expression 
profiles for inflammatory responses due to trauma, burns, and endotoxemia were 
compared between human and mouse. The results showed little correlation 
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between the species in terms of gene expression profiles for the same condition 
[Seok et al., 2013]. They also found no correlation in expression at the pathway 
level [Seok et al., 2013]. These findings have since been contested. Using the 
same dataset a strong correlation was found between the inflammation gene 
expression profiles of human and mouse [Takao and Miyakawa, 2014]. The 
discrepancy between these reports can be attributed to different standards for 
data inclusion in the correlation analysis [Takao and Miyakawa, 2014]. At 
present, the validity of both reports is under question and it has been suggested 
that an additional study is warranted [Leslie, 2014].  
 
1.1.5 Understanding and predicting model species discordance 
The various examples presented in Section 1.1.4 highlight a problem often 
neglected by biologists; model organisms occasionally are unable to mimic 
human biology. The remainder of the introduction reviews two distinct 
evolutionary methodologies with the potential to identify and predict the genetic 
causes of species discordance. Section 1.2 reviews the application of selective 
pressure analysis to infer potential functional discordance from protein coding 
genes under positive selection. Section 1.3 reviews the application of network 
theory to identify introgressive (non-vertical inheritance) that may attribute to 
functional discordance.  
 
  
17 
1.2 Natural Selection and Molecular Evolution 
1.2.1 Evolutionary theory 
The theory of natural selection was first proposed as the gradual process by 
which the traits of a population change in frequency depending on their impact 
on reproductive success [Darwin, 1859]. In the modern era, the study of 
molecular evolution has sought to understand the process of evolution (including 
natural selection) from the sequences of organisms and this has shown that 
saltational events also occur. While the relative roles for genetic drift and 
selection have been debated in molecular evolutionary biology [Lynch, 2007; 
Hahn, 2008], the modern synthesis is well developed to describe the processes 
and patterns we observe in molecular sequence data. 
 
1.2.2 Neutral theory 
The neutral theory of evolution postulates that the majority of molecular 
variations observed within a genome are caused by random genetic drift of 
neutral alleles rather than natural selection [Kimura, 1968]. Neutral alleles are 
defined as variation that has no fitness effect on the organism and were believed 
to be responsible for the vast majority of variation within populations and 
between species [Kimura, 1968]. Early adoption of the neutral theory was aided 
by studies demonstrating the highly polymorphic nature of DNA within 
populations and between species, evidence that could not be explained by 
adaptive evolution alone [Zuckerkandl and Pauling, 1965; Harris, 1966; 
Lewontin and Hubby, 1966]. The theory was later expanded upon by the 
inclusion of nearly neutral mutations, accounting for slightly advantageous or 
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deleterious mutations that may become fixed within a population due to random 
genetic drift [Ohta, 1973; Ohta and Gillespie, 1996].  
 
The probability of neutral or nearly neutral mutations becoming fixed within a 
diploid population with an effective population size 𝑁𝑒  due to random genetic 
drift is shown in the following equation (Equation 1.1).  
 
Equation 1.1: Probability of fixed of neutral mutations within a population. 
𝑃𝑥 =  
1
2𝑁𝑒
 
 
As the equation states, the probability of neutral or nearly neutral mutations 
becoming fixed within a population increases with smaller 𝑁𝑒 [Kimura, 1968].  
 
1.2.3    Natural Selection 
Natural selection was postulated by Darwin to influence the frequency of 
particular phenotypes within a population depending on their impact on 
reproductive success [Darwin, 1859]. From a modern molecular standpoint, 
natural selection may be subdivided into distinct categories: i) positive selection, 
whereby an advantageous spontaneous mutation increases in frequency within a 
population and ii) purifying selection, whereby a deleterious mutation decreases 
in frequency. In the absence of selection, frequency is dependent on neutral 
evolution and therefore dependent on random genetic drift (and of course Ne).  
 
By comparing homologous sequences across populations or species (See Section 
1.2.4 for details) it is possible to determine the selective pressures that have acted 
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upon individual protein coding genes (Section 1.3 the section on how this is 
done). In general, it is presumed that the majority of the sequence within protein 
coding genes is evolving under purifying selection due to functional constraints 
[Hughes, 1999; Peterson et al., 2009]. Nonetheless, studies have identified high 
levels of positive selection among the protein coding genes of Drosophila [Smith 
and Eyre-Walker, 2002; Begun et al., 2007], E. coli [Charlesworth and Eyre-
Walker, 2006], and mammals [Kosiol et al., 2009]. These findings have 
prompted some to state that the nearly neutral theory may not be an appropriate 
description of molecular evolution and that an adaptationist regime may be a 
more appropriate explanation [Hahn, 2008]. 
 
1.2.4 Positive selection and functional shift 
Population geneticists traditionally define positive selection as a type of natural 
selection in which a spontaneous mutation that confers an advantage increases in 
frequency within the population [Sabeti et al., 2006]. In comparison to harmful 
or neutral spontaneous mutations, positive selection is defined by an increase in 
the fixation rate of an advantageous allele [Sabeti et al., 2006]. Selection (and 
possible fixation) of the advantageous allele is documented to confer a 
hitchhiking effect, whereby neutral, nearly neutral, and deleterious alleles linked 
to the advantageous allele also increase in frequency [Smith and Haigh, 1974; 
Chun and Fay, 2011]. Depending on the strength of selection event, hitchhiking 
may lead to a notable reduction in variation in the region surrounding the 
advantageous allele termed a selective sweep (Figure 1.3) [Andolfatto, 2001]. 
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Figure 1.3: Schematic for impact of selective sweep at the population level 
 
In this simplified scenario, variation in the population of size 6 is shown in blue and advantageous alleles in red. Prior to the selective sweep of 
an advantageous allele, the population will exhibit a number of neutral alleles (blue) surrounding the locus of the advantageous allele (red) – 
leftmost panel. After the positive selection and fixation of the advantageous allele in red, a hitchhiking effect will be observed whereby the 
linked neutral alleles in blue also increase in frequency (i.e. a decrease in variation in the region surrounding the advantageous allele) – central 
panel. Loss of evidence of the selective sweep will eventually occur due to the occurrence of spontaneous mutations (i.e. slow return of genetic 
diversity) – rightmost panel. 
Before selection
After selection
“Selective Sweep” Loss of evidence
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The various methods developed to determine selective pressure from molecular 
signatures are described in Section 1.3. Genetic diversity will slowly return to the 
region due to the occurrence of spontaneous mutations and eventually eliminate 
the molecular signatures of the selective sweep (this is within approximately 
250,000 years for humans) [Sabeti et al., 2006]. 
 
From the perspective of species-level comparisons, positive selection is often 
defined as the molecular signature of species adapting to their environment and 
for that reason has been hypothesized to be a marker of functional discordance 
between species [Tennessen, 2008]. The primary method for detecting positive 
selection between species is calculating the ratio of replacement non-
synonymous substitutions per non-synonymous site (Dn) over synonymous 
substitutions per synonymous site (Ds) [Hurst, 2002]. This ratio of Dn/Ds, 
termed omega () throughout the thesis has three potential outcomes: i) an  > 1 
is indicative of positive selection, ii)  = 1 is indicative of neutral evolution, and 
iii)  < 1 is indicative of purifying selection (Figure 1.4). 
 
Concerns have been raised over attempts to associate positive selection with 
functional discordance [Hughes, 2007; Yokoyama, 2008]. It is now widely held 
that positive selection requires in-vitro confirmation by the reconstruction and 
rational mutagenesis of ancestral proteins [Yokoyama, 2013]. For more details 
on in-vitro confirmation by ancestral reconstruction see Section 1.4.4. More 
recent studies focusing on the link between positive selection and phenotypic 
discordance have met with some success.  
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Figure 1.4: A schematic for how to measure selective pressure variation 
 
The simplified example above shows two outcomes of mutating the fourth codon 
(CTC or leucine) in a protein. A synonymous substitution (shown in green) 
mutates the codon CTC to CTG but has no observable protein alteration. A non-
synonymous substitution mutates CTC to CCC (shown in red) and results in the 
substitution of leucine for proline, and this mutation results in an altered 
conformation (illustrated as a “kink”). The consequence of the observed kink 
may be separated into three outcomes: neutral (i.e. no fitness effect), deleterious, 
or advantageous. If neutral, the non-synonymous “kink” (in addition to other 
neutral non-synonymous substitutions) would be fixed within a species at the 
same frequency as the synonymous substitutions – as the likelihood of fixation is 
the same for both the neutral non-synonymous and synonymous mutations – and 
would result in ω = 1 (i.e. the gene is evolving neutrally) [Hurst, 2002]. If 
deleterious, the non-synonymous “kink” (in addition to other deleterious non-
synonymous substitutions) would be eliminated, resulting in a higher frequency 
of synonymous substitutions becoming fixed and therefore ω < 1 (i.e. the gene is 
under purifying selection) [Hurst, 2002]. If advantageous, the non-synonymous 
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“kink” (in addition to other advantageous non-synonymous substitutions) would 
be fixed more frequently than synonymous substitutions, thus resulting ω > 1 
(i.e. the gene is under positive selection) [Hurst, 2002]. It should be noted that 
the omega (ω) measurement is not without fault. For example, if a specific region 
of a protein is under positive selection whereas another region is under purifying 
selection, ω may incorrectly indicate the protein is evolving neutrally [Hurst, 
2002]. In addition, the measurement does not account for the infrequency of 
transversions in comparison to transitions and therefore results in unrealistic Ds 
and Dn values [Yang and Bielawski, 2000]. 
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A frequently cited species comparison  of TRIM5α, a HIV-1 restriction factor in 
old world monkeys [Stremlau et al., 2004], used positive selection to identify an 
11- to 13-amino acid segment of the SPRY domain responsible for species-
specific retroviral restriction [Sawyer et al., 2005]. And a rational mutagenesis 
approach by Loughran et al found that three positively selected residues (N496, 
Y500, and L504) in the mammal myeloperoxidase protein were responsible for 
the evolution of this dual functioning enzyme capable of both peroxidation and 
chlorination activity [Loughran et al., 2012]. Other recent studies have also 
shown a clear relationship between positive selection and functional discordance 
[Moury and Simon, 2011; Farhat et al., 2013].  
 
1.2.5 The relationship between orthologs, paralogs, and function 
Homologs are genes that share common ancestry and are traditionally classified 
by their origin, orthologs by speciation events and paralogs by gene duplication 
[Fitch, 1970]. More recently, discussion centered around the long held 
assumptions of the ortholog conjecture, i.e. that orthologs are more conserved 
than paralogs in terms of sequence and function [Dessimoz et al., 2012]. 
Questions about how orthologs should be defined were raised, for example, 
should it be by sequence similarly [Gabaldón et al., 2009], domain architecture 
[Forslund et al., 2011], intron structure [Henricson et al., 2010], protein structure 
[Peterson et al., 2009], or expression patterns [Huerta-Cepas et al., 2011]. The 
debate was further complicated by research that found functional annotations 
more often correlate with paralogs than orthologs, thereby directly challenging 
the assumptions of the ortholog conjecture [Nehrt et al., 2011]. Subsequent 
studies found that the reported functional correlation of paralogs was primarily 
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due to biases introduced by the use of computationally annotated Gene Ontology 
(GO) terms and they report that the corrected correlations supported the ortholog 
conjecture [Altenhoff et al., 2012]. The debate on the most appropriate 
framework to define orthologs continues [Haggerty et al., 2014]. 
 
If the ortholog conjecture holds true, paralogs are expected to exhibit greater 
functional divergence [Dessimoz et al., 2012]. Gene duplication is the biological 
mechanism that generates paralogs and is hypothesized to provide an opportunity 
for functional divergence to occur. Gene duplication events, are predicted to 
frequently result in one of the duplicates becoming pseudogenized by 
degenerative mutations [Ohno et al., 1970]. However, both duplicates may 
become preserved by either beneficial mutations that generate a novel function 
(neofunctionalization) or mutations that necessitate the fixation of both 
duplicates  (subfunctionalization) [Force et al., 1999; Ohno et al., 1970].  
 
In subfunctionalization, duplicates become fixed within a population if partial 
functional loss necessitates functional complementation of the daughter genes to 
maintain parental function [Zhang, 2003]. A recent example of 
subfunctionalization was reported in the H3-H4 histone chaperones ASF1a and 
ASF1b [Abascal et al., 2013]. The duplication event that produced ASF1a and 
ASF1b was reported to have occurred in the ancestor of jawed vertebrates. The 
single ASF1 of Saccharomyces cerevisiae is reported to interact with HIRA and 
CAF-1 chaperones with equal affinity [Abascal et al., 2013]. After the 
duplication event, ASF1a and ASF1b became divergent in their gene expression 
profiles and positive selection acted on both paralogs (C-terminal of ASF1b and 
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N-terminal of both paralogs). Considering these hallmarks of functional 
divergence, it may not be surprising that ASF1a and ASF1b exhibit preferential 
interaction affinities, ASF1a with HIRA and ASF1b with CAF-1 [Abascal et al., 
2013].  
 
In neofunctionalization, a mutation that confers a novel function may cause both 
duplicates to become fixed by positive selection or genetic drift [Conant and 
Wolfe, 2008], such as in the human SRGAP2 genes [Dennis et al., 2012]. 
SRGAP2 is a neuronal migration gene that is highly conserved in mammal 
evolution. Multiple “Homo”-specific gene duplication events led to three 
duplicates of SRGAP2A (SRGAP2B-D) in humans. These duplications had not 
been previously sequenced or characterized due to a misassembled SRGAP2. 
Subsequent analysis supported that only SRGAP2A and SRGAP2C were likely 
functional and that the incomplete duplication that created SRGAP2C had 
created a novel antagonism mechanism of parental SRGAP2A [Dennis et al., 
2012]. 
 
1.3 Methods for assessing selective pressure variation  
1.3.1 Distance-based methods  
One of the earliest approaches for assessing selective pressure variation across 
sites was developed by Li et al., (1985). The method classified nucleotide 
positions in coding regions into four categories: non-degenerate sites are 
classified as non-synonymous (any mutation results in replacement of the amino 
acid), fourfold degenerate sites are classified as synonymous (all mutations are 
silent i.e. do not change the amino acid), twofold degenerate sites are classified 
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as synonymous for transitions, and twofold degenerate sites are classified as non-
synonymous for transversions. The issue with this method is that the twofold 
degenerate category overestimates synonymous counts due to the infrequency of 
transversions in comparison to transitions and later refinements were made to 
improve the efficiency in this regard [Li, 1993]. This approach to assessing 
selective pressure has been found to be unsatisfactory as it lacks power to detect 
positive selection if only a few sites are under selection [Pond and Frost, 2005; 
Murray, 2011]. Distance-based sliding window approaches were later developed 
so that selective pressures across coding sequences could be classified along the 
length of the sequence [Comeron, 1999; Creevey and McInerney, 2003; Fares, 
2004; Liang, 2006]. Sliding window based approaches have since been shown to 
have undesirable characteristics including the estimation of artifactual trends of 
synonymous and nonsynonymous rate variation and not correcting for multiple 
testing [Schmid and Yang, 2008].  
 
1.3.2 Phylogeny-based methods 
In comparison to the distance-based methods, phylogeny-based methods enable 
the assessment of selective pressure variation across lineages as well as sites 
[Creevey and McInerney, 2002; Yang, 2002]. The Creevey-McInerney method 
uses the G-test to test the hypothesis that sequences are evolving neutrally when 
the ratio of silent invariable (SI) sites to silent variable (SV) sites is equal to the 
ratio of replacement invariable (RI) sites to replacement variable (RV) sites 
[Creevey and McInerney, 2002]. Significant deviations indicate a departure from 
neutrality. The method implements a rooted phylogeny (that is assumed to be 
correct) to reconstruct the ancestral sequences at each internal node using a 
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maximum parsimony approach [Hennig, 1966; Creevey and McInerney, 2002]. 
The reconstructed phylogeny is then used to identify all substitutions that 
occurred across the tree and determine whether they resulted in a non-
synonymous (replacement) or synonymous (silent) codon change. Significantly 
high rates – reported by the G-test – of RI are indicative of directional selection 
whereas significantly high rates of RV are indicative of non-directional selection 
[Creevey and McInerney, 2002]. The Creevey-McInerney method is effective for 
detecting selective pressure variation across lineages, but cannot identify sites 
under lineage-specific positive selection [Creevey and McInerney, 2002].  
 
1.3.2.1 Maximum likelihood methods 
Maximum likelihood (ML) methods use models of evolution to determine the 
likelihood of observing the experimental data given the characteristics of the 
specified model. A variety of methods have been developed to identify selective 
pressure variation under a maximum likelihood framework (in addition to 
methods using a Bayesian framework not specified for brevity) [Massingham 
and Goldman, 2005; Pond et al., 2005; Yang, 2007]. The sitewise likelihood-
ratio (SLR) test was an approach primarily designed to detect evidence of non-
neutral evolution and estimate the likelihood of each site under being under 
either purifying of positive selection [Massingham and Goldman, 2005]. The 
program HyPhy carries out a variety of likelihood-based analyses, including the 
assessment of selective pressures acting on sites and lineages combined [Pond et 
al., 2005]. The codeML program from the PAML software package was 
designed to identify positive selection acting on specific sites within an 
alignment and positive selection unique to a specific foreground lineage [Yang, 
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2007]. The codeML program was selected for our analysis for three reasons: i) 
the method is highly developed and regularly updated, ii) the robustness of the 
most recent lineage-site models and their appropriate null models [Yang and dos 
Reis, 2011], and iii) low false discovery rate of the lineage-site models in the 
presence of GC content deviations and indels (see Section 1.4 for details) 
[Fletcher and Yang, 2010; Gharib and Robinson-Rechavi, 2013]. 
 
1.3.2.2 CodeML 
The codeML program from the PAML package implements a large number of 
codon substitution models developed to account for various substitution rate 
characteristics (i.e. Transition/transversion rate bias and codon usage bias) 
between the various amino acids, and also to estimate the Dn/Ds ratio (ω) 
[Goldman and Yang, 1994; Yang, 2007]. Codon substitution models have been 
developed that account for heterogeneous selective pressure at codon sites and 
that allow for ω to be estimated for a lineage or subset of lineages (referred to in 
the codeML literature as “foreground lineages”) on the phylogeny [Yang et al., 
2000; Yang and Nielsen, 2002; Zhang et al., 2005]. 
 
As the primary aims in chapters 2 and 3 of this thesis is the identification of 
species-specific positive selection, only the relevant codon substitution models 
will be discussed. The codon-based models of evolution implemented by 
codeML are nested likelihood models, indicating that models differ in 
complexity by the addition of free parameters (Figure 1.5). The M1a model is a 
nearly-neutral model where the ω values are permitted to be below neutrality (ω0 
< 1), and p0 is the proportion of sites that have that value. The remaining 
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proportion of sites (p1 = 1 - p0) is expected to be evolving neutrality (ω1 = 1). The 
branch-site (also known as the lineage-specific) model used in the analyses in 
Chapters 2 and 3 is the updated model A [Zhang et al., 2005]. Previous versions 
of model A were found to have an unacceptably high rates of false positives (19-
54%) when there was a relaxation of purifying selection in the foreground 
[Zhang, 2004; Zhang et al., 2005]. The modified branch-site model A (hereafter 
referred to as model A) has four free parameters. Three of these parameters are 
the same for foreground and background lineages, p0  = the proportion of sites 
with the estimated ω below neutrality (0 < ω0 < 1), and p1 = the proportion of sites 
evolving neutrality (ω1 = 1). The fourth and final free parameter in model A is ω2 
which is the estimated ω in the foreground lineage alone (ω2 is free to be > 1). 
The proportion of sites for ω2 is broken into two site categories: p2a whereby 
foreground sites are evolving with ω2 > 1 and background sites are evolving with 
ω0 between 0 and 1, and p2b whereby foreground sites are evolving with ω2 > 1 
and background sites are evolving with a ω1 = 1. The null hypothesis of model A 
has three free parameters and is referred to throughout as model A null where ω2 
= 1. Model A null allows sites in the background to be evolving neutrally (ω1 = 
1) or under purifying selection (0 < ω0 < 1), Figure 1.5. The ML implementation 
of these models could report results from a local minimum on the likelihood 
plain, for this reason codeML analyses conducted in this thesis used multiple 
starting omega values (0, 1, 2, 10) as in previous publications to increase the 
likelihood of finding and reporting estimates from the global minimum [Yang, 
1997; Yang et al., 1998; Loughran et al., 2008; Morgan et al., 2010]. 
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The likelihood ratio test (LRT) is used to determine the significance of parameter 
rich models by a comparison to alterative less parameter rich models [Nielsen 
and Yang, 1998; Yang et al., 2000]. The LRT is defined as the difference 
between the log-likelihood (lnL) values of the two models (Δl) multiplied by 
two, and follows a chi-squared (χ2) distribution [Nielsen and Yang, 1998]. The 
degrees of freedom (d.f.) between the two models is then used to determine the 
χ2 critical value for significance. If 2Δl is larger than the χ2 critical value then the 
parameter rich model is found to be significant as in Figure 1.5. If a codon 
substitution model is found to be significant by the LRT, the posterior 
probability of a specific codon being under positive selection is calculated by 
applying an Empirical Bayes estimate to ω for each codon. By default codeML 
uses two Empirical Bayes methods: i) Naïve Empirical Bayes (NEB) [Yang et 
al., 1998] and ii) Bayes Empirical Bayes (BEB) [Yang et al., 2005]. When 
possible, the BEB values were used in the analyses conducted in this thesis as 
they have been reported to be more statistically robust then NEB values 
particularly for smaller datasets [Anisimova et al., 2002; Yang et al., 2005]. 
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Figure 1.5: Codon based models of substitution used in the analyses 
 
(a) The three nested likelihood models required for detecting species-specific 
positive selection. The parameters for each model are specified within their 
respective grey boxes, fixed parameters are shown in black whereas free 
parameters are shown in orange (please note that for branch-site model A ω2 is a 
single free parameter). The parameters for branch-site model A and model A null 
are shown for both the foreground in red (S1) and background in black (S2, S3, 
and S4) of the given phylogeny. The free parameters for the nested likelihood 
models are as follows: Model A with 4 (P0, P1, ω0, and ω2), Model A null with 3 
(P0, P1, and ω0), and M1a with 2 (P0 and ω0). The number of free parameters of 
the nested likelihood models is then used to perform a likelihood ratio test 
(LRT). (b) The table shows the two comparisons required to determine the 
significance of Model A. The degrees of freedom (d.f.) of a comparison is 
determined from the difference in free parameters between the two models. For 
example, the comparison of M1a (Null) and Model A (alterative) diffeences in 2 
free parameters and therefore has a d.f. of 2. As the LRT follows a χ2 
distribution, the d.f. of the models is used to determine the χ2 critical value for the 
comparison. The χ2 critical values given in the table are for a p-value of 0.05. 
S1
S2
S3
S4
 p0 : ω0 < 1
 p1 : ω1 = 1
 p2a : ω2 > 1
 p2b : ω2 > 1
Foreground
 p0 : ω0 < 1
 p1 : ω1 = 1
 p2a : ω0 < 1
 p2b : ω1 = 1
Background
Model A: Branch-Site
 p0 : ω0 < 1  p1 : ω1 = 1
M1a: Nearly Neutral p0 : ω0 < 1
 p1 : ω1 = 1
 p2a : ω2 = 1
 p2b : ω2 = 1
Foreground
Model A null
 p0 : ω0 < 1
 p1 : ω1 = 1
 p2a : ω0 < 1
 p2b : ω1 = 1
Background
Comparison Null Model FP Alternative Model FP d.f. Critical !2 values
M1a vs. Model A M1a 2 Model A 4 2 > 5.99 (P = 0.05)
Model A null vs. Model A Model A null 3 Model A 4 1 > 3.84 (P = 0.05)
a.
b.
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1.3.2.3    Phylogenetic Reconstruction 
Phylogenetic trees describe relationships caused by linear descent and may be 
constructed from a variety of data types, including (but not limited to): 
morphological, microRNAs, mitochondrial, and nuclear coding sequences 
[Wiens, 2004; Pedersen et al., 2006; McCormack et al., 2012; Morgan et al., 
2013; Morgan et al., 2014; Yang and Rannala, 2012]. The most common modern 
methods for phylogeny reconstruction include Bayesian and ML approaches 
[Felsenstein, 1981; Yang and Rannala, 1997]. Both approaches use the likelihood 
function and therefore share many statistical properties [Yang and Rannala, 
2012]. However, there are major differences between these approaches: (i) ML 
approaches identify the most probable phylogeny whereas Bayesian approaches 
search for the most credible trees, and (ii) Bayesian implementations allow a 
prior hypothesis whereas ML cannot [Huelsenbeck et al., 2002; Yang and 
Rannala, 2012]. The results of Bayesian inference are also far easier to interpret, 
with the posterior probability being the support for a given node based on the 
data and specified model [Yang and Rannala, 2012]. 
 
Considering the focus of this thesis is to understand the mechanisms of protein 
evolution that underpin the formation of vertebrate proteins (namely positive 
selection and domain shuffling), phylogenetic trees are most suitable for 
detecting and explaining linear descent such as gene duplication and substitution 
processes over time such as adaptive evolution (Chapters 2 and 3). However, to 
capture gene remodeling by domain shuffling a network approach is required 
(Section 1.5 and Chapter 4).  
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1.3.4 Population-based methods 
1.3.4.1 McDonald–Kreitman test 
One of the earliest implementations of population level tests for selective 
pressure variation was the McDonald–Kreitman test [McDonald and Kreitman, 
1991]. The approach uses a simple phylogeny, the advantage of which is to 
provide the user with the ability to distinguish the amount of variation within a 
species (polymorphism) from the substitutions between species. The McDonald–
Kreitman test works by comparing the ratio of non-synonymous to synonymous 
polymorphisms within a species to the ratio of non-synonymous to synonymous 
fixed substitutions between species by means of a contingency table which is 
used to conduct a G-Test [McDonald and Kreitman, 1991]. Mutations under 
positive selection will fix within a population more rapidly than by random 
genetic drift alone [McDonald and Kreitman, 1991; Gillespie, 1998]. Adaptive 
evolution is therefore observed if the ratio of non-synonymous to synonymous 
polymorphisms within a population is lower than the ratio of non-synonymous to 
synonymous variation across species [McDonald and Kreitman, 1991]. It should 
be noted that the McDonald–Kreitman test requires population data from both 
species being compared and therefore due to a lack of mouse population data was 
not employed in this thesis, however other population level approaches are 
possible with the species we study and these are detailed below.  
 
1.3.4.2 Tajima’s D test statistic 
Tajima’s D test statistic is a population-based approach to determine if a 
nucleotide sequence in a population is evolving neutrally or evolving under a 
non-random process [Tajima, 1989]. Tajima’s D requires two values to be 
35 
calculated from a multiple sequence alignment of the population: the observed 
nucleotide diversity (π) and the expected heterozygosity (θ). The observed 
nucleotide diversity is the average number of pairwise nucleotide differences 
within the population. The expected heterozygosity of a population is calculated 
using the following equation (Equation 1.2).  
 
Equation 1.2: Expected heterozygosity of a population 
𝜃 =  
𝑆
∑
1
𝑖
𝑛−1
𝑖=1
 
 
where 𝑆 is the number of segregating sites, 𝑛 is the number of individuals, 𝑖 is 
the index of summation, and θ is the expected heterozygosity.  
 
In populations evolving neutrally, the observed and expected values should be 
equal and therefore return a Tajima’s D of approximately zero. If the population 
however is evolving under a non-random process, Tajima’s D may result in a 
positive value (higher observed to expected i.e. possibly balancing selection or 
population decrease) or it may result in a negative value (lower observed to 
expected i.e. possible selective sweep or population growth) [Simonsen et al., 
1995; Tajima, 1989].  
 
Tajima’s D has also been applied using sliding window approaches [Rogers et 
al., 2010]. In these approaches, Tajima’s D is calculated at regular intervals from 
segments of sequence in the genomic region surrounding a nucleotide sequence 
of interest, as each window is an independent test with no overlap it does not 
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have the multiple testing flaw of the distance-based sliding window methods 
[Schmid and Yang, 2008]. In comparison to only calculating Tajima’s D for a 
nucleotide sequence of interest, sliding windows enable the identification of 
significant departures from neutrality across the sequence [Rogers et al., 2010]. 
 
Tajima’s D is commonly tested for significance by obtaining a confidence 
interval for the true value of 𝜃 [Simonsen et al., 1995]. Obtaining a confidence 
interval is achieved by generating a large number of samples under a Wright-
Fisher neutral model of genetic variation [Simonsen et al., 1995]. One of the 
most commonly used approaches to generate a confidence interval is 
implemented in MS where the user supplies 𝜃, 𝑆, or 𝜃 and 𝑆  [Hudson, 2002].  
 
1.3.4.3 Fay and Wu’s H test statistic 
Fay and Wu’s H test statistic is a population-based approach often described as 
an improvement on Tajima’s D [Fay and Wu, 2000]. In comparison to Tajima’s 
D statistic, Fay and Wu’s H accounts for the presence of derived alleles (i.e. non-
ancestral alleles that arose by mutation) by determining the ancestral state of 
alleles on a phylogenetic tree. Derived alleles are typically expected to be present 
at lower frequencies than ancestral alleles [Watterson and Guess, 1977]. This 
expectation becomes violated in the presence of positive selection, resulting in 
the presence of high-frequency derived alleles [Hamblin et al., 2002]. In 
populations evolving neutrally, Fay and Wu’s H is expected to be approximately 
zero [Fay and Wu, 2000]. However, if the population is evolving under a non-
random process then Fay and Wu’s H may result in a positive value (i.e. few 
high-frequency derived alleles) or negative value (i.e. many high-frequency 
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derived alleles) [Fay and Wu, 2000]. Like Tajima’s D, Fay and Wu’s H is a 
statistical test and therefore resultant values must be tested for significance. This 
is achieved using a similar approach as described for Tajima’s D (Section 1.3.4). 
Tajima’s D and Fay and Wu’s test statistics are employed in Chapter 3 using 
human population genomic data from the 1000 human genomes project 
[Abecasis et al., 2012]. 
 
1.4 Data limitations in analyses of selective pressure variation 
Beyond the limitations of specific methods for measuring selective pressure 
variation, the data itself may have sequencing, assembly and/or alignment errors 
that can influence the estimates of parameters across sites and lineages 
[Schneider et al., 2009]. The use of high quality genomes and assemblies is 
highly recommended for selective pressure analysis (see Section 2.12). The 
following sections briefly detail some of the major sources of potential error in a 
selective pressure analysis.  
 
1.4.1 Alignment Error 
Alignment error is reported to cause unacceptably high rates of false positives 
when using model A in codeML [Fletcher and Yang, 2010]. This source of error 
is not from aligned insertions and deletions but rather from poorly aligned 
codons [Fletcher and Yang, 2010]. It is advisable therefore to use a variety of 
alignment methods for a given dataset and independently assess which is the best 
alignment for the data [Muller et al., 2010]. Programs such as MetAl  
[Blackburne and Whelan, 2012], AQUA (Automated quality improvement for 
multiple sequence alignments) [Muller et al., 2010], and NorMD (Normalized 
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Mean Distance) [Thompson et al., 2001] provide a way of comparing various 
alignment methods and selecting the most appropriate method for a given 
multiple sequence alignment (MSA). A combination of the methods MetAl and 
NorMD was implemented in Chapter 2. 
 
1.4.2 Non-adaptive evolutionary signals mistaken as positive selection 
Recombination is the process by which nucleotide sequences exchange genetic 
information and has been reported to produce new combinations of alleles 
[Posada and Crandall, 2001]. Recombination has also been documented to alter 
codon usage [Marais et al., 2001] in addition to affecting the accuracy of 
phylogenetic reconstruction [Posada and Crandall, 2002]. It has been reported 
that high levels of recombination may result in an unrealistic LRT analysis and 
therefore produce molecular signatures indistinguishable from those of positive 
selection [Anisimova et al., 2003]. Recombination has also been associated with 
GC-biased gene conversion (gBGC) [Katzman et al., 2011]. gBGC is a neutral 
process whereby GC content increases due to the DNA mismatch repair 
machinery favoring G:C pairs at recombination breakpoints [Galtier and Duret, 
2007]. gBGC has been reported to associate with false positives in selective 
pressure analyses, primarily due to the inflation of ω [Ratnakumar et al., 2010]. 
Studies have used GC and GC3 (wobble base) content to imply evidence of 
gBGC [Romiguier et al., 2013]. However, a recent report on the branch-site 
model used in this thesis (modelA) found that deviating GC frequencies have no 
significant effect on false positives [Gharib and Robinson-Rechavi, 2013]. 
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1.4.3 Purifying Selection acting on silent sites mistaken for positive 
selection 
Exonic splice enhancers (ESEs) are nucleotide sequence motifs that are reported 
to aid in pre-mRNA splicing and have been reported to be under purifying 
selection [Cáceres and Hurst, 2013; Parmley et al., 2006; Hurst and Pál, 2001]. 
ESEs are most likely enriched in regions of exonic sequence that are close to 
splice sites and they have been proposed as a potential driving force behind the 
observed reduced rates of synonymous and non-synonymous sites towards the 
ends of exons [Fairbrother et al., 2002; Parmley et al., 2006; Parmley et al., 
2007; Woolfe et al., 2010]. Therefore the presence of ESEs may cause an 
inflation of ω due to a reduction in Ds rather than an increase in Dn [Parmley et 
al., 2006]. Recently the net impact of ESEs has been conservatively estimated to 
result in a 4% reduction in Ds [Cáceres and Hurst, 2013]. While ESEs do present 
a potential source of false positives, many of the ESE datasets are reported to not 
reflect the known properties of ESEs (for example: enriched near exon 
boundaries, associated with weak splice sites, and enriched near longer introns) 
[Cáceres and Hurst, 2013]. In addition, it is currently unknown how ESEs (or the 
number of ESEs within a sequence) would alter the false-positive rate of the 
branch-site model. The presence of ESEs does warrant the exploration of 
proteins known to have ESEs to determine the effect the reported robustness of 
the branch-site model (modelA) [Gharib and Robinson-Rechavi, 2013; Yang and 
dos Reis, 2011] and determine how ESEs should be considered in future 
analyses. 
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1.4.4 In vitro validation of positive selection  
The traditional approach to site-directed mutagenesis mutates specific amino 
acids within modern day proteins. This simple approach is problematic for in-
vitro studies of positive selection because it does not account for epistatic 
interactions with other amino acids in the background, this can lead to erroneous 
genotype–phenotype correlations [Yokoyama et al., 2012; Yokoyama, 2013]. 
One possible solution is to first reconstruct the ancestral protein which will 
provide a more “realistic” background to place the sites of interest [Yokoyama 
and Radlwimmer, 2001; Shi and Yokoyama, 2003; Bridgham et al., 2006; Harms 
and Thornton, 2010]. By performing site-directed mutagenesis on these 
synthesized ancestral proteins it is possible to accurately characterize the 
relationship between positive selection and function [Yokoyama et al., 2013]. 
Model A has been previously used to identify positively selected residues in a 
mammal protein by reconstructing the ancestral protein and then performing 
rational mutagenesis in that background. It was shown that the positively 
selected residues elicited a direct functional impact [Loughran et al., 2012]. Such 
in vitro studies were not performed in this thesis as here we are focused on 
software design for large-scale analyses (Chapter 2) and mechanisms of protein 
evolution in vertebrates (Chapters 3 and 4).  
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1.5 Graph theory and molecular evolution 
1.5.1    Introduction to graph theory 
Graph theory is the subdiscipline of mathematics that studies the nature of 
graphs, which are mathematical representations of connections between objects 
(Figure 1.6). Since the initial application of graph theory by computational 
biologists, the discipline has primarily published research on protein interaction, 
sequence homology, cell signaling, and genetic association [Katoh and Katoh, 
2007; Goh et al., 2007; Bapteste et al., 2012; Franceschini et al., 2012]. One of 
the most significant discoveries revealed by biological graphs (often referred to 
as networks) was that despite their complex nature, they shared the common 
governing principles of scientific and technological graphs (e.g. the Internet and 
social networks) [Barabasi and Oltvai, 2004]. Of particular importance is that 
biological graphs are theorized to be scale-free rather than random graphs. In 
random graphs, the degree of each node does not significantly deviate from the 
average degree of the graph (Figure 1.7a). In contrast to the random model, the 
scale-free model is characterized by a power-law degree distribution, which is 
characterized by a small number of hub nodes that strongly influence the 
properties of the graph (Figure 1.7b). For example, a protein interaction graph of 
the TLR signaling pathway displays scale-free characteristics with MyD88 as a 
central hub node. The existence of hub nodes in scale-free graphs is founded on 
two concepts, growth and preferential attachment. Growth denotes that graphs 
grow overtime. Preferential attachment indicates that nodes with higher degree 
are more likely to gain new connections as they grow [Barabasi and Oltvai, 
2004].  
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Figure 1.6: Basic graph nomenclature and general types of graphs. 
 
 (a) Graphs are composed of objects and the connections between those objects, 
respectively termed nodes and edges. (b) The degree of a node is the total 
number of edges it has to other nodes (i.e. nearest neighbors). (c) Nodes may be 
referred to as hubs if they have a large degree in respect to other nodes (e.g. the 
Google in yellow). (d) The shortest path between two nodes is the smallest 
number of edges required to connect the two nodes (e.g. the shortest path from 
the UCSC genome browser (yellow) to Ensembl BioMart (orange) only requires 
4 edges if Google is bypassed. (e) Graphs may be directed and permit edges to 
have direction associated with them, or (f) undirected if edges have no direction 
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associated with them. (g) Graphs are bipartite if they incorporate relationships 
between two independent sets of data (e.g. use of the EBI [European 
Bioinformatics Institute] database connects DCU and TCD). (h) Relationships 
between members of the same independent set of a bipartite network may be 
determined by inferring a unipartite network projection. For example, upon 
removal of EBI, DCU and TCD are connected in a unipartite graph (unipartite 
projection of the bipartite graph). This connection is due to both the DCU and 
TCD nodes being previously associated (i.e. sharing edges) with EBI. 
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Figure 1.7: The properties of random and scale-free graphs 
 
 (a) The Erdös-Rényi model of a random graph is generated by selecting the 
number of nodes (N) and the probability (p) of a connection and constructs a 
graph with approximately 
𝑝𝑁(𝑁−1)
2
 randomly placed edges [Barabasi and Oltvai, 
2004]. The degree distribution (i.e. the distribution of node degree values) of 
random graphs is expected to follow a Poisson distribution, indicating that most 
nodes have approximately the same number of edges and do not significantly 
deviate from the average degree of the graph [Barabasi and Oltvai, 2004]. 
Therefore the nodes of random graphs are expected to uniform in respect to 
connectivity. (b) The scale-free model is characterized by a power-law degree 
distribution, whereby the probability that a node has a connection k is 
𝑃(𝑘) ~ 𝑘−γ , where γ is a constant typically between 2 and 3 [Barabasi and 
Oltvai, 2004]. Graphs created from the power-law equation are characterized by 
a logarithmic decrease in probability of a node existing as the degree of the node 
increases. Therefore, in scale-free graphs, the majority of nodes exhibit small 
degree values whereas a small number of nodes exhibit high degree values (i.e. 
are hub nodes) [Barabasi and Oltvai, 2004]. Because of this, the nodes of scale-
free graphs are disproportionate in respect to connectivity. 
a b
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Duplication events have been proposed as one mechanism that creates 
preferential attachment in biological networks. As hub proteins naturally exhibit 
greater connections, they have a higher probability of being connected to a 
protein that undergoes duplication thereby creating an additional connection 
[Barabasi and Oltvai, 2004]. Evidence of this concept is illustrated by the 
duplication events that resulted in TLR7, TLR8, and TLR9 [Leulier and 
Lemaitre, 2008] each of which shares a connection with MyD88 in a protein 
interaction graph of the TLR signaling pathway. 
 
1.5.2 Characterizing Graphs 
1.5.2.1 Centrality 
Centrality is concerned with measuring the influence (or importance) of each 
node on the structure of the entire graph. While a plethora of measurements have 
been developed independently, the three most prominent and frequently used 
measurements of centrality are: degree, closeness, and betweenness [Freeman, 
1979].   
 
Degree centrality is the simplest measurement of centrality and is defined as the 
total number of edges (or adjacencies) for a given node [Freeman, 1979]. The 
degree of a given node can also be thought of as the initial importance of a given 
node in the graph. Applying this concept to infection networks, hub nodes 
unsurprisingly pose the greatest initial risk for spreading an infection [Borgatti, 
2005]. The best method for calculating degree centrality of a given node is by 
using an adjacency matrix of the graph (Figure 1.8), as shown in Equation 1.3: 
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Equation 1.3: Degree centrality. 
𝐶𝑖
𝐷𝐸𝐺 = ∑ 𝑎𝑖𝑗
𝑁
𝑗
 
           𝑎𝑖𝑗 ∶=  {
 1     𝑖𝑓 𝑖 = 𝑗     
0   𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
       
 
where 𝑖  is the given node, 𝑗 is the remaining nodes, 𝑁  is the total number of 
nodes in the graph, and 𝑎𝑖𝑗 is the adjacency matrix.  
 
The adjacency matrix is necessary to define if an edge exists between the current 
nodes [Opsahi et al., 2010; Borgatti and Everett 2006].  
 
Closeness centrality is the measurement that states how close a given node is to 
all other nodes within a graph. The closeness of a given node is the inversed sum 
of the shortest paths to each of the remaining nodes within the graph [Opsahi et 
al., 2010; Borgatti and Everett, 2006]. Therefore, nodes with high closeness 
exhibit a smaller overall distance to the remaining nodes in the graph. In an 
infection network, nodes exhibiting the highest closeness pose the greatest risk of 
being positioned for early infection [Borgatti, 2005]. Calculating closeness is 
achieved using a shortest path adjacent matrix of the graph (Figure 1.8), as 
shown in Equation 1.4: 
 
Equation 1.4: Closeness centrality. 
𝐶𝑖
𝐶𝐿𝑂 =  
𝑁 − 1
∑ 𝑑𝑖𝑗
𝑁−1
𝑗
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where 𝑖  is the given node, 𝑗 is the remaining nodes, 𝑁  is the total number of 
nodes in the graph, and 𝑑𝑖𝑗 is the shortest path adjacent matrix [Opsahi et al., 
2010]. Equation 1.4 is normalized by the total remaining nodes (i.e. 𝑁 − 1). 
 
Betweenness centrality is the measurement of centrality that defines the total 
number of times a given node belongs to the shortest path of two separate nodes 
[Freeman, 1979]. Nodes with high betweenness are regularly required for 
connection between nodes that are distantly connected in a graph. For example, 
shipping canals (e.g. Panama and Suez) typically exhibit high betweenness in 
global shipping networks as they are frequently visited en route to other ports 
[Kaluza et al., 2010]. Betweenness centrality is calculated using Equation 1.5: 
 
Equation 1.5: Betweenness centrality. 
𝐶𝑖
𝐵𝐸𝑇 = ∑ ∑
𝜎(𝑗, 𝑘|𝑖)
𝜎(𝑗, 𝑘)
𝑘𝑗
 
 
where 𝑖 is the given node, 𝜎(𝑗, 𝑘) is the number of shortest paths between the 
nodes 𝑗 and 𝑘, and 𝜎(𝑗, 𝑘|𝑖) is the number of those shortest paths that that require 
𝑖  [Borgatti and Everett, 2006]. Betweenness may also be normalized by 
calculating the maximum number of edges in a graph of 𝑁 nodes (
2
(𝑛−1)(𝑛−2)
), 
see Equation 1.6 for the normalized betweenness:  
 
Equation 1.6: Normalized betweenness centrality. 
𝐶𝑖
𝑁𝑜𝑟𝑚𝐵𝐸𝑇 =
2 (∑ ∑
𝜎(𝑗,𝑘|𝑖)
𝜎(𝑗,𝑘)𝑘𝑗
)
(𝑁 − 1)(𝑁 − 2)
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Figure 1.8: Calculating degree and closeness centrality using adjacency 
matrices. 
 
 (a) Degree centrality can be calculated by summing the number of edges of the 
node of interest in an adjacency matrix. For example, the degree centrality of the 
EBI (highlighted in yellow on the matrix) is four due to having edges with the 
DBJ, Google, NCBI, and ENSEMBL nodes. (b) Closeness centrality can be 
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calculated by dividing the total number of nodes in the graph minus the given 
node (i.e. N - 1) by the sum of the shortest paths to all remaining nodes in the 
graph. This can be accomplished using a shortest path adjacency matrix. For 
example, the shortest path between UCSC and EBI is two as two edges (shown 
in orange above) is the fewest number of edges required to connect the nodes. 
The closeness centrality of UCSC to all other nodes on the graph is 0.45 based 
on this calculation.    
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1.5.2.2 Assortativity 
Assortativity measures the correlation between degree and node connectivity. 
Depending on the observed correlation, graphs may be defined as showing 
assortative, neutral, or disassortative mixing patterns. Assortative mixing is a 
preference for any given node to attach to other nodes displaying a similar degree 
(e.g. high-degree nodes attached to high-degree nodes) [Newman, 2002; 
Newman, 2003]. Disassortative mixing is a preference of attachment to nodes of 
dissimilar degree (e.g. high-degree nodes with low-degree nodes) [Newman, 
2002; Newman, 2003]. Graphs rarely exhibit neutral mixing, where neither a 
preference for assortative nor disassortative mixing is detected [Newman, 2002; 
Newman, 2003]. A variety of social, technological, and biological graphs have 
undergone assortativity measurements. Biological (e.g. protein interaction and 
metabolic) and technological (e.g. internet and world-wide-web) networks are 
predominantly disassortative whereas social networks (e.g. co-authorship and 
actor collaborations) are predominantly assortative [Newman, 2003].  
 
Depending on the robustness of the assortativity analysis, methods of varying 
complexity have been devised to determine the mixing pattern of a graph. The 
simplest and often initial method is constructing a chart of each edge in a graph, 
whereby the axes of the chart are scaled by the degree of the nodes in an edge 
[Newman, 2003]. It should be noted that edge charts are only ideal for 
deciphering predominantly assortative or disassortative mixing (Figure 1.9a and 
b). Another method for investigating degree correlation is plotting average 
degree of nearest neighbors for a node in respect to the degree of the node in 
question [Pastor-Satorras and Vespignani, 2001]. The assortativity of the graph is 
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then estimated from the linear regression of the data - a positive slope indicating 
assortative, negative indicating disassortative, and a slope of zero indicating 
neutral (Figure 1.9c and d). Lastly, the assortativity coefficient may be calculated 
for a graph using a Pearson correlation to determine the linear correlation 
between degree connectivity [Newman, 2002]. The assortativity coefficient (𝑟) 
of a graph lies between -1 ≤ r ≤ 1 with positive indicating assortative mixing, 
negative indicating disassortative, and 0 indicating neutral [Newman, 2002]. To 
determine the statistical significance of the assortativity coefficient of a graph, a 
number of randomized graph with the same degree distribution are used to obtain 
a confidence interval of the assortativity coefficient [Foster et al., 2010]. 
 
1.5.2.3 Cliques and Communities 
Cliques are defined by graph theory as subgraphs in which every pair of nodes is 
connected by an edge (i.e. fully connected or complete) [Luce and Perry, 1949] 
(Figure 1.10a). Cliques are often defined by their size k (i.e. k-clique), where k is 
the number of nodes within the clique. Cliques may also be designated as 
maximal or maximum [Butenko and Wilhelm, 2006]. Maximal cliques are 
defined as cliques that cannot expand by incorporating neighboring nodes. A 
maximum clique is the clique of the greatest size in the graph. It should be noted 
that identifying either the maximum clique or all maximal cliques within a given 
graph is considered an NP-complete problem, problems in which a given 
solution may be verified in polynomial time but computing an exact solution 
cannot be completed in an efficient manner [Karp, 1972; Leeuwen, 1998]. 
Despite this innate difficultly, algorithms have been developed to approximate 
the maximum clique or all maximal cliques [Butenko and Wilhelm, 2006].  
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Figure 1.9: Methods for characterizing graph assortativity 
 
There are two common approaches to plot graph assortativity: (a and b) degree 
plots and (c and d) neighbor connectivity plots. Two datasets are shown for each 
plot approach: (a and c) an assortative dataset and (b and d) a disassortative 
dataset. (a and b) Degree plots are constructed by plotting the degree values (K) 
of each pair of nodes connected by an edge (one value for each axis). Comparing 
the mixing pattern generated by (a) the assortative dataset to (b) the 
disassortative dataset illustrates the difficulty of verifying the assortativity 
pattern from degree plots. Only highly assortative or disassortative networks will 
result in patterns that are not ambiguous. (c and d) Neighbor connectivity plots 
are constructed by plotting the average degree of nearest neighbors (<Knn>) of a 
given node with the degree (K). In comparison to degree plots, neighbor 
connectivity plots are able to the accurately identify both weakly assortative and 
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disassortative graphs. This is achieved by determining the linear regression of 
<Knn> on the y-axis to and K on the x-axis, with a positive slope indicating 
assortative mixing and a negative slope indicating disassortative mixing. For 
example, linear regression was able to correctly identify (c) the assortative 
dataset with a positive slope and (d) the disassortative dataset with a negative 
slope. 
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Communities in graphs are defined as subsets of nodes that exhibit dense internal 
connections but sparse connections elsewhere [Girvan and Newman, 2002] 
(Figure 1.10b). Various methods to distinguishing community structure within 
large graphs have been developed, however, these methods are limited to 
approximations as identifying the most dense subgraph in a graph is classified as 
an NP-hard problem [Rivera et al., 2010]. Similar to NP-complete problems, NP-
hard problems are unable to be solved in an efficient manner (i.e. polynomial 
time), however, NP-hard problems occasionally are unable to verify a given 
solution in polynomial time [Leeuwen, 1998]. Another limitation of many of 
these community detection methods is user-defined parameters, which if 
incorrectly specified may give unrealistic results. The NeMo algorithm was 
selected for this thesis due to the accuracy of the algorithm and the absence of 
user-defined parameters [Rivera et al., 2010]. NeMo detects communities by 
calculating a log odds score for observing a certain number of shared neighbors 
between nodes [Rivera et al., 2010].  
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Figure 1.10: Visual representation of cliques and communities detection. 
 
 (a) A clique is characterized by a subset of nodes in which each pair is 
connected by an edge. Both cliques shown (k=3 and k=4) are maximal cliques, 
as they cannot grow larger. The maximum clique of the graph is k=4 (shown in 
red). (b) A community is characterized by a subset of densely interconnected 
nodes that are sparsely connected elsewhere. 
 
a
k=3
k=4
Clique Detection
b
Community 
Detection
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1.5.2.4 Clustering 
Two coefficients of graph clustering were employed within this thesis: average 
clustering and transitivity. Clustering coefficients are typically used to measure 
the degree to which nodes cluster [Luce and Perry, 1949; Watts and Strogatz, 
1998]. 
 
Average clustering is the average of the local clustering coefficients of all nodes 
in a graph [Watts and Strogatz, 1998]. The local clustering coefficient of a given 
node is defined as the percentage of nearest neighbor (i.e. nodes sharing an edge 
with the given node) pairs that share an edge (Figure 1.11a). Local clustering 
coefficients range from 0 to 1; a coefficient of 0 indicates that the nearest 
neighbors of the given node share no connections whereas a coefficient of 1 
indicates the nearest neighbors are completely connected (along with the given 
node) and are a clique (Figure 1.11b). 
 
Transitivity is a global clustering coefficient based on the number of node triplets 
within a graph (Figure 1.12a). Node triplets are either defined as open or closed, 
an open triplet only possesses two edges and therefore is not fully connected 
whereas a closed triplet possesses three edges and is fully connected (i.e. a 
clique) (Figure 1.12b). Transitivity is measured by dividing the closed triplets 
(often defined as triangles) by the total number of node triplet (open or closed) in 
the graph (Figure 1.12c). Graph transitivity ranges from 0 to 1; a coefficient of 0 
indicates that all triplets are open whereas a coefficient of 1 indicates that all 
triplets are closed (i.e. cliques). 
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Figure 1.11: Visual representation of average clustering. 
 
(a) The local clustering coefficient of node A (shown in blue) is the percentage 
of edges shared by pairs of the nearest neighbors of node A, which are: B, C and 
D (shown in red). (b) The clustering coefficient (C) of four scenarios: C = 0 if 
there no edges between nearest neighbors, C = 1/3 if there is a single edge 
between nearest neighbors, C = 2/3 if there are two edges between nearest 
neighbors, and C = 1 if the nearest neighbors and the given node (node A) are a 
clique (i.e. fully connected). 
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Figure 1.12: Visual representation of transitivity. 
 
(a) The given network has two connected components: 1) nodes A, B, C, D, and 
E and 2) nodes X, Y, and Z. These components are then broken into triplets (i.e 
three nodes connected by at least two edges). Component 1 (A, B, C, D, and E) 
can be broken into three triplets: A-B-C, B-C-D, and C-D-E. Component 2 is 
only made of a single triplet: X, Y, Z. (b) Triplets are either open and contain 
only two edges (i.e. not fully connected) or closed – often termed triangles – and 
contain three edges (i.e. a clique). (c) The transitivity coefficient is calculated by 
dividing the number of closed triplets (triangles) over the number of all triplets 
(open and closed). 
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1.5.3 Graphs and introgressive descent 
Of the various biological relationships characterized by graphs, sequence-
similarity networks have recently become of particular interest to evolutionary 
biologists due to their ability to accurately represent the molecular signatures of 
non-linear or introgressive descent [Bapteste et al., 2013]. Sequence-similarity 
networks represent sequences as nodes and infer edges from homology data 
provided by programs such as BLAST, FASTA, or HMMER [Eddy, 1998; 
Altschul et al., 1990; Lipman and Pearson, 1985]. In a sequence-similarity 
network the homology connections of both monophyletic orthologs and 
introgressive descent are characterized by distinct edge patterns (Figure 1.13). 
Networks therefore enable the evolutionary impact of events such as domain 
sharing, mosaic genes, plasmids, and phages to be accurately evaluated in 
addition to the traditional tree-like molecular signatures [Bapteste et al., 2013].  
 
1.5.3.1 Tools for detecting introgressive events in networks 
Currently, there are a small number of tools that have been devised to identify 
introgressive events in large sequence-similarity networks. The recently released 
program MosaicFinder identifies composite genes – a gene generated by a fusion 
between two previously separate/distinct genes – by constructing a sequence-
similarity graph from BLAST alignment data [Jachiet et al., 2013]. MosaicFinder 
identifies composite genes by equating them to clique minimal separators 
[Jachiet et al., 2013]. A clique separator is a node that if removed will cause the 
graph to separate into connected components, that separator is minimum if no 
subset of the node also causes separation (i.e. an independent separator that does 
not require the node in question) [Berry et al., 2010], e.g. Human M in Figure 
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1.11. MosaicFinder subsequently confirms potential composites using the 
BLAST output data [Jachiet et al., 2013].  
 
1.5.4 Composite genes and functional discordance. 
Composite genes (introgressive events caused by fusion of two or more genes) 
have been reported to have unique species-specific functional properties 
[Thomson et al., 2000; Rogers et al., 2010; Molero et al., 2013]. These instances 
of non-vertical descent have resulted in the alterations to cellular localization 
(e.g. the human fusion Kua–UEV [Thomson et al., 2000]), distinct regulatory 
profiles (e.g. the Drosophila fusion Quetzalcoatl [Rogers et al., 2010]), and 
combine of distinct functions (e.g. Schizosaccharomyces pombe fusion gene hal3 
[Molero et al., 2013]). The ability of composite genes to elicit a variety of 
species-specific functions demonstrates the importance of characterizing non-
vertical events. Therefore the unique ability of graphs to accurately identify non-
vertical events provides an additional method to understand functional 
discordance between species.  
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Figure 1.13: Basic characteristics of introgressive descent in graphs 
 
Graphs are capable of displaying the unique characteristics of both monophyletic 
orthologs (vertical decent) and mosaics (non-vertical descent). Monophyletic 
orthologs typically manifest as cliques as they share coalescent orthologs e.g. 
Gene A (human, chimp, rat, and mouse orthologs of gene A) in blue & Gene B 
(human, chimp, rat, and mouse orthologs of gene B) in red. Graphs depict mosaic 
sequences, human Gene M (human mosaic of human A gene and human B gene), 
as sparsely connected nodes that typically connect unrelated groups with strong 
interconnectivity.  
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Chapter 2: Design and development of the bmeTools package 
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2.1 Chapter Aim 
Analysis of selective pressure heterogeneity requires a large number of steps 
from ortholog identification through to phylogeny reconstruction and likelihood 
ratio tests of the codon models applied. Therefore, the primary aim of chapter 
two was the development of a highly automated bioinformatic pipeline for 
selective pressure analysis. We called this pipeline the Bioinformatics and 
Molecular Evolution Tools package or simply bmeTools. The pipeline was 
designed to minimize potential biases of the user by including software that 
automates the selection of alignments and/or substitution models based on the 
sequence data rather than user assumptions. Therefore there were two major aims 
in the design of this pipeline (1) to simplify the analysis and (2) to reduce 
potential human error. These goals were achieved by designing a pipeline that 
included software for all steps from data acquisition to the analysis of the 
selective pressure results, the major steps involved were: (i) identification of 
gene families, (ii) alignment, (iii) phylogeny reconstruction, (iv) selective 
pressure analyses, and (v) Likelihood ratio test calculations to determine the 
codon based model of best fit for each gene alignment.  
 
The bmeTools package was then applied to the comparative genomic analysis of 
the newly sequenced Bowhead whale genome to test all functionality of the 
software.  
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2.2 Introduction 
Since the initial release of the human genome in 2001 [Lander et al., 2001], 
technological advances in both computing and sequencing have enabled the 
release of genome assemblies of approximately eighty different vertebrates 
[Flicek et al., 2014]. In this same period, researchers in the field of molecular 
evolution have developed techniques capable of evolutionary analyses on a 
genome-wide scale (for example [Kosiol et al., 2008]). One of the most widely 
used approaches to estimate the selective pressure variation across homologous 
protein-coding genes is to calculate the ratio of non-synonymous substitutions 
per non-synonymous site (Dn) over synonymous substitutions per synonymous 
site (Ds) (Dn/Ds or ω). An ω value >1 is the classical signature of molecular 
adaptation and until recently has been theorized to indicate potential functional 
divergence [Sawyer et al., 2005]. Recently there have been a number of 
independent studies that have successfully linked positive selection to protein 
functional divergence in a wide variety of species [Loughran et al., 2012; Moury 
and Simon, 2011; Levasseur et al., 2006; Sawyer et al., 2005]. Large-scale 
genomic studies of selective pressure variation across species have the potential 
therefore to identify e.g. the molecular underpinnings of species-specific traits 
[Kosiol et al., 2008]. The focus here was to design and implement a pipeline for 
large-scale selective pressure analysis, thereby positioning us to identifying 
protein functional shifts between mouse and human that underpin species-
specific immune responses [Mestas and Hughes, 2004].  
 
To date, a number of methods and software packages of varying complexity have 
been released with the purpose of calculating ω [Delport et al., 2010; Yang, 
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2007; Pond and Frost, 2005]. One of the most highly cited is codeML from the 
PAML software package [Yang, 2007]. CodeML uses codon-based models of 
evolution to assess selective pressures in protein coding sequence alignments at 
specific sites or restricted to sites in a predefined lineage [Yang and dos Reis, 
2011]. Operating codeML requires a complex file structure to accurately 
compute the parameters under multiple nested models, calculate the associated 
likelihood ratio tests (LRTs), and perform the statistics required to infer putative 
positive selection. Overcoming these complexities and properly interpreting the 
results for most evolutionary biologists is achieved by creating in-house software 
pipelines, which are rarely publically available. Lack of a flexible toolkit for 
upstream and downstream analyses has proven problematic for many organismal 
biologists working on next-generation sequence data and is an additional 
stumbling block for analysis and interpretation of their novel data. Attempts have 
been made to solve this problem by creating a simplified and automated pipeline 
for codeML analysis, but most have only focused on the codeML package itself 
(e.g. BioPerl PAML, Lazarus, etc.) [Hanson-Smith et al., 2010; Stajich et al., 
2002; Walsh, 2013]. These attempts have ignored the various steps required prior 
to and following codeML analysis, which would still present a problem to the 
non-programming biologist. Enabling codeML analysis for organismal biologists 
requires a broad functioning pipeline that streamlines and automates the many 
analyses prior to the codeML stage – such as data collection, homology 
searching, sequence alignment and phylogenetic reconstruction – as well as 
automating the various mathematical analyses required to interpret the output 
from codeML.  
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Here we present bmeTools, a software package for the automation of codeML 
and associated upstream and downstream analyses. bmeTools was primarily 
designed for users unfamiliar with the command-line environment of codeML by 
eliminating the majority of data manipulation requirements, enabling large-scale 
analyses, and automatically analyzing codeML output. But bmeTools is equally 
useful for the more experienced user as it provides a flexible system for a variety 
of analyses. bmeTools produces results that are easy to interpret and allow 
simplified assessment and identification of false positive results for 
inexperienced users. All bmeTools related functions can be found in Appendix 2. 
 
2.3 Aims for selective pressure analysis package 
1) Create a simple and comprehensive analysis package to enable researchers 
with limited bioinformatics experience to conduct large-scale molecular 
evolutionary analyses such as homology searching, alignment and phylogeny 
reconstruction as well as codeML analyses.  
2) Create a robust and flexible analysis package to enable high-throughput 
molecular evolutionary analyses for experienced researchers.  
 
2.4 Motivation behind the development of bmeTools 
2.4.1 Minimize human error 
A major motivation for the bmeTools package was minimizing potential sources 
of error in selective pressure analyses. Assessing selective pressure variation 
requires a complex pipeline composed of numerous independent analyses, 
including: ortholog identification, multiple sequence alignment, phylogenetic 
reconstruction, and assessment of codon-based models of evolution. The pipeline 
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requires multiple data manipulation steps to combine the output of each of these 
different techniques (e.g. parsing BLAST result files to identify homologs and 
assessment of the suitability of the phylogenetic tree for selective pressure 
analysis). For researchers with limited bioinformatics knowledge, manual data 
manipulation is prone to error, is potentially unstandardized, and is difficult to 
reproduce. bmeTools was designed to be an easily reproducible method to 
eliminate the need for manual data manipulation by creating functions that 
automatically complete the majority of data manipulation steps using a 
standardized approach. In addition, the use of bmeTools should minimize the 
requirements for inexperienced users to create their own programs, which may 
be vulnerable to programming errors.  
 
Another potential source of error that motivated the creation of the bmeTools 
package was the potential for inexperienced researchers to use aberrant pipelines 
for data analysis. While the procedures within each stage of a selective pressure 
analysis are independent, there are requirements on the order in which the phases 
are carried out. bmeTools was designed to mitigate these complications by 
creating a standardize pipeline of analyses with a specific ordering of phases in 
the process. In addition, the package encompasses multiple specialized pipelines 
to accurately assess selective pressure and reduce potential false positives (such 
as those caused by alignment error [Fletcher and Yang, 2010]). 
 
2.4.2 Increase user productivity 
Another motivation in the development of bmeTools was to increase user 
productivity by automating labour intensive tasks. Increasing productivity in this 
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respect can be achieved in two ways: i) automation by recursion – used to repeat 
an analysis on a number of files  (e.g. cleaning and translating a directory of 
genomes), and ii) automation of analysis methods – used to complete tasks that 
are normally demanding but invariable in execution (e.g. identifying homologs 
within BLAST output data). Automating these procedures within bmeTools has 
created an analysis package that is highly scalable (i.e. from a single gene to 
whole genomes) and that is suitable for the needs of all levels of expertise.   
 
2.5 Rationale behind the development of bmeTools 
2.5.1 Selection of python programming language 
The primary rationale for using the python programming language was the high 
productivity of the language [Prechelt, 2000]. The general syntax of Python 
requires fewer lines than traditional compiler languages (C and C++) while still 
maintaining a competitive runtime [Prechelt, 2000; Fourment and Gillings, 
2008]. Python also incorporates a number of built-in libraries that reduce 
development time by enabling previously designed functions to be easily 
incorporated into a program [van der Walt et al., 2011; Sukumaran and Holder, 
2010; Hunter, 2007]. 
 
‘Pythonic’ programs, or programs that are minimalistic and highly readable is a 
major goal [Fourment and Gillings, 2008]. This is beneficial within a PhD 
environment as any student proficient in python is able to easily understand 
‘Pythonic’ software. High readability also allows for software to be easily 
maintained and recycled within a laboratory years after the initial development. 
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Python programs are executable without compilation, and to run python 
programs, users are only required to install Python on their system.  
 
2.5.2 Separation of package into analysis phases 
The rationale behind separating the bmeTools package into analysis phases 1 - 5 
(Figure 2.1) was primarily to aid users in understanding the distinct procedures 
involved in selective pressure analysis and to provide more advanced users with 
a flexible and adaptable pipeline. All functions within a phase analyze the same 
input type (e.g. sequences, BLAST output, etc.), only specific functions can be 
combined and the overall output of a phase produces a new data type.  
 
2.6 General overview of bmeTools 
There are five separate analysis phases and two analysis pipelines in the 
bmeTools package, a basic pipeline for single gene orthologs (SGOs) and an 
advanced pipeline for both SGOs and multi-gene families (MGFs). The basic 
pipeline was designed to bypass the phylogenetic reconstruction techniques 
(phase 3) by inferring a gene phylogeny from a user defined species phylogeny. 
Usage of the basic pipeline is only recommended if the genes are confirmed 
SGOs. See Figure 2.1 for additional details on the pipeline. The output of each 
phase in the bmeTools package requires an analysis step that must be completed 
by the user with third-party software (Figure 2.1). These analyses are not 
automated by bmeTools for two reasons: i) these analyses are far too 
computationally intensive, and ii) the submission process for these programs may 
differ from user to user. In addition, software updates may create bugs within the 
pipeline.   
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Figure 2.1: Overview of the bmeTools package. 
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boxes indicate third-party programs. (a) Phase 1 (Section 2.6) is the data 
preparation phase and includes the functions: ensembl_clean/clean (Section 
2.6.1), translate (Section 2.6.2), create_database (Section 2.6.3), and 
gene_selection (Section 2.6.4). This phase ends with the requirements for 
sequence similarity searching. (b) Phase 2 (Section 2.7) is the similarity group 
creation phase and includes the following functions: similarity_groups (Section 
2.7.2), reciprocal_groups (Section 2.7.2) and best_reciprocal_groups (Section 
2.7.3). This phase results in the creation of requirements for multiple sequence 
alignment (MSA). (c) Phase three (Section 2.8) is the alignment assessment stage 
and includes both a basic pipeline (on the left) for MSA files that contain only 
single gene orthologous (SGOs) and an advanced pipeline (on the right) for 
unconfirmed MSA files. The phase includes the following functions: 
metal_compare (Section 2.8.1), protest_setup (Section 2.8.2), protest_reader 
(Section 2.8.2), and mrbayes_setup (Section 2.8.3). This phase results in either: i) 
a phylogenetic trees of the MSAs for the advanced pipeline or ii) selected MSAs 
for the basic pipeline. (d) Phase four (Section 2.9) is the selective pressure phase 
and continues the basic pipeline and advanced pipeline of the previous phase. 
The phase four basic pipeline includes: map_alignment (Section 2.9.1), 
infer_genetree (Section 2.9.2), create_branch (Section 2.9.6), and setup_codeml 
(Section 2.9.3). The phase four advanced pipeline includes: create_subtrees 
(Section 2.9.4), mrbayes_reader (Section 2.9.5), create_branch (Section 2.9.6), 
and setup_codeml (Section 2.9.3). This phase results in the input requirements 
for selective pressure analysis by codeML. (e) The final phase (Section 2.10) 
includes the function codeml_reader (Section 2.10.1) that analyzes the results of 
the codeML analysis.  
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2.7 Phase 1 – Data Preparation 
The data preparation phase was included in bmeTools for users with limited 
bioinformatics training. The phase prepares downloaded genomes for homology 
searching using the two bmeTools supported homology search tools: BLAST 
[Altschul et al., 1990] and HMMER [Eddy, 1998]. Many of the included 
functions were designed to operate in various circumstances by incorporating 
additional options. The phase also includes a number of supplementary functions 
not required for either pipeline shown in Figure 2.1 but rather to aid 
inexperienced users in homology searching.  
 
2.7.1 Functions: clean and ensembl_clean 
The basic ‘clean’ function was designed as a quality control (QC) filter for 
downloaded nucleotide sequences and/or genomes (Figure 2.2a). Each sequence 
is confirmed as protein coding by using a conditional statement to verify that the 
nucleotide sequence encompasses only complete codons (Figure 2.2b). This is an 
essential step to confirm gene annotation quality and permit the codon 
substitution models of codeML [Yang, 2007]. Only sequences that pass QC are 
retained (Figure 2.2c). 
 
The more advanced ‘ensembl_clean’ function was designed to identify the 
longest nucleotide (canonical) transcript within an Ensembl nucleotide genome 
that passed the above QC step. This is achieved by exploiting the pattern of 
ensembl sequence identifiers, which consistently begin with the gene identifier 
followed by the transcript identifier (Figure 2.2d). The longest transcript is then 
identified for each ensembl gene identifier and saved within the output file. 
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Shorter transcripts along with the sequences that failed the QC filter are reported 
in a separate log file. 
 
2.7.1.1 Additional options of ‘clean’ and ‘ensembl_clean’ 
Both clean functions have a single enabled option (‘rm_internal_stop’) and two 
disabled options (‘label_filename’ and ‘infer_ensembl_species’) that may be 
manually configured by the user. The option ‘rm_internal_stop’ will remove 
sequences if they contain an internal stop codon (Figure 2.2g), those removed 
will be reported in the log file. It should be noted that while ‘rm_internal_stop’ is 
configurable, codeML does not permit nonsense mutations and the option should 
be enabled if the toolkit is being used for that purpose. The options 
‘label_filename’ and ‘infer_ensembl_species’ alter sequence headers (i.e. 
Ensembl gene and transcript identifiers) by adding an additional identifier at the 
beginning of the header: ‘infer_ensembl_species’ adds the common species name 
of the respective Ensembl identifier (Figure 2.2e) and ‘label_filename’ adds the 
filename (without the file extension) (Figure 2.2f). It should be noted that 
executing a labeling option is required for enabling bmeTools to automate the 
creation of gene trees and setup of the codeML branch-site models (for details 
see Section 2.9.6 for automation and Section 1.3.2.2 for branch-site models).  
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Figure 2.2: Overview of ‘clean’ and ‘ensembl_clean’ functions. 
 
FastA formatted files are shown as grey boxes and the associated white boxes 
show the filename. Data confirmation steps shown as readout beneath each 
example indicates if the results passed the check. The following QC checks are 
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illustrated here: (a) Cleaning an input file, (b) initiates with codon confirmation, 
(c) only sequences that pass are saved in the output. If the ‘ensembl_clean’ 
function is invoked, in addition to codon confirmation, each transcript of an 
ensembl gene undergoes (d) a longest transcript confirmation and only the 
longest transcript is saved in the output. Two options are available to append a 
prefix to sequence headers: (e) ‘infer_ensembl_species’ to append the Ensembl 
genome, or (f) ‘label_filename’ to append the input filename. Invoking (g) 
‘rm_internal_stop’ will remove genes that fail stop codon confirmation. 
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2.7.2 Function: translate 
The ‘translate’ function translates nucleotide sequences that passed previous QC 
(Figure 2.3a). The function operates by splitting the nucleotide sequence into 
codons and then translating them into amino acids (Figure 2.3b). Translation is a 
mandatory step to produce alignments permitted by the codon substitution 
models of codeML (see Section 2.9.1) [Yang, 2007]. The resulting protein 
sequences are then saved (Figure 2.3c). If non-coding sequences (incomplete 
codons or internal stop codons) were not removed prior to invoking the 
‘translate’ function, the function will produce a warning message. The warning 
reports that the function is designed to only translate protein-coding sequences 
and non-coding sequences will be removed from the pipeline and will be 
recorded within a separate log file.  
 
The ‘translate’ function incorporates a single unique option ‘cleave_terminal’ 
and the previously described options of the clean functions (Section 2.6.1.1). If 
not manually configured, ‘cleave_terminal’ is enabled by default and is designed 
to cleave the terminal stop codon of each sequence (Figure 2.3d). The function 
and default status of the remaining options are detailed in Section 2.6.1.1. 
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Figure 2.3: Overview of ‘translate’ function. 
 
FastA formatted files are shown as grey boxes and their filenames are given in 
white boxes. (a) Translating an input file using ‘translate’ initiates the translation 
procedure by separating the sequence (as in (b)) into each codon to determine the 
respective amino acid, (c) translated sequences are saved in the ‘Translated’ 
output file. (d) If the ‘cleave_terminal’ option is invoked, terminal stop codons 
will be removed from each applicable sequence. 
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2.7.3 Function: create_database 
The ‘create_database’ function was designed for inexperienced users to 
concatenate multiple genomes into the single database required for homology 
searching. The function operates by building the database a single sequence at a 
time (Figure 2.4a and b). The command-line version of BLAST requires 
additional commands to create a BLAST-formatted database. If the user enables 
the option ‘format_blast’ and BLAST is installed on the system the function will 
attempt to automate the additional steps required for producing a BLAST-ready 
database (Figure 2.4c). If ‘create_database’ is unable to create the BLAST-
formatted database, a warning message will be produced.  
 
2.7.4 Function: gene_selection 
If the user is only interested in a subset of genes, the ‘gene_selection’ function 
was designed to enable the user to search a database for gene identifiers specified 
in a separate file. The function operates by searching the sequence headers of the 
database for matches with the user specified gene identifiers (Figure 2.5a). The 
matching process only requires the user-specified identifiers to match a portion 
of the database sequence headers (Figure 2.5b). The function saves a single 
sequence file for each matched identifier (Figure 2.5c). If a user-specified 
identifier matches more than a single sequence header in the database, or indeed 
no sequence in the database, the function will produce a warning message.  
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Figure 2.4: Overview of ‘create_database’ function. 
 
FastA formatted files are shown as grey boxes and their filenames in white 
boxes. Invoking the ‘create_database’ function (a) combines numerous sequence 
files into (b) a single sequence database file. (c) Shows the ‘format_blast’ option 
that will generate the required database files for BLAST [Altschul et al., 1990]. 
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Figure 2.5: Overview of ‘gene_selection’ function. 
 
FastA formatted files are shown as grey boxes and their filenames in white 
boxes. Data confirmation steps indicate if the results passed the check. (a) The 
‘gene_selection’ function requires two files to operate: a database (Human.fasta) 
and a user specified gene identifiers file (genes.csv). (b) The function operates 
using header confirmation to identify sequences in the database that match to 
those specified by the user. (c) The output of the function is a single sequence 
file for each user specified genes found.  
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2.8 Phase 2: Homology searching 
The second phase of bmeTools is concerned with identifying homologous groups 
of sequences from either BLAST or HMMER searches. A homologous group of 
sequences is restricted to those that are found by a recursive connection function 
(Figure 2.6). Three types of homology are recognized by bmeTools: non-
reciprocal (unidirectional), reciprocal (bidirectional), and best-reciprocal. “Non-
reciprocal similarity” is characterized by sequence similarity that is only detected 
by one of the pair of sequences, commonly resultant of an E-value near the 
threshold. Non-reciprocal similarity is generally distantly related sequences. 
“Reciprocal similarity” is similarity identified by both sequences in the pair. 
Reciprocal similarity is typically closely related orthologs or paralogs. “Best-
reciprocal similarity” requires that the sequences pass two criteria: (i) they are 
sequences from different species, and (ii) in the pair-wise connection each 
sequence finds no other sequence in the respective species with a lower E-value. 
These requirements limit identification to orthologs (non-orthologs may be 
identified due to identical E-values).   
 
Each type of similarity connection is invoked using a separate function and will 
generate the families specific to that connection type. Each function is required 
to be linked to a protein sequence database (Section 2.6.3). The database is used 
to produce an output file of each similarity group containing the protein 
sequences of each member. Each protein sequence file then undergoes multiple 
sequence alignment using bmeTools currently supported methods (MUSCLE and 
PRANK). More experienced users may wish to use unsupported methods – the 
package is flexible enough to permit these changes. 
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Figure 2.6: Recursive homology group creation function 
 
Genes are represented as circles and sequence similarity as grey arrows. Each of 
the similarity functions of bmeTools (‘similarity_groups’, ‘reciprocal_groups’, 
and ‘best_reciprocal_groups’) uses the same method for group creation. (a) The 
function begins by reading BLAST/HMMER input and sequentially identifying 
pairwise connections (connection requirements differ for each function, see 
Sections 2.7.2 and 2.7.3 for details). The arrow numbers indicate the sequential 
position (i.e. order of identification) of the respective pairwise connection. (b) 
The program will then generate the respective similarity groups using these 
connections. For example, two groups are created in the example above, one 
group contains five members (highlighted in blue) and another has three 
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members (highlighted in red). (c) The program will eventually encounter a new 
pairwise connection related to two previously generated similarity groups. (d) 
Such events will join the previous similarity groups – shown highlighted in blue 
and red – and a union of the groups – highlighted in green – will be reported in 
the results. 
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2.8.1 Core options 
Each function within Phase 2 includes three threshold options (default = 
disabled). The three options enable the user to define threshold values for the E-
value, alignment length, and percentage identity of each homology connection. 
Enabled thresholds must be passed for a pair-wise homology connection to be 
used. If the user has not enabled an E-value threshold, each function is designed 
to only incorporate E-values < 1, otherwise warning message is printed.  
 
2.8.2 Functions: similarity_groups and reciprocal_groups 
The ‘similarity_groups’ and ‘reciprocal_groups’ functions both construct 
sequence homology groups using a similar approach. Both functions iteratively 
read a single line of input (BLAST or HMMER output) and record only the name 
of the query and subject if they pass enabled thresholds. Limiting the recorded 
data of the homology search to sequence names and their respective role (query 
or subject) results in reduced computational requirements, increased function 
speed, and permits the function to parse larger BLAST or HMMER input files. 
Both functions are able to recognize and record input that denotes reciprocal 
homology of a previously recorded entry. Once each function has completed 
processing the input, the pair-wise homologs are used to build families (Figure 
2.6). The ‘similarity_groups’ function allows both non-reciprocal and reciprocal 
connections within a sequence group (Figure 2.7a) whereas ‘reciprocal_groups’ 
is restricted to reciprocal connection within a sequence group (Figure 2.7b). 
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2.8.3 Function: best_reciprocal_groups 
The ‘best_reciprocal_groups’ function constructs sequence homology groups by 
iteratively reading each line of input and storing the record within a database in 
reference to the query sequence. Once the function has completed parsing the 
input, the database is used to determine the best-homolog for each query 
sequence. This is achieved by identifying which subject sequence has the best E-
value for each designated species. The designated best-hit for each query are then 
parsed to determine if the relationship is reciprocal (i.e. the subject sequence [as 
a query] identifies the query [as a subject]).  If a query and subject are identified 
as best-reciprocal homology hits, they are used to create families (Figure 2.7c). 
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Figure 2.7: Similarity groups created by functions 
 
The families created using (a) ‘similarity_groups’, (b) ‘reciprocal_groups’, and 
(c) ‘best_reciprocal_groups’. Shorter lines represent better E-values between two 
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sequences (circles). Lines with a single arrow represent non-reciprocal or 
unidirectional similarity connections. Lines with arrows on both sides represent 
reciprocal or bidirectional similarity connections. Sequence identifiers are shown 
for each sequence, different species are designated in this figure by lowercase 
letter at the beginning of each sequence identifier – h (human), m (mouse), r 
(rat), g (gorilla). (a) the ‘similarity_groups’ function connects all sequences as 
they are connected by either unidirectional or bidirectional similarity 
connections. (b) the ‘reciprocal_groups’ function creates two groups because the 
sequences mGY and rGY only exhibit a bidirectional similarity connection with 
each other.  (c) the ‘best_reciprocal_groups’ function creates a three groups as 
the gorilla GX2 (gGX2) exhibits a stronger (i.e. lower e-value) bidirectional 
similarity connection with human GX2 (hGX2)  than  human GX (hGX).  
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2.9 Phase 3: Alignment assessment and phylogeny reconstruction 
Phase 3 of bmeTools combines multiple third-party programs to automate the 
assessment of protein MSAs and enable simplified phylogenetic reconstruction. 
Alignment error is reported to cause high rates of false positives in a selective 
pressure analysis (Section 1.4.1). Therefore, bmeTools incorporates third-party 
programs for MSA comparison and scoring. A complete analysis of the MSAs 
from each method is recommended. The next step in this phase is the selection of 
the empirical model of evolution that best-fits each MSA [Foster, 2004; Keane et 
al., 2006]. Phase 3 concludes with an automated method for phylogenetic 
reconstruction using the selected MSA and model of evolution. As bmeTools 
was created with inexperienced users in mind, the functions of this phase are 
primarily designed to interface with selected third-party programs. However, 
each step of this phase has been made optional if the user has different 
preferences. 
 
2.9.1 Function: metal_compare 
The ‘metal_compare’ function is designed to fully automate MSA comparison 
and scoring. The function operates using the third-party program MetAl 
[Blackburne and Whelan, 2012] to compare two protein MSAs (as described in 
Section 1.4.1). If MetAl indicates that the two MSAs are dissimilar, the function 
employs the third-party program noRMD [Thompson et al., 2001] (as described 
in Section 1.4.1) to score each protein MSA using column-based similarity. The 
MSA with the highest noRMD (i.e. column-based similarity) score is then 
selected for subsequent analysis.  
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The ‘metal_compare’ function incorporates two additional options 
(‘metal_cutoff’ and ‘alignment_preference’) that may be configured by the user. 
The ‘metal_cutoff’ option assigns the numeric threshold determining MSA 
dissimilarity and by default is fixed at 5% (0.05). Alignment methods that yield 
MetAl scores lower than 0.05 are considered comparable, and in that case the 
‘alignment_preference’ option may be used to specify an alignment method 
preference. If ‘alignment_preference’ is not configured the function by default 
will select the MSA from the first alignment method.  
 
2.9.2 Functions: prottest_setup and prottest_reader 
The ‘prottest_setup’ function is designed to automate the process of identifying 
the best-fit model of amino acid replacement for a specified protein alignment 
using the third-party program ProtTest3 [Darriba et al., 2011]. The function is 
designed to test each amino acid replacement model in both the presence and 
absence of rate-heterogeneity (i.e. invariant sites, gamma categories). The 
‘prottest_reader’ function automates the process of reading the output of 
ProtTest3. The function creates two output files: best_models.csv and 
best_supported_models.csv. The best models file reports the best-fit model of 
amino acid replacement (± rate-heterogeneity) reported by ProtTest3 whereas the 
best supported file reports the best-fit model of amino acid replacement (± rate-
heterogeneity) supported by the third-party phylogenetic reconstruction program 
MrBayes [Ronquist and Huelsenbeck, 2003]. The two output files are given to 
enable the user to use different phylogenetic reconstruction software if desired.  
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2.9.3 Function:  mrbayes_setup 
The ‘mrbayes_setup’ function is designed to simplify the process of phylogenetic 
reconstruction using the third-party program MrBayes [Ronquist and 
Huelsenbeck, 2003]. The function begins by converting each protein MSA into 
the nexus format (Figure 2.8a). Each nexus-formatted MSA is then appended 
with a standardized MrBayes command block that defines the variables required 
for phylogenetic reconstruction (Figure 2.8b-d) (Section 1.3.2.3), they include 
the number of MCMC generations, the number of chains (trees) to be examined 
per generation, the temperature of the heated chain, the burn-in percentage, and 
the best-fit model of amino acid replacement (Section 2.8.2).  
 
The ‘mrbayes_setup’ function incorporates multiple options (‘mcmc_gen’, 
‘mcmc_chains’, ‘mcmc_temp’, ‘mcmc_burnin’) for permitting the user to alter 
variables within the MrBayes command block (Figure 2.8b-d). The ‘mcmc_gen’ 
option sets the number of generations for the phylogenetic reconstruction and 
should be increased from the default value of 200,000 if previous attempts failed 
to converge. The remaining options have the following recommended settings by 
default: ‘mcmc_chains’ i.e. the number of chains (default = 4), ‘mcmc_temp’ i.e. 
the temperature of the heated chain (default = 0.2), and ‘mcmc_burnin’, i.e. the 
burn-in percentage respectfully (default = 0.25).  
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Figure 2.8: Overview of ‘mrbayes_setup function. 
 
 (a) The NEXUS file is separated into two blocks, a sequence alignment block 
and a MrBayes command block. (b) The specific commands within the MrBayes 
command block are each assigned default values (in bold) based on recommend 
values and previous commands. (c) The commands lset and prset by default are 
assigned from the ‘best_supported_models.csv’ file generated in Section 2.8.2. 
(d) The remaining commands are assigned based on recommended values, but 
may configured by the user is desired. 
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2.10 Phase 4: Selection analysis 
Phase 4 of bmeTools automates selective pressure analysis using codeML from 
the PAML package [Yang, 2007]. Phase 4 is characterized by specific commands 
for the simple and advanced pipeline options (Figure 2.1). These pipeline-
associated functions are designed to process the specific input of each pipeline 
into a standardized file format for the common functions used by both pipelines. 
Following standardization, bmeTools automates the normally labor-intensive 
process of creating the necessary files and directory structures for codeML. 
Phase 4 also incorporates a single optional function ‘branch-label table’ (Section 
2.9.6) that may be invoked to enable the branch-site models of codeML.  
 
2.10.1 Function: map_alignments 
The ‘map_alignments’ function is designed to automate the conversion of protein 
MSAs to nucleotide MSAs. This process is mandatory - codon substitution 
models of codeML require nucleotide alignments. Protein-MSA guided 
nucleotide MSAs are generated rather than directly generating nucleotide MSAs 
because: i) each column within the protein MSA represents aligned codons and 
therefore avoids aligning incomplete codons or frame-shift mutations, and ii) 
protein MSAs represent a comparison of the phenotype-producing elements of 
protein-coding sequences (Figure 2.9a). The function begins by reading the 
protein MSA to map the non-gap position of each codon within the inferred 
nucleotide alignment (Figure 2.9b). The sequence of the mapped codons is then 
inferred using the nucleotide dataset (Figure 2.9c). If the mapping process results 
in no errors, the respective nucleotide MSA is created (Figure 2.9d). All errors 
detected by the function will be returned within a separate log file.  
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Figure 2.9: Overview of the ‘map_alignments’ function 
 
Sequence files are shown above as grey boxes indicating the sequences and 
white boxes indicating the filename. The ‘map_alignments’ function requires (a) 
two files to operate: a protein alignment (Alignment.fasta) and a nucleotide 
sequence database (Database.fasta). The function initiates by (b) mapping the 
gaps of the nucleotide alignment. (c) The nucleotide sequence of each alignment 
is then mapped using the sequence database to produce (d) the completely 
mapped output file. 
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2.10.2 Function: infer_genetree 
The ‘infer_genetree’ function is designed to automate the creation of the 
corresponding gene tree for a user-specified MSA. This is achieved by 
associating the taxa specified on a user-defined species tree with the headers 
created by ‘label_filename’ and ‘infer_ensembl_species’ (Section 2.6.1.1) within 
the MSA. The function operates by first creating a copy of the species tree with 
the species names (Figure 2.10a). The species names are then replaced with their 
associated MSA headers (Figure 2.10b). If any species names remain after the 
MSA associating phase, the taxa and their respective branches are removed from 
the tree to create the finished gene tree (Figure 2.10c). It should be noted that the 
‘infer_genetree’ function incorporates the non-standard python library dendropy 
[Sukumaran et al., 2010], details on this requirement can be found in Section 
2.11.2. 
 
The ‘infer_genetree’ function incorporates a single option ‘allow_paralogs’ that 
is disabled by default. Normally, ‘infer_genetree’ is designed to only allow a 
single MSA header to associate with a species name (Figure 2.10d). If multiple 
headers are found to associate with a species name, bmeTools will produce a 
warning message. The ‘allow_paralogs’ may be enabled in these situations if the 
association error(s) are caused by within-species paralogs, in this case a gene tree 
will be created with associated headers shown as within-species paralogs (Figure 
2.10e). 
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Figure 2.10: Overview of the ‘infer_genetree’ function. 
 
 (a) The ‘infer_genetree’ function requires two files to operate: a nucleotide 
alignment (Sequence_group_00.fasta) and a species phylogeny to determine the 
phylogenetic relationship of the sequences within the alignment in relation to the 
species phylogeny. (b) The function begins by replacing each species name 
within the phylogeny with their respective gene identifier (i.e. Human  
Human|TLR2) located in the nucleotide alignment. (c) The function then creates 
the gene phylogeny by removing the species that have not been replaced by a 
gene identifier. (d) If the nucleotide alignment specified by the user contains 
paralogs (Chicken TLR2A and TLR2B) bmeTools will produce an error 
message. (e) If the ‘allow_paralogs’ option is enabled the function will create a 
new branch to house the paralogs with the original species acting as an ancestral 
node.  
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2.10.3 Function: setup_codeml 
The ‘setup_codeml’ function is designed to simplify the creation of the complex 
codeML directory structure. This is achieved by incorporating previously written 
in-house software ‘GenerateCodemlWorkspace.pl’ written by Dr. Thomas Walsh 
to produce the codeML directory structure [Walsh, 2013]. The purpose of 
automating the program ‘GenerateCodemlWorkspace.pl’ via ‘setup_codeml’ was 
to simplify input requirements and enable high-throughput analyses. The 
function requires only a protein-inferred nucleotide MSA (Section 2.9.1) and an 
associated phylogenetic tree (Section 2.9.6) to construct the directory structure 
for the codeML site-specific models [Walsh, 2013]. However, if the user has 
created the optional branch-label table (Section 2.9.6) and enabled the 
‘label_table’ option the function will create the directory structure for the 
codeML branch-site models (Section 1.3.2.2 for description of models). 
Automating the branch-site models requires a specific directory for each species 
and/or lineage specified by the user in the optional branch-label table (Figure 
2.11a). Next the ‘setup_codeml’ function will produce a codeML “taskfile” that 
contains each codeML command line command to be computed (Figure 2.11b). 
Following creation of the taskfile, a separate log file reporting the branch-site 
models that cannot be tested (due to missing taxa) is produced.  
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Figure 2.11: Overview of the ‘setup_codeml’ function. 
 
 (a) Using the branch-label table (branch_table.txt) the function produces 
species-labelled (highlighted) phylogenies for each species or ancestral node 
specified and then automates the production of the codeML directory for the 
branch-site models. (b) The function terminates by producing a codeML taskfile 
with all the codeML command line commands required to complete the job. 
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2.10.4 Function: create_subtrees 
The ‘create_subtrees’ function is designed for high throughput tree pruning. This 
optional step is often required to prune very large multigene family phylogenies 
into smaller phylogenies. User phylogenies may require pruning due to 
feasibility concerns as subfamilies increase data manageability and decrease 
computational requirements. Users may require this option for pruning out SGOs 
for selection analyses that are focused on single genes. The function operates by 
displaying the current phylogeny with a set of pruning commands/options. The 
user is then prompted to select of the four commands: ‘select subtree’, ‘remove 
subtree’, ‘remove leaf’, or ‘keep original’. If either ‘select subtree’ or ‘remove 
subtree’ is selected, the user is prompted to select a single node (numbered on the 
displayed phylogeny) for selection or removal respectively (Figure 2.12a/b). If 
‘remove leaf’ is selected, the user is prompted to select a leaf label (sequence 
header) for removal (Figure 2.12c). If ‘keep original’ is selected the tree 
manipulation step is skipped. The ‘create_subtrees’ function will produce a 
protein sequence file of the remaining nodes in the phylogeny (Figure 2.12d). 
The protein sequence file is then required to undergo re-alignment and it 
proceeds from Phase 3 through the remainder of the pipeline (Figure 2.1). The 
‘create_subtrees’ function will also produce a separate log file of the original 
phylogeny, the selected command, and the resulting phylogeny. The 
‘create_subtrees’ function incorporates the non-standard python library dendropy 
[Sukumaran et al., 2010] (Section 2.11.2). 
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Figure 2.12: Overview of the ‘create_subtrees’ function. 
 
 (a-c) shows an example of the node-labelled phylogeny displayed for the user is 
shown on the left for each option. (a) If the user specifies the ‘select subtree’ 
option along with a node, the function will create the subtree by separating the 
specified node from its next common ancestor node and returning the requested 
subtree. (b) The ‘remove subtree’ options functions identically to ‘select subtree’ 
except that requested subtree is discarded and rather the subtree containing the 
common ancestor node is returned. (c) The ‘remove leaf’ option will remove the 
specified taxa from the phylogeny. (d) The function terminates by creating 
sequence files for each pruned phylogeny. 
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2.10.5 Function: mrbayes_reader 
If phylogenetic reconstruction has been performed by MrBayes then the 
‘mrbayes_reader’ function is designed to replace ‘infer_genetree’ [Ronquist and 
Huelsenbeck, 2003]. The function operates by converting the nexus-formatted 
phylogeny into the newick format supported by bmeTools and codeML. If the 
function is unable to locate the original amino acid fasta-formatted MSA 
required by ‘mrbayes_setup’ (Section 2.8.3) the nexus-formatted MSA will be 
converted and placed with the newick-formatted phylogeny. It should be noted 
that ‘mrbayes_reader’ is unable to check phylogenies for convergence. Instead 
users are directed to confirm convergence using the third party program Tracer 
[Rambaut et al., 2014].  
 
2.10.6 Function: create_branch 
The ‘create_branch’ function is designed to simplify the creation of the branch-
label table required for the optional branch-site models of codeML (Section 
1.3.2.2). The branch-label table (previously shown in Figure 2.11a) indicates the 
lineages or ‘branches’ that will undergo lineage-specific selection analysis, i.e. 
designation of the “foreground lineages” for codeML. Each line indicates one 
lineage, either a species or an ancestral node. Ancestral nodes (uniquely named 
by user [i.e. Eglires]) are followed by a list of descendant (extant) species (Figure 
2.11a). The function operates by displaying a user-specified species phylogeny 
and promoting the user to select the species and/or ancestral nodes (numbered on 
the displayed phylogeny) of interest for the study (identical display methodology 
as described in Section 2.9.4 - see phylogeny in Figure 2.12a for example). When 
the user has finished their selection, the function will automatically produce the 
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branch-label table. It should be noted that this function is completely optional as 
the branch-label table may be easily created by hand. The ‘create_branch’ 
function incorporates the non-standard python library dendropy [Sukumaran et 
al., 2010] (Section 2.11.2). 
 
2.11 Phase 5: Selection analysis assessment 
2.11.1 Function: codeml_reader 
The ‘codeml_reader’ function is designed to parse the complex codeML 
directory structure and create simplified results for inexperienced users. This is 
achieved by incorporating in-house software ‘CreateSummaryReport.pl’ written 
by Dr. Thomas Walsh [Walsh, 2013] to produce the majority of the codeML 
results. In addition to automating ‘CreateSummaryReport.pl’, ‘codeml_reader’ 
produces supplementary output files that are designed for detection of false 
positives. If the user specifies a branch-label table (Section 2.9.6) 
‘codeml_reader’ will produce codeML MSAs, these MSAs are characterized by 
the addition of i) the putative positively selected sites, and ii) the codons/amino 
acids that are positively selected in the respective lineage/s (Figure 2.13).  
 
2.12 General requirements of the software package 
2.12.1 Core functions 
Each phase of bmeTools incorporates multiple core functions that are designed to 
minimize code redundancies. Primary core functions include: a log file creator, a 
sequence reader, a sequence writer, general sequence tools (translator, labeller, 
stop-codon detector, and length calculator), homology connection reader, 
homology group creator, general output creators, and sequence/alignment 
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verifiers. Each core function is designed with high flexibility to allow general 
use. 
 
2.12.2 Software dependencies 
The bmeTools software package is designed to minimize potential software 
dependencies, as additional software requirements may be difficult for 
inexperienced users to install on their systems. Currently, the non-standard 
python library dendropy [Sukumaran et al., 2010] is the only dependency that 
remains in bmeTools. Dendropy incorporates numerous functions for storing 
phylogenetic information and simplifying tree-based analyses. Removal of 
dendropy would require substantial development time and the design of 
numerous core functions. However, installation of dendropy is simple and only 
requires a single command to be invoked by the user. If the user invokes a 
dendropy-dependent function, bmeTools is designed to print a warning message 
detailing the installation process of dendropy if the software is not installed. 
 
2.13 Case study 
2.13.1 Project overview 
The feasibility of the bmeTools software package for simplifying large-scale 
selective pressure analysis was explored in our international collaboration on the 
bowhead whale genome project. From a biological perspective this investigation 
was of particular interest given the unusually long lifespan of bowhead whales 
and their apparent lack of cancer [George et al., 1999; Caulin and Maley, 2011; 
de Magalhaes, 2013]. We compared the bowhead, minke, and orca to 20 other 
placental mammals, with marsupial, and monotreme outgroups (Figure 2.13). 
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This unique opportunity to explore cetacean molecular evolution was made 
possible by the recent publication of the minke whale genome [Yim et al., 2013], 
our collaboration with the bowhead and orca whale genome-sequencing efforts 
and our bmeTools software package.  
 
2.13.2 Analysis Pipeline 
Here we applied the simple SGO option in the bmeTools package (Figure 2.1), 
this was mostly due to time constraints imposed by the consortium. A genome-
wide analysis of the protein coding elements of all genomes (as per Sections 
2.6.1 – 2.6.3) was performed by carrying out an all-vs-all BLASTp with an E-
value cutoff of 10
-7
.  BLASTp results were then examined and 866 reciprocal 
SGOs were identified (as per Sections 2.7.2). Protein MSAs were created using 
PRANK to account for the high levels of indels observed in the bowhead and 
minke genomes. CodeML analysis focused on the branch-site models of each 
extant cetacean lineage and the two ancestral lineages (i.e. the most recent 
common ancestor (MRCA) of all cetaceans and the MRCA of baleen whales) 
using phylogenies inferred from a mammal species tree and protein-inferred 
nucleotide MSAs (Sections 2.9.1 - 2.9.3 and 2.9.6). CodeML results were 
subsequently verified for potential alignment-based false positives using 
codeML-enhanced alignments (Section 2.10.1). 
 
2.13.3 Overview of Original Findings 
Examining the three extant cetacean genomes for the number of SGOs exhibiting 
lineage-specific positive selection resulted in the following: bowhead (112 
SGOs), minke (112 SGOs), and orca (28 SGOs). It should be noted that data 
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quality varied greatly across the cetacean genomes and may contribute to 
elevated values observed in the baleen whales (bowhead and minke). A 
functional survey by the genome-sequencing queried the putative cases of 
positive selection in the bowhead whale for previous published links to longevity 
and resulted in the following genes of interest: COQ6 (coenzyme Q6 
monooxygenase), ERCC1 (Excision repair cross-complementation group 1), 
TP53TG5 (TP53 [tumor protein p53] target 5), TTI1 (TELO2 [telomere 
maintenance 2] interacting protein 1), and XRCC2 (X-ray repair complementing 
defective repair in Chinese hamster cells 2). 
 
2.13.4 Data Quality Concerns and Importance of filters 
In-depth analysis of the bowhead sequences of COQ6, ERCC1, TP53TG5, TTI1, 
and XRCC2 by the genome-sequencing effort identified evidence of potential 
annotation error. The genes of interest were subsequently re-annotated to 
eliminate the possibility of false positives (Section 1.4). Repeating the codeML 
analysis with the re-annotated bowhead COQ6, ERCC1, TP53TG5, TTI1, and 
XRCC2 resulted in no evidence of lineage-specific positive selection.  
 
To minimize other potential false positives in the selection results, the MSAs of 
the 866 SGOs underwent strict data-quality filtering. The first imposed filter 
prohibited the presence of gaps in the MSA if created by unique insertions in 
either Bowhead or Minke sequences. The second imposed filter required 
unaligned Bowhead or Minke sequences to be at least half the length of their 
respective MSA. These two filters reduced the number of testable SGOs to 319. 
Examining the refined SGOs for evidence of lineage-specific positive selection 
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resulted in the following: bowhead (14 SGOs), minke (10 SGOs), and orca (6 
SGOs), (Figure 2.13 and Table 2.1). 
 
Both the re-annotation effort that led to the identification of the false positives in 
the bowhead lineage (i.e. COQ6, ERCC1, TP53TG5, TTI1, and XRCC2) and the 
substantial impact of data-quality filtering highlight the importance of genome 
quality and annotation in selective pressure analyses. We can only reliably 
predict selective pressure variation if each protein coding sequence is accurate. 
For this reason, high-quality genomes with high quality annotations are required 
for an accurate inference of positive selection and are strongly recommended for 
use with this pipeline.  
 
2.13.5 Feasibility of bmeTools 
Employing bmeTools in the analysis of the bowhead whale resulted in a 
streamlined and simple analysis that could be completed within the imposed time 
constraints. Data manipulation techniques that would have typically been time 
consuming and error-prone in an analysis of this size have been completely 
automated. For example, the inference of nearly one thousand gene phylogenies 
from a single species phylogeny was completed in less than five minutes without 
error. In addition, the interpretation of the codeML results and identification of a 
great number of alignment-based false positives (Section 1.4.1) was greatly 
simplified by employing the bmeTools-produced alignments. The inability of 
bmeTools to directly detect the annotation errors of the bowhead and minke 
whale indicate that the pipeline is only suitable for users experienced in 
identifying high-quality genomes with high quality annotations. For this reason, 
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bmeTools will remain a software package for internal laboratory (and trusted 
collaborators) use for the time being. Updates to bmeTools will be made in the 
near future to verify the suitability of the data for analysis to remedy this 
shortcoming (in addition to other improvements).  
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Figure 2.13: Phylogeny of mammals used in comparison of selective 
pressure variation. 
 
The figure shows the mammals used in the selective pressure analysis conducted 
with bmeTools. The number of candidate genes under positive selection on each 
extant species – bowhead (blue), minke (red), and orca (dark green) – and 
ancestral lineages – baleen whales (i.e. bowhead and minke [in yellow]) and – 
cetaceans (i.e. orca, bowhead, and minke [in light green]) is indicated within the 
color boxes. 
  
Chimp
Bushbaby
Human
Macaque
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Orangutan
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Microbat
Dog
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Cow
Minke
Bowhead
Orca
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Table 2.1: Proteins with evidence of lineage-specific positive selection 
 
Lineage Protein Position of Positively Selected Residues
Bowhead BAMBI BEB: 204
Bowhead C19orf38 BEB: 88
Bowhead CCDC181 BEB: 65, 89, 91, and 265
Bowhead TBC1D19 BEB: 469
Bowhead ZNF646 BEB: 211, 608, 702, 796, and 829
Bowhead ARL6IP6 BEB: 18
Bowhead DMP1 BEB: 322 and 386
Bowhead IFI30 BEB: 316
Bowhead GAPT BEB: 197**, 228**, 265**, 269**, 271*, a nd 278**
Bowhead SPP2 BEB: 15
Bowhead C22orf15 BEB: 46* and 75
Bowhead ZGLP1 BEB: 333**
Bowhead LIME1 BEB: 148 and 330
Bowhead Gm15440 BEB: 117
Cetacea SRRD BEB: 176 and 289
Cetacea TMEM119 BEB: 102 and 340**
Cetacea C12orf68 BEB: 124 and 150**
Minke NDC80 BEB: 193**
Minke CRHBP BEB: 331**
Minke MLEC BEB: 15** and 115*
Minke AKAP12 BEB: 160, 217, 250, 268, 295, 592, 609, 627, 821, 1065, 1563, a nd 1923**
Minke DMP1 BEB: 24, 84, 145, 153**, 184, 214, 241, 261, 279, 292, 322, 342**, a nd 360
Minke PIGV BEB: 232
Minke GPLD1 BEB: 690, 831**, and 865
Minke C3orf49 BEB: 237
Minke MN1 BEB: 162, 1089**, and 1152
Minke LIME1 BEB: 140, 257**, and 326
Mysticeti BAMBI BEB: 24**, 127**, and 181
Mysticeti ESPL1 BEB: 166, 1054**, 1081, 1220, 1748, a nd 2005
Mysticeti SRRD BEB: 148, 316, and 319
 109 
Table 2.1: Proteins with evidence of lineage-specific positive selection 
 
The table shows the proteins identified under lineage-specific positive selection. 
The proteins are sorted into the respective lineage in which the positive selection 
was observed. Each protein is reported with the positions of the residues 
identified as positively selected and the empirical Bayes model used – BEB or 
NEB – to calculate the posterior probability of the residues being under positive 
selection (see Section 1.3.2.2 for details). The probability of the residues being 
under selection is also reported at three cutoffs: residues with a probability only 
Lineage Protein Position of Positively Selected Residues
Mysticeti IGSF6 BEB: 65**, 69, 106, and 207
Mysticeti ODF1 BEB: 41**, 64, 76**, and 99**
Mysticeti C4orf29 BEB: 35, 56, 317, 342, 344, a nd 375
Mysticeti DNALI1 BEB: 95 and 355
Mysticeti BBS12 NEB: 535*
Mysticeti TC2N BEB: 109, 154, 301, and 399
Mysticeti C17orf59 BEB: 57** and 243
Mysticeti PPP1R15A BEB: 75, 113, 624*, and 691
Mysticeti PODXL BEB: 774 and 779
Mysticeti BRICD5 BEB: 19**
Mysticeti CXCL17 BEB: 17, 21**, 28, 45, 110, 113, and 124
Mysticeti C22orf15 BEB: 36
Mysticeti HPS6 BEB: 14, 152**, 187, 248, 420, 557**, a nd 574
Mysticeti C9orf131 BEB: 251**, 584, 713, 1028, 1048, a nd 1053
Mysticeti MBLAC1 BEB: 22, 23**, 218, and 255**
Orca AP5M1 BEB: 15, 93**, 130, 406, 439, 532**, 533**, 534**, a nd 535**
Orca IL33 BEB: 37, 45**, 77, 173, a nd 217
Orca GAPT BEB: 173, 192**, 193, 195, 225, 271, 272*, a nd 276**
Orca APOA2 BEB: 33**, 64, and 94
Orca G0S2 BEB: 22**, 54, 56**, and 101
Orca LIME1 BEB: 205, 252, 256, 274, 276, a nd 290
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greater than 0.50 are unmarked, residues with a probability only greater than 0.90 
are marked with a single asterisk (*), and residues with a probability greater than 
0.95 are marked with a double asterisk (**). See table of abbreviations for the 
name of each protein shown above. 
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Chapter 3: Evolutionary immunology: exploring the potential of identifying 
species-specific innate immune responses from sequence data 
 
  
 112 
3.1 Chapter Aim 
Human and mouse last shared a common ancestor approximately 100 million 
years ago. Therefore their systems such as the innate immune system have 
approximately 200 million years of independent evolution. The primary aim of 
chapter three was to assess what level of lineage specific positive selection had 
occurred in the human and mouse lineages since they diverged and whether these 
positively selected residues were fixed or variable in modern populations. Then 
we wished to determine if positive selection had occurred whether it was 
confined to specific pathways or interacting proteins. And finally, with the 
growing body of literature on human mouse innate immune discordance we 
wished to determine if positive selection identified in the innate immune system 
correlated with known phenotypic discordance in immune response between 
human and mouse.  
 
To achieve these goals, the bmeTools package developed in chapter two was 
applied as we carried out a genome-wide lineage-specific selective pressure 
analysis in the human, mouse, and multiple ancestral lineages of the 
Euarchontoglires clade (primate, rodent, and murinae).  
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3.2 Introduction 
The study of innate immunology relies predominately upon the mouse as a 
model organism. However, it is becoming increasingly evident from the 
literature that there are inconsistencies between human and our model organisms 
in terms of response to pathogenic infection [Mestas and Hughes, 2004]. For 
example, a key receptor in innate immunity is toll-like receptor (TLR) 4, upon 
detecting gram-negative bacteria TLR4 triggers the activation of factors 
(MYD88, TIRAP, and TRAF6) that regulate immune and inflammatory 
responses [Kawai and Akira, 2010]. Coding sequence mutations in TLR4 have 
been shown to produce nickel sensitivity in human but not mouse [Schmidt et 
al., 2010]. This unpredictability of immune response between human and our 
model organisms is particularly problematic in clinical trials as outlined in 
Section 1.1.4 [Stebbings et al., 2007]. Discordance is a significant issue 
contributing to the unpredictability of modelling human disease [Mestas and 
Hughes, 2004]. The completion of a large variety of vertebrate genomes, 
including the recently completed 1000 Human and 17 Mouse genome projects 
[Keane et al., 2011; Abecasis et al., 2012], and the increased quality attained for 
the Neandertal [Green et al., 2010], provide us with a unique opportunity to 
approach the problem of discordance in immune response from an evolutionary 
perspective, permitting us to address the molecular underpinnings of known 
discordance cases along with predicting novel discordance candidates at the 
molecular level. 
 
The “Red Queen hypothesis” describes the evolutionary arms race between host 
and pathogen [Van Valen, 1973]. This dynamic results in signatures of positive 
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selection (synonymous with protein functional shift) detectable at the molecular 
level in immune related genes [Sawyer et al., 2005]. It is not surprising therefore 
that genes of the immune system tend to have the highest levels of positive 
selection in comparison to other functional categories of genes [Kosiol et al., 
2008]. Indeed it is known that this can also occur at the species-specific level 
[Sawyer et al., 2005]. The relationship between positive selection and protein 
functional shift has also recently been elucidated using rational mutagenesis of 
positively selected residues in a human enzyme called myeloperoxidase (MPO) 
that is produced by neutrophils [Loughran et al., 2012]. MPO exhibits a novel 
chlorination activity among the mammalian heme peroxidase family [Loughran 
et al., 2012]. Three positively selected residues (N496, Y500, and L504) were 
attributed to conferring chlorination activity as mutating them to their respective 
ancestral peroxidase residues abolished novel function [Loughran et al., 2012]. 
These and other recent studies have shown a clear relationship between positive 
selection and protein functional shift [Farhat et al., 2013; Moury and Simon, 
2011]. In this chapter we set out to determine if orthologous innate immune 
proteins function in precisely the same way across different species using an in 
silico approach. We also set out to predict which innate immune proteins are 
most likely to have altered function in a given species thereby contributing to 
observed discordance in response to infection.  
 
Here we have used patterns of conservation and variation to map regions of 
possible discordance in the innate immune system of human, mouse, and their 
closest MRCAs. We have combined comparative genomics, molecular evolution, 
structural modeling and population data analyses to identify both human and 
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mouse-specific adaptive evolutionary events. Not only do our results correlate 
with known discordance cases from the literature - thereby showing the value of 
our approach - but these findings also provide us with a platform for the 
prediction of novel molecular and phenotypic discordance of relevance to 
modeling of human disease. 
 
3.3 Materials and Methods 
3.3.1 Generating the vertebrate innate immune gene dataset 
The full list of documented innate immune genes was downloaded from 
InnateDB [Lynn et al., 2008] (Appendix 3.1). The InnateDB database is 
manually curated and requires experimental evidence for all entries [Lynn et al., 
2008]. The InnateDB dataset was filtered for documented evidence of a human 
ortholog, which restricted our dataset to 725 Ensembl gene identifiers. This filter 
was imposed as our primary interest is in discordance between human and mouse 
innate immune response and due to InnateDB housing data for human, mouse, 
and bovine. 
 
The 21 high coverage (>6x) vertebrate genomes were downloaded from Ensembl 
BioMart (Ensembl Gene 60) [Kinsella et al., 2011] (Table 3.1). The longest 
transcripts for all protein coding genes were taken for each genome [Kinsella et 
al., 2011]. The downloaded genomes underwent a simple quality check using the 
‘clean’ function within the program ‘FastaTools.py’  (Appendix 3.2 – function in 
bmeTools package [Section 2.6.1]). This function tested the integrity of the 
protein coding sequences by ensuring they had complete codons. Transcripts 
then underwent translation into proteins using the ‘translate’ function from the 
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program ‘FastaTools.py’ (Appendix 3.2 - function in bmeTools package [Section 
2.6.2]).  
 
Homologs for the 725 innate immune genes were identified from the 21 
vertebrate genomes using standalone BLASTp (v2.2.23+) [Altschul et al., 1990]. 
The query sequences required by BLAST were provided by the ‘GeneSelect’ 
function within ‘FastaTools.py’ (Appendix 3.2 - function in bmeTools package 
[Section 2.6.4]). The database to query was created using the ‘database’ function 
within ‘FastaTools.py’ (Appendix 3.2 - function in bmeTools package [Section 
2.6.3]). BLASTp was run with an E-value threshold of 1.0e-10.  
 
Initial clustering of the BLAST results using MCL produced large multigene 
families containing more than one innate immune gene each. Therefore, a 
conservative E-value threshold of 1.0e-100 was imposed along with an alignment 
length threshold of approximately 85-87%. These thresholds were applied as 
they maximized the number of gene families that contained only orthologous 
genes while accounting for the possible presence of species-specific gene 
duplications, which are known to affect selective pressure variation [Zhang, 
2003]. A best reciprocal BLAST approach was deemed unsuitable, as the 
approach is unable to account for gene duplications. Gene families were created 
with these thresholds using the ‘brc’ or Reciprocal Check function in 
‘BLASTer.py’ (Appendix 3.2 - function in bmeTools package [Section 2.7.2]). 
Gene families that contained six or more members were retained for further 
analysis.  
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Table 3.1: Details on the vertebrate genomes used in this study. 
 
The phylogenetic relationship, common name, genome assembly, fold coverage, 
and contig N50 are given for each the 21 vertebrate genomes used in this chapter. 
All details given were gathered from Ensembl [Kinsella et al., 2011], NCBI 
Assembly, and respective genome publications. 
 
 
 
 
 
Species Assembly Coverage Contig N50
Human GRCh37 High 38Mb
Chimpanzee CHIMP2.1.4 6 50kb
Gorilla gorGor3.1 2.1 & 35 11kb
Orangutan PPYG2 6 15kb
Marmoset culJac3 6 29kb
Mouse NCBIM37 High 32Mb
Rat RGSC3.4 6 52kb
Guinea Pig cavPor3 6.79 80kb
Rabbit OryCun2 7 64kb
Dog CanFam3.1 7.6 267kb
Horse EquCab2 6.79 112kb
Cow Btau_4.0 7 78kb
Pig Sscrofa9 24 69kb
Elephant loxAfr3 7 69kb
Opossum MonDom5 7.33 108kb
Platypus OANA5 6 11kb
Chicken WASHUC2 7.1 45kb
Zebrafinch taeGut3.2.4 6 39kb
Xenopus JGI41 7.6 22kb
Fugu FUGU4.0 8.5 52kb
Zebrafish Zv9 7.5 1Mb
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3.3.2 Selection of multiple sequence alignment method 
MSAs were created for each gene family using two distinct alignment methods 
under standard conditions: MUSCLE (v3.8.31) [Edgar, 2004] and PRANK 
(v100802) [Loytynoja and Goldman, 2005]. MUSCLE was selected due to the 
reported accuracy and efficiency of the algorithm [Edgar, 2004]. PRANK was 
selected due to the unique ability of the algorithm to distinguish insertions from 
deletions within an alignment [Loytynoja and Goldman, 2005]. Excluding the +F 
option for PRANK designates that the algorithm should not align inferred 
insertions, but the algorithm still correctly distinguishes insertions from deletions 
but inferred insertions may be aligned [Loytynoja and Goldman, 2008]. Reports 
indicate that including the +F option improves sequence alignments and 
downstream analyses in comparison to traditional alignment methods [Loytynoja 
and Goldman, 2008]. However, the +F option is only recommend if the 
phylogeny can be fully trusted [Loytynoja and Goldman, 2008; Loytynoja and 
Goldman, 2010]. For this reason, the PRANK alignments were constructed 
without the +F option. 
 
The MUSCLE and PRANK MSAs for each family were subsequently compared 
by MetAl (v1.1.0) [Blackburne and Whelan, 2012] using the function 
‘scoreMetAl’ from the ‘metalman.py’ program (Appendix 3.2 - function in 
bmeTools package [Section 2.8.1]). MetAl measures variation between MSAs 
produced by different alignment methodologies. Using the default metric (d-pos) 
a percentage is returned indicating the difference between the alignment methods 
[Blackburne and Whelan, 2012]. MSAs were treated as identical if the returned 
percentage was ≤ 0.05 (5%) [Communication with Blackburne and Whelan]. If 
 119 
alignments were reported as identical, we chose the MUSCLE alignment. If the 
alignments were >5% different they were subsequently compared using noRMD 
(v1.2) [Thompson et al., 2001] with the function ‘noRMDchk’ from the 
‘metalman.py’ program (Appendix 3.2 - function in bmeTools package [Section 
2.8.1]). MSAs with greater column-based similarity will return higher noRMD 
scores. The methods that returned the higher noRMD was used, if the noRMD 
scores were identical, again MUSCLE alignments were favoured.  
 
3.3.3 Selecting the best-fit model of protein evolution using ProtTest3 
ProtTest3 (v3.0) [Darriba et al., 2011] was selected for identifying the best-fit 
substitution model. Using the function ‘SetupProtTest’ in the program 
‘MUSCLEman.py’ (Appendix 3.2 - function in bmeTools package [Section 
2.8.2]), each MSA was assessed by ProtTest3 with a subset of the substitution 
models (JTT [Jones et al., 1990], Dayhoff [Dayhoff et al., 1978], Blosum62 
[Henikoff and Henikoff, 1992], VT [Muller and Vingron, 2000], and WAG 
[Whelan and Goldman, 2001]), see per command below. Limiting the number of 
substitution models because software used in subsequent steps of our analysis 
pipeline only used these models. 
 
Substitution models were also assessed in the presence of different variables of 
rate-heterogeneity, including: invariable sites (+I) [Reeves, 1992], variable rate 
categories (+G/Γ) [Yang, 1993], and a combination of these two factors 
(+I+G/Γ). Using a maximum likelihood approach ProtTest3 determines the 
likelihood of each substitution model (± rate-heterogeneity), and compares these 
scores using the Bayesian Information Criterion (BIC) [Schwarz, 1978]. Using 
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the function ‘CheckProtTest’ in ‘MUSCLEman.py’ (Appendix 3.2 - 
subsequently incorporated into bmeTools.py [See 2.5.2.3]), the substitution 
model (± rate-heterogeneity) for each MSA with the highest overall BIC value 
was identified as the best-fit model of protein evolution. 
 
3.3.4 Phylogenetic reconstruction by MrBayes 
Phylogenetic reconstruction was carried out for all gene families using MrBayes 
(v3.1.2) [Ronquist and Huelsenbeck, 2003]. The function ‘SetupMrBayes’ in 
‘MUSCLEman.py’ (Appendix 3.2 - function in bmeTools package [Section 
2.8.3]) was used to automate the generation of nexus formatted alignments and to 
append the MrBayes command-block, see Figure 2.8 for example. The function 
‘SetupMrBayes’ reads the output of ProtTest3 and assigns two parameters within 
the command-block: i) the substitution model, and ii) rate-heterogeneity (Figure 
2.8).  
 
For each gene family, the standard number of four Markov chain Monte Carlo 
(MCMC) chains were set. As is standard practice, three of the chains acted as 
“heated” chains to better allow the regular sampling "cold" chain to escape local 
maxima/peaks [Ronquist et al., 2011]. Each MCMC chain ran for a minimum of 
10
6
 generations or until MrBayes reported convergence and the average standard 
deviation of split frequencies reflected convergence < 0.01 [Ronquist et al., 
2011]. Chains were sampled every 200 generations with a standard burn-in of 
0.25 (25%) to remove the initial generations prior to likelihood stabilization 
[Ronquist et al., 2011]. 
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3.3.5 Extracting SGOs from multigene family 
A number of phylogenies contained gene duplicates. Where appropriate the 
program ‘nodes_picker.py’ (Appendix 3.2 - function in bmeTools package 
[Section 2.9.4]) was used to remove (or prune) the SGO of interest alongside its 
respective orthologous genes (Figure 2.12). Following such extraction the 
reduced gene family were realigned (Section 3.2.2) and continued through the 
analysis. 
 
3.3.6 Selective pressure analysis 
Selective pressure analyses were performed using codeML from the PAML 
package (v4.4e) [Yang, 2007]. CodeML examines nested codon-based models of 
evolution in a Maximum Likelihood framework to determine ω [Yang, 2007] 
(See Section 1.3.2.2 for more details). We employed branch-site specific models 
to scan for positive selection unique to a specific foreground lineage [Yang and 
dos Reis, 2011]. Using the function ‘SetupCodeml’ in ‘MUSCLEman.py’ 
(Appendix 3.2 - function in bmeTools package [Section 2.9.3]), the codeML 
input for each homologous group was generated: i) a nucleotide MSAs inferred 
form the previously selected protein MSAs (Appendix 3.3) (Section 2.9.2), and 
ii) the labeled phylogenetic trees required for the branch-site specific models for 
the extant species (human and mouse) and ancestral lineages (primates, murinae, 
and rodents) of interest. Using the programs ‘GenerateCodemlWorkspace.pl’ and 
‘SetupCodemlTaskfarm.pl’ written by Dr. Thomas Walsh, the nucleotide MSAs 
and labeled phylogenetic trees were assessed for the modelA branch-site specific 
model. 
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The codeML results were interpreted by implementing likelihood ratio tests 
(LRTs) using the program ‘CreateCodemlReports.pl’ written by Dr. Thomas 
Walsh [Walsh, 2013]. The LRT test statistic approximates the chi-squared (χ2) 
distribution critical value with degrees of freedom equal to the number of 
additional free parameters in the alternative model. If branch-site specific models 
passed LRT and positive selection is inferred, the posterior probability of the 
positively selected site is estimated by ‘CreateCodemlReports.pl’ using two 
calculations: NEB or BEB [Yang, 2007]. If both BEB and NEB are predicted, we 
used the BEB results as they have been reported to be more statistically robust 
[Yang, 2005]. The candidate positively selected sites were then compared to 
UniProt protein entries using the program ‘swissAlign.py’ (Appendix 3.2).  
 
3.3.7 Identifying evidence of recombination breakpoints 
Detection of recombination breakpoints was performed on the nucleotide 
alignments of each putative positively selected gene using RDP3 [Martin et al., 
2010]. RDP3 implements a wide range of independent recombination detection 
methods: RDP [Martin and Rybicki, 2000], BOOTSCAN [Martin et al., 2005], 
GENECONV [Padidam et al., 1999], MAXCHI [Smith, 1992], CHIMAERA 
[Posada and Crandall, 2001], SISCAN [Gibbs et al., 2000], and 3SEQ [Boni et 
al., 2007]. Implementing multiple detection methods in tandem has been 
recommended to more accurately detect recombination [Posada and Crandall, 
2001]. Additionally, these methods are broadly categorised into two distinct 
detection approaches: phylogeny-based (RDP, Bootscan, and SISCAN) and 
substitution-based (CHIMAERA, MAXCHI, GENECONV, and 3SEQ). A past 
comparative study of recombination detection methods reported GENECONV, 
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CHIMAERA, and MAXCHI as the most powerful substitution-based methods, 
with CHIMAERA and MAXCHI performing best overall [Posada and Crandall, 
2001]. The more recent substitution based detection method, 3SEQ has been 
reported to be comparable in power to CHIMAERA [Boni et al., 2007]. 
Comparisons of the phylogeny-based detection methods have found 
BOOTSCAN and SISCAN to perform well [Martin et al., 2005; Posada and 
Crandall, 2001]. 
 
The program ‘recombReader.py’ (Appendix 3.2) was then used to parse the 
RDP3 output for the nucleotide alignment (created in 3.2.6) for each gene with 
signatures of positive selected. Due to the inherent difficulty of identifying 
recombination breakpoints, all recombination events were required to be 
statistically significant for at least one substitution-based and one phylogenetic-
based detection method.  
 
3.3.8 Structural analysis of TLR3 
Three-dimensional structures of mouse and human toll-like receptor 3 (TLR3) 
ectodomain were modeled using MODELLER [Eswar et al., 2008]. We obtained 
100% sequence identity between the target sequences and template structure for 
mouse (PDB id: 3CIG) and human (PDB id: 2A0Z). The dynamic flexibility 
index (dfi) [Gerek et al., 2013] was then computed. The dfi score quantifies the 
dynamic properties of individual residues in the protein structure and the stability 
change caused by mutating residues.  
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Certain positions in a 3-D structure are more susceptible to perturbation, showing 
high fluctuation responses and high dfi values, whereas other positions with low 
dfi values are stable and the stability of the proteins does not deviate significantly 
upon perturbation. Therefore, higher dfi means greater chance that this mutation 
does not alter the 3D structure and by assuming that structure and function are 
tightly linked [Lee et al., 2007], these high dfi scores indicate non-function 
altering mutations.  
 
Using this approach, stability change is estimated by the protein folding free 
energy (ΔΔG). A ΔΔG value for each amino acid substitution (mutant) is 
calculated from ΔGmutant - ΔGwt where ΔGwt is the wild type free energy of 
unfolding.  To compute the ΔΔG values for each amino acid substitution, we 
applied the FoldX method [Guerois et al., 2002; Schymkowitz et al., 2005] that 
uses empirical potential combining both physical force fields and free parameters 
fitted with known experimental data. If the value of ΔΔG is greater than 0, the 
mutation has a destabilizing effect on the protein structure, while ΔΔG<0, the 
mutation is stabilizing, we used 1kcal/mol as a threshold. First, we computed the 
stability change of positively selected residues in the mouse structure and then 
the corresponding orthologous residues in the human structure. Finally, we 
estimated ΔΔG for all possible amino acid substitutions in the human structure, 
including disease-associated sites in human. Disease-associated sites were 
obtained from the Human Gene Mutation Database (HGMD) [Stenson et al., 
2003]. We also estimated ΔΔG caused by all possible amino acid substitutions 
for randomly selected sites. 
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3.3.9 Fixation of positively selected sites in populations 
To determine if the positively selected sites for each positively selected gene 
were fixed within their respective populations, variation data was downloaded 
from Ensembl Biomart (Ensembl Variation 72) [Kinsella et al., 2011]. Human 
variation data was limited to validated single nucleotide polymorphisms (SNPs) 
to increase accuracy of the assessment; this limitation was not imposed on mouse 
variation due to the small number of validated mouse SNPs. Using the program 
‘buildVariation.py’ (Appendix 3.2) a total of 559 SNPs were mapped onto the 
protein sequence of 29 positively selected genes (Human 2, Mouse 27), see 
Table 3.2. Using the program ‘buildFixationData.py’ (Appendix 3.2) the SNP-
mapped protein sequences were combined with positive selection data (Section 
3.2.6) to identify the positively selected sites that were not fixed in the 
population. 
 
3.3.10 Assessing positively selected genes for evidence of selection within 
human population data: 
To determine if population data corroborated the findings from the species-level 
comparisons for positive selection in human lineage, variation data was 
downloaded from the 1000 Genomes Project website, with each individual 
consisting of two chromosomal samples [Abecasis et al., 2012]. Using the 
program ‘1000Reader.py’ (Appendix 3.2) the SNP data from the 1000 Genomes 
Project for each was separated into individuals. Population sequence alignments 
for each positively selected gene were created using ‘genemapper.py’ (Appendix 
3.2), this program built alignments in two steps: i) it created the genomic 
sequence of the individual by mapping their respective SNPs onto the reference 
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genome [Kinsella et al., 2011], and ii) it added each completed individual 
nucleotide sequence to the overall alignment. Using DnaSP [Librado and Rozas, 
2009], we calculated Tajima’s D [Tajima 1989] and Fay and Wu’s H [Fay and 
Wu, 2000] for these population alignments. Fay and Wu’s H requires an 
outgroup sequence, to satisfy this requirement the respective chimpanzee 
genomic sequences (with 1kb of flanking DNA) for each positively selected gene 
was obtained from Ensembl Biomart (Ensembl Gene 72) [Kinsella et al., 2011]. 
Chimpanzee sequences were aligned to the human population data using 
MUSCLE [Edgar, 2004] and chimpanzee-flanking sequence was cleaved using 
TrimAl [Capella-Gutiérrez, 2009]. To determine the significance of Tajima’s D 
and Fay and Wu’s H, 10,000 coalescence simulations were conducted for each 
gene [Hudson, 2002].  
 
To determine if the regions surrounding the genes identified as positively 
selected in human from the species-level comparative analysis exhibited 
evidence of selective sweep, we created 1kb alignments between 100kb upstream 
and 100kb downstream of each positively selected gene. Population sequence 
alignments for the regions surrounding the positively selected genes were created 
using a modification to ‘neutralSetup.py’ (Appendix 3.2); alignments were 
created as described above with the reference sequence. DnaSP [Librado and 
Rozas, 2009] was used to calculate Tajima’s D [Tajima, 1989] for each window. 
Significance was determined for Tajima’s D [Tajima, 1989] for each window as 
described above. All graphs were created using the matplotlib python library 
[Hunter, 2007].  
  
 127 
Table 3.2: Genes tested for positively selected site fixation in their 
population. 
 
The table shows the gene name, species, and the number of available non-
synonymous SNPs from Ensembl Biomart (Ensembl Variation 72) [Kinsella et 
al., 2011] for each of the 29 genes under positive selection. The SNP site column 
indicates the number of non-synonymous SNP that mapped to protein coding 
residues.   
Gene Species SNP Sites Gene Species SNP Sites
CARD6 Human 38 Nlrp14 Mouse 16
IRF9 Human 9 Lgals3 Mouse 15
Stat2 Mouse 58 Ifit2 Mouse 14
C6 Mouse 53 Irf5 Mouse 14
Nlrp6 Mouse 53 Il1rapl2 Mouse 11
Il4ra Mouse 51 Adipoq Mouse 9
Plcg2 Mouse 51 Cfh Mouse 8
Lrrfip1 Mouse 49 Cd63 Mouse 6
C8b Mouse 36 Card6 Mouse 4
Lbp Mouse 33 Tlr3 Mouse 4
Rnf31 Mouse 24 Atg9a Mouse 3
Tcf4 Mouse 20 Trif Mouse 3
C1ra Mouse 16 Snap23 Mouse 2
Grn Mouse 16 Ecsit Mouse 1
Ltb4r1 Mouse 16
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3.4 Results 
3.4.1 Selection analysis reveals species-specific adaptation in mouse and 
human innate immune genes: 
A total of 457 protein coding single gene orthologous families were analyzed. As 
functional divergence could have emerged prior to the divergence of modern 
human and mouse all ancestral lineages across the Euarchontoglires clade were 
tested (Figure 3.1), i.e. the ancestral primate, murinae and rodent branches, as 
well as modern human and mouse. Following LRT analyses [Yang, 2007] five 
candidate genes were identified as under positive selection in the human lineage 
(LAP2, CARD6, C1RL, INPP5D, and IRF9). Analysis of the lineage leading to 
modern mouse revealed 44 genes under positive selection this is out of a total of 
366 gene families that had a mouse ortholog (Appendix 3.4). The branch leading 
to primates, murinae and rodents showed evidence of positive selection specific 
to these lineages in 19 (12.93%), 23 (14.20%), and 9 (11.25%) of testable genes 
respectively (Appendix 3.4). These results emphasize the heterogeneity in 
selective pressures on innate immunity in different lineages.  
 
3.4.2 Filtering for false positives due to recombination removes potential 
candidate genes from the positively selected gene set: 
To reduce the level of false positive detection for adaptive evolution we applied a 
number of subsequent filters on the results outlined above. The first was a test for 
recombination that has previously been associated with potential false positives 
[Anisimova et al., 2003]. Any putative positively selected gene that had evidence 
of recombination proximal to positively selected sites was removed from our list 
of positively selected genes (Figure 3.1). In total, 12 positively selected genes 
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were identified with evidence of recombination, three human genes (C1RL, 
LAP2, and INPP5D) and nine mouse genes (Cd22, Csf2rb, Itgam, Ptk2, Sirpa, 
Tlr8, Traf5, Tyro3, and Zp3r), these were subsequently removed from the list of 
genes under positive selection (Table 3.3). See Table 3.4 for an updated list of 
the positively selected genes. From the analysis of the ancestral branches there 
were a total of three murinae genes (Igf1r, Itgam, and Tyro3), two primate genes 
(BCAR1 and NLRP9), and one rodent gene (Tyro3) removed (Table 3.5). 
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Figure 3.1. Phylogeny of species included in this study and summary of 
lineage-specific positive selection results.  
 
The lineages within the Euarchontoglires clade (denoted by grey box) tested for 
species-specific selective pressure variation are shown in colored boxes: human 
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(yellow), ancestral primate lineage – human, chimpanzee, gorilla, orangatun, and 
marmoset – (red), mouse (dark green), ancestral murinae lineage – mouse, rat – 
(light green), and ancestral rodent lineage – mouse, rat, and guinea pig – (blue). 
Dashed lines are provided to increase clarity of the species and are unrelated to 
the branches of the phylogeny. The initial number and percentage of genes 
displaying evidence of species-specific positive selection are shown in grey. 
Totals after the filter for recombination are shown in black. 
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Table 3.3: Recombination within human and mouse positively selected genes. 
 
The gene name and positively selected residues are given for each gene exhibiting a recombination event. The location of the recombination 
event is given alongside the sites within the event (internal) and within close proximity of the event (proximal). 
Gene 
Name
Positively Selected Residue Positions
Recombination 
Event
Internal Recombination 
Sites 
Proximal 
Recombination Sites 
C1RL 103 127 - 247 103
INPP5D 72, 223, 227*, 228**, 235, 239, 241, 244, 249, a nd 250 218 - 248
223, 227*, 228**, 235, 
239, 241, and 244
249 and 250
LAP2 714 and 1194 1197 - 1261 1194
Cd22 137, 190, 271, 474, and 812 1 - 68
Csf2rb 169, 271, 288, 473, 536, 569, a nd 576 68 - 161 169
Itgam 23, 45, 820, 831, 844, 1035, 1089, 1092, a nd 1131 1110 - 1206 1131
Ptk2 390** and 800 366 - 447 390** 
Sirpa
23, 51, 52**, 69, 77, 83, 91, 193, 202, 221, 224, 226, 237, 238, 
250, 276, 297, 305, 307, 338**, 344, a nd 490
 6 - 74 23, 51, 52**, and 69 77
Tlr8 44, 751, 764*, 778, 802*, 864, a nd 1003 23 - 80 44
Traf5 133, 308, 309, and 339 223 - 302 308, 309, and 339
Tyro3 85, 101, 825, and 826 0 - 88 & 700 - 787 85
Zp3r
3, 7, 39, 110, 174, 179, 206, 212, 219, 244, 31 1, 454, 460, 461, 
470, 485, 488, 510, 514, 518**, 524*, 528, 537, 541, a nd 546
396 - 445 454, 460, and 461
Genes under positive selection specifically in the human lineage
Genes under positive selection specifically in the mouse lineage
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Table 3.4: Positively selected genes identified in this study. 
 
Gene name Position of positively selected residues
CARD6 264, 346, 382, 750, 767, 805, 818, 903, 916, 937, 998, 1010, a nd 1031
IRF9 119, 129, and 333
Adipoq 25, 27, 29, and 82
Atg9a 634 and 662*
C1inh 332*, 365, 468, 479
C1ra 468, 520, 574, 631, 633, a nd 634*
C6 220, 233, 319, 353, 378, 408, 419, 430, 554, 655, 681, 703, 792, and 930
C8b 242*, 263, 278, 383*, and 488
Card6 394, 501, and 702
Cd200 129 and 177
Cd63 31, 118, 143, 184*, 194, and 203
Cfh 209, 243, 474, 767, 1005, 1068, 1074, 1104, 1181, and 1227
Ecsit 10, 12, 75, 82, 176, 325, 330**, 348, and 371
Eif2ak2 136, 155, 181, 182*, 344, and 345
F12 45, 65, 166, 243**, and 454
Grn 18, 101, 198, 303, 375*, 382, 411, 549, and 597
Ifit2 191, 402, and 420
Il1rapl2 566, 628, and 666*
Il2rb 4, 13, 31, 55, 174, 202, 347*, 402, 418, 491, 496, a nd 516
Il4ra 47, 67, 308, 330, and 626
Irf5 232, 259, and 262
Lbp 24, 40 and 329
Lgals3 22, 92, 94, and 260
Lrrfip1 328, 449, 468, 480, a nd 571
Ltb4r1 53, 101, and 175
Nlrp14
77, 79*, 186, 212, 219, 254, 257, 263, 272, 281, 284, 291, 294, 315, 319, 333, 
358, 393, 415, 424, 453, 465, 530, 549 , 552, 553, 584, 613, 657, 679, 684, 
685, 687, 696, 782,  810, 814, 829, 846, 848, 902, 908, 912, 931, 953, 956, 
958, 978, 982, 984, and 986
Genes under positive selection specifically in the human lineage
Genes under positive selection specifically in the mouse lineage
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Table 3.4: Positively selected genes identified in this study. 
 
The table shows the proteins identified under lineage-specific positive selection 
that showed no evidence of recombination proximal to positively selected 
residues. The proteins are sorted into the respective lineage in which the positive 
selection was observed. Each protein is reported alongside the positions that 
were identified by the BEB empirical Bayes model (see Section 1.3.2.2 for 
details). See table of abbreviations for the name of each protein shown above. 
Gene name Position of positively selected residues
Nlrp6
22, 25, 72, 77, 80, 81, 85, 96, 101, 113, 114, 190, 192, 251, 260**, 329, 344, 
479, 488, 515, 553, 571, 628, 657, 727, 737, 739, 744, 771, 775*, 776, 793, 
807, 865, 877, and 880
Oas2 55, 56, 139, 171, 199, 211, 221, 298, 481, 549, and 711 
Plcg2 461 and 594*
Ptpn2 166, 206, 319, 321, and 329
Rnf31 203, 431, and 1025
Sirt1 107, 537, 698, and 701
Snap23 109, 133, and 197
Stat2 21, 130, 149, 157, 195, 205, 218, 354, 623*, 869, 871, 874, 876, and 877
Tcf4 139
Tlr3 266, 297, and 603 
Trif 18, 327, 338, 388, 482, 556, a nd 711
Genes under positive selection specifically in the mouse lineage
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Table 3.5: Recombination within the ancestral lineages. 
 
The gene name and positively selected residues are given for each gene exhibiting a recombination event. The location of the recombination 
event is given alongside the sites within the event (internal) and within close proximity of the event (proximal). 
Gene 
Name
Positively Selected Residue Positions Recombination Event Internal Recombination Sites 
Proximal 
Recombination Sites 
BCAR1 475** and 602 84 - 916 475** and 602
IFNGR2 99, 126, 170, 195, 197, a nd 253 2 - 45
NLRP9 37, 362, and 502 94 - 106, 466 - 499, & 558 - 728 502
TLR8
142, 188, 193*, 212, 213, 255, 309, 312, 335, 349, 386, 387, 432, 562, 580, 
605, 634, 641, 690, 722, 793, 835, 850, 923, 975, 1013, 1087, 1089, a nd 1103
41 - 98
TRIM5 433, 520, 523, 538, 568, 584, 654, 767, 810, 842, 848, a nd 859 242 - 276
Mst1r 736 and 964* 267 - 376 & 814 - 880
Tyro3 91* 1 - 89 91*
Ccdc88a
195, 221, 443, 601, 613, 635, 638, 675, 995, 1021, 1031, 1037, 1219, 1230, 
1235, 1607, 1704, 1728, 1730, 1733, 1817, a nd 1827
89 - 113
Mst1r 97, 268, 291, 553, 769, a nd 1041 267 - 376 & 814 - 880  268 and 291
Traf6 16* 275 - 313
Igf1r 155 and 257** 39 - 227 155
Itgam 98, 132, 214, 226, 468, a nd 784 1 - 1111 98, 132, 214, 226, 468, a nd 784
Tyro3 101, 105, 127, 202, 223, 240, 406*, a nd 445 1 - 89 101 and 105
Genes under positive selection specifically in the primate lineage
Genes under positive selection specifically in the rodent lineage
Genes under positive selection specifically in the murinea lineage
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3.4.3 A subset of mouse innate immune pathways are enriched for 
adaptive evolution:  
Assessment of the two candidate genes in the human lineage (CARD6 and IRF9) 
revealed no evidence of protein-protein interaction among these proteins and no 
evidence for enrichment in particular innate immune pathways. Conversely, the 
35 candidates in mouse exhibited a number of proteins involved in direct 
interaction with one another (Figure 3.2) and in the same pathways: 5 genes in 
the complement cascade (C1ra, C1inh, C6, C8b, and Cfh - Figure 3.2a), 4 genes 
in the TLR signalling pathway (Irf5, Lbp, Tlr3, and Trif - Figure 3.2b), 3 genes 
in the JAK-STAT pathway (Stat2, Il2rb, and Il4ra), and a single genes in the 
MAPK signalling pathway (Ecsit). Of particular interest was the interaction 
between Trif and Tlr3. Trif exhibits positive selection within the Tlr3 interaction 
interface (Figure 3.2) [Oshiumi et al., 2003].  
 
3.4.4 The Ancestral nodes have unique subsets of genes under positive 
selection: 
We identified 18 genes with evidence of positive selection in the ancestral 
primate lineage alone and nowhere else on the tree. In terms of the functional 
classification of these genes they fell broadly into five categories: Nod-Like 
Receptors (NLRP1, NLRP5, NLRP8, and NLRP9), TRIM receptors (TRIM5 and 
TRIM25), Interferon gamma receptors (IFNGR1 and IFNGR2), TLR (TLR8), 
and one breast cancer related gene (BCAR1) (Appendix 3.4). Within this set of 
genes there is one known protein-protein interaction between IFNGR1 and 
IFNGR2 associated with the JAK-STAT pathway [Kanehisa and Goto, 2000]. 
Analyses of the ancestral rodent and murinae branches identified 7 and 14 genes 
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respectively as under positive selection (Appendix 3.4). There was limited 
information on function and associated pathways for these genes and there were 
no reports of direct protein-protein interactions in these subsets of the data. The 
C1inh protein from the complement cascade also featured as under positive 
selection in the ancestral murinae branch, and there was evidence for a murinae 
unique positive selection event in the TRAF6 protein, a gene known to interact 
with the TLR signaling pathway [Kanehisa and Goto, 2000]. 
 
3.4.5 Positively selected residues map to essential functional domains: 
To determine potential functional effects of positive selection we compared the 
positively selected residues identified in this study to functional data available on 
SwissProt [The UniProt Consortium, 2012]. Assessment of the 35 candidate 
genes under positive selection in the mouse lineage alone identified numerous 
examples of positively selected residues within known functional domains 
(Appendix 3.4). Where data permitted additional functional assessment was 
performed on the genes of the complement cascade (Figure 3.2c).  
 
  
 138 
Figure 3.2: Innate immune pathways containing positively selected genes.   
 
The positively selected genes in (a) the complement system and (b) the TLR 
signaling pathway are shown as darkened rectangles. Signaling cascades are 
depicted as arrows and inhibitors are depicted as blunt-ended lines. Defined 
pathways and complexes are shown in grey boxes with the given name. (c) 
Positively selected residues of the complement system alongside information on 
domain structure. Information on the function of these domains is also given. See 
table of abbreviations for the name of each protein shown above. 
b
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3.4.6 Positively selected residues in mouse TLR3 have predicted effects on 
structural stability: 
The dynamic flexibility index (dfi) measures the contribution of each residue to 
the overall structural dynamics and stability of the protein [Gerek et al., 2013]. 
The dfi approach measures the spatial fluctuation of each residue in response to 
perturbing residues along the peptide. Dfi values indicate the resilience of each 
residue to perturbations; a low dfi indicates a residue essential for dynamic 
stability as they absorb the transfer of perturbation (i.e. structurally inflexible) 
whereas high dfi implies the residue is prone to perturbation (i.e. structurally 
flexible) [Gerek et al., 2013]. Dfi values are reported to significantly correlate 
with known neutral variants (high dfi values) and residues strongly linked with 
genetic disease (low dfi values) [Gerek et al., 2013]. This correlation of dfi to 
biological function was also reported to have a greater ability to discern 
functionally critical from non-critical sites as compared to the solvent accessible 
surface area (ASA) metric frequently used to assess functional significance 
[Gerek et al., 2013]. 
 
LR3 was chosen for this analysis as it is well characterized and displayed lineage 
specific positive selection in mouse but not human. The human TLR3 disease-
associated residues displayed low dfi values [Stenson et al., 2003] (Figure 3.3) 
whereas the positively selected residues from mouse TLR3 (i.e. E266, Y297, and 
E604) and their counterparts in human (i.e. N265, W296, and P602) had 
moderate to high dfi values indicating structural flexibility (Figure 3.3). These 
findings are in keeping with the red queen hypothesis and the potential role of 
these sites in pathogen recognition or binding at the surface of the TLR3 
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ectodomain. We then calculated the change in protein stability for all possible 
amino acid substitutions at each position in the ectodomain of human and mouse 
TLR3 (Figure 3.3). We found no evidence of a destabilizing effect for the 
positively selected residues in the ectodomain of mouse TLR3 (E266, Y297, and 
E603) (Figure 3.3), indicating that these positions in mouse are tolerant to 
mutation and are structurally flexible. Mutating the homologous residues in 
human (N265, W296, and P602) we found two sites (W296 and P602) that 
exhibited an effect on folding stability. More specifically, of the 19 possible 
mutations of W296 and P602, destabilizing effects were observed in 13 and 18 
substitutions, respectively (Figure 3.3). Substitutions of W296 and P602 exhibit 
dfi profiles comparable to disease-associated sites, leading us to propose that in 
human these positions may also be fundamental for protein stability and 
structurally inflexible. Testing the effect of mutating randomly chosen residues 
we found no obvious patterns in protein destabilizing effects (Figure 3.3). Taken 
together, these data suggest that two of the positively selected residues in mouse 
TLR3 and their homologous positions in human TLR3 contribute differently to 
overall protein stability in these two species. 
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Figure 3.3: Dynamic flexibility index of human TLR3 ectodomain. 
 
Ribbon diagrams of the crystal structure of the TLR3 ectodomain of (a) human 
(PDB id: 2A0Z) and (b) mouse (PDB id: 3CIG). (a) and (b) are colored with a 
spectrum of red-yellow-green-cyan-blue representing the dynamic flexibility 
index (dfi), where red indicates the highest dfi values down to blue which 
indicates the lowest values. (c) The stability change for all possible substitutions 
was computed for: the positively selected sites in mouse (E266, Y297, and 
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E603), their human homologs (N265, W296 and P602), known human disease-
associated sites (N284, F303, L412, and P554) [Stenson et al., 2003], and 
randomly selected sites. Except for the randomly selected sites, sites have been 
indicated on the respective ribbon diagrams in the following colors: mouse 
positively selected sites in black, human homologs in brown, and human disease 
sites in red. 
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3.4.7 The majority of positively selected residues are fixed within human 
and mouse populations:  
Positive selection rapidly drives advantageous alleles to fixation within a 
population [Haldane, 1927]. Depending on the age of the event, effective 
population size (Ne) and the strength of selection, positively selected sites will 
either be fully fixed within a population or will have some degree of variability 
[Sabeti et al., 2006]. We sought to determine if the positively selected residues 
identified in human and mouse are fixed in their respective populations or 
whether they are variable (Table 3.6). We gathered all available SNP data for all 
positively selected genes, i.e. two human candidates and 27 mouse candidates. 
The majority of positively selected sites in both human (15/16 or 94%) and 
mouse (207/214 or ~97%) were entirely fixed in their lineage. The exceptions 
were the CARD6 gene in human and six mouse genes (C6, C8b, Ecsit, Il4ra, 
Nlrp14, and Stat2) (Table 3.6). Of the total of 8 positively selected residues 
across all 7 genes showing variability at the population level, four SNPs resulted 
in the ancestral residue present at the homologous position in other species, they 
were as follows: human CARD6 (G264E) and mouse Ecsit (S75L); Nlrp6 
(R744K); and Stat2 (L874M). In addition, there were two substitutions at 
positively selected residues in mouse genes that resulted in amino acids with 
similar physicochemical properties as the homologous position in another 
species: C6 (L554) and Il4ra (G626) (Table 3.6).  
 
The positively selected residues in human CARD6 and IRF9 genes were 
compared to the recently released Neanderthal genomes [Green et al., 2010]. The 
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same positively selected residues that are fixed in the modern human lineage 
were also found in Neanderthal.   
 
3.4.8 Population level data shows no ongoing selective sweep in modern 
humans: 
Within a population, positive selection not only leads to the fixation of an 
advantageous allele, but a notable reduction in variation in the surrounding 
region [Sabeti et al., 2006]. The regions identified in the species level analyses as 
positively selected were tested to determine if they are evolving neutrally in 
modern human populations, this was done using Tajima’s D statistic [Tajima, 
1989]. Tajima’s D is a scaled measurement of the difference between the number 
of segregating sites and average nucleotide diversity, the value of D is expected 
to be close to zero if sequences are evolving neutrally [Tajima, 1989]. Therefore, 
significant deviations from zero indicate sequences that are evolving non-
neutrally. To determine if our two candidate genes from human (CARD6 and 
IRF9) were evolving neutrally, their Tajima’s D was calculated (Figure 3.4a). 
Both had a negative Tajima’s D, indicating non-neutral evolution. These values 
were found to be statistically significant.  
 
We wished to determine if this “non-neutral” signal from the Tajima’s D statistic 
for CARD6 and IRF9 in human was due to positive selective pressure or 
purifying selective pressure. Fay and Wu’s H test was applied, as it accounts for 
derived alleles using an outgroup sequence [Fay and Wu, 2000]. Derived alleles 
are non-ancestral recent mutations that are expected to be at lower frequencies.  
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Table 3.6: Fixation of human and mouse positively selected genes. 
 
The gene name, number of positively selected residues, number of protein coding 
SNPs, and unfixed residues for each positively selected gene with variation data. 
If a coding SNP produces a positively selected residue that is not fixed within the 
Genes PS Residues Coding SNPs  
Residue(s) 
not fixed
Details
CARD6 13 38 G264E Ancestral residue
IRF9 3 9 None
Adipoq 4 9 None
Atg9a 1 3 None
C1ra 6 16 None
C6 14 53 R554L
Similar physicochemical 
properties
C8b 5 36 M263I
Card6 3 4 None
Cd63 6 6 None
Cfh 10 8 None
Ecsit 9 1 S75L Ancestral residue
Grn 9 16 None
Ifit2 3 14 None
Il1rapl2 3 11 None
Il4ra 5 51
F47S & 
D626G
D626G: Similar 
physicochemical properties
Irf5 3 14 None
Lbp 2 33 None
Lgals3 4 15 None
Lrrfip1 5 49 None
Ltb4r1 3 16 None
Nlrp14 51 16 A613S
Nlrp6 36 53 None Ancestral residue
Plcg2 1 51 None
Rnf31 3 24 None
Snap23 3 2 None
Stat2 14 58 L874M Ancestral residue
Tcf4 1 20 None
Tlr3 3 4 None
Trif 7 3 None
Genes under positive selection in the human lineage
Genes under positive selection in the mouse lineage
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population, the respective polymorphism and position are given. If the 
polymorphism is to an ancestral residue present at the homologous position in 
other species, it is designated as: Ancestral residue. If the polymorphism is to a 
residue that shares similar physicochemical properties to the residue as the 
homologous position in another species, it is designated as: Similar 
physicochemical properties.  
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However, derived alleles within close proximity of an advantageous allele may 
spread by hitchhiking and thereby become high frequency [Sabeti et al., 2006]. 
Assessment of CARD6 and IRF9 by Fay and Wu’s H test resulted in negative 
values that failed to reach significance, indicating that these regions are evolving 
neutrally (Figure 3.4a).  
 
The rapid fixation of an advantageous allele within a population results in a 
notable and skewed decrease in variation at linked neutral sites, termed a 
selective sweep [Sabeti et al., 2006]. To determine if our candidates from the 
species-level analyses exhibited evidence of reduced variability, a 1kb sliding 
window analysis of allele frequency was carried out incorporating 100kb of 
upstream and downstream sequence for each candidate gene. Departure from 
neutrality was measured in each window [Tajima, 1989], graphical 
representations of the results can be found in Figure 3.4b. The analysis of IRF9 
and CARD6 identified comparable levels of variation for all windows assessed. 
The results for the human candidate genes IRF9 and CARD6, are consistent with 
a potential positive selective pressure/sweep to fixation in the ancestral human 
lineage prior to the divergence of Neanderthal, and a relaxation of selective 
pressure in the current human population.  
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Figure 3.4: Neutrality tests for positively selected genes in the human 
lineage. 
 
 (a) Results of calculating Tajima’s D and Fay and Wu’s H and their respective 
95% confidence intervals from coalescent simulations for IRF9 and CARD6. (b) 
Sliding window analysis of Tajima’s D of the positively selected genes identified 
in human. The analysis was conducted using a window size of 1kb within 100kb 
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upstream and downstream of each gene. The 95% confidence interval is shown 
as red highlighted region. 
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3.5 Discussion 
In agreement with previous large-scale surveys of positive selection [Kosiol et 
al., 2008], we find a high frequency of positive selection in innate immune genes 
in the mouse lineage as compared to human. These high levels of species-
specific positive selection in human and in mouse were not observed in ancestral 
mammal lineages, suggesting that these sites are responding to more recent 
selective pressures.  
 
The candidate genes of both mouse and human exhibited some evidence of 
recombination breakpoints. It has been reported that this may produce molecular 
signatures indistinguishable from those of positive selection [Anisimova et al., 
2003] and genes with signatures for recombination were removed. 
 
The positively selected genes in mouse are components of well-known innate 
immune pathways, and are involved upstream and downstream in these 
pathways. In pathways enriched for positively selected members (e.g. TLR 
signaling pathways and complement system), more than half the components are 
involved directly or indirectly with initiation (Cfh, C1r, C1inh, Tlr3, and Lbp), 
indicating that upstream positions may be subjected to stronger positive selective 
pressure. Recent studies have reported a relaxation in selective constraint as you 
progress downstream through a pathway [Ramsay et al., 2009] whereas other 
reports detail patterns similar to those presented here [Alvarez-Ponce et al., 
2009]. The enrichment for positive selection that we observe in proteins 
functioning at the start of the pathways is most likely because many of these 
proteins interact directly with pathogens (C6, C8, and Lbp); bind to pathogens 
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for immunological defense (Cfh); or are pathogen recognition receptors (Tlr3) 
and are most likely under increased positive selective pressure from the pathogen 
[Van Valen, 1973]. The absence of human-specific positively selected genes 
within the TLR signaling pathways and complement system may be partially 
explained by a previous study of the evolution of TLRs in primates [Wlasiuk and 
Nachman, 2010] where they found primate TLRs exhibit an episodic pattern of 
evolution. In agreement with this pattern, we identified positive selection in 
TLR8 in the ancestral primate lineage.  
 
As positively selected sites have been documented to result in protein functional 
shifts [e.g. Loughran et al., 2012; Saywer et al., 2005], our results may implicate 
positively selected residues responsible for the emergence of divergent protein 
functions between human and mouse. We identified positively selected genes in 
the alternative, classical, and lectin pathways of the complement system in 
mouse indicating possible functional shift in these pathways in the mouse lineage 
alone. The complement system is reported to neutralize herpes simplex virus 
(HSV) in rat, mouse, and human [Wakimoto et al., 2002]. However, complement 
activation proceeds uniquely for each species: via the lectin pathway in mouse, 
via the alternative and lectin pathways in rat, and in human via the classical 
pathway [Wakimoto et al., 2002]. The exclusive use of the lectin pathway in 
mouse is of interest due to the presence of positively selected genes in the 
alternative (C1inh), classical (C1r and C1inh), and lectin (Cfh) pathways that 
offer potential molecular markers of in vitro study of the observed species-
specific functional shift. 
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The complement system is also reported to display functional discordance in 
response to Acanthamoeba infection. Both human and mouse are reported to 
initiate the complement system by the alternative pathway leading to 
Acanthamoeba binding with C9 of the membrane attack complex (MAC) 
[Pumidonming et al., 2011]. By contrast, the MAC of mouse is unable to lyse 
Acanthamoeba [Pumidonming et al., 2011]. Here we present evidence of 
positively selected residues in the C6 and C8b proteins of the complement 
cascade unique to the modern mouse lineage. Both the C6 and C8b proteins are 
essential to MAC formation and cell lysis [Aleshin et al., 2012], therefore these 
residues provide the community with a molecular target for the observed 
phenotypic discordance between human and mouse in their MAC activity. 
 
In comparison to innate immune genes with phenotypic discordance and a known 
molecular cause, our results were found to be moderately successful. The 
restriction factor TRIM5α is reported to confer a species-specific resistance to 
HIV-1 in rhesus macaque but not humans [Stremlau et al., 2004]. Selective 
pressure analysis performed on TRIM5α identified an 11- to 13-amino acid 
segment of the SPRY domain responsible for species-specific retroviral 
restriction [Sawyer et al., 2005]. In contrast, our analysis was able to identify 
TRIM5α as under positive selection within the ancestral primate lineage 
(Appendix 3.4), but was unable to identify the reported causative region. It 
should be noted that our analysis did not include the rhesus macaque and this 
could partially explain the variation in the results. Another example of a known 
innate immune discordance is TLR8, which is reported as being able to confer 
NF-B activation in response to multiple RNA ligands in human but not mouse 
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[Jurk et al., 2002; Forsbach et al., 2008; Liu et al., 2010]. The cause of this 
species-specific activation was determined to be a 5-amino acid motif – RQSYA 
– that was not present within mouse TLR9 [Liu et al., 2010]. Our analysis was 
able to identify TLR8 as being under positive selection in the ancestral primate 
lineage but the causative motif was not identified as being under positive 
selection.   
 
The preferred approach to test functional effect of positive selection is by in vitro 
analysis. The same approach (albeit with a less sophisticated branch-site model) 
has been shown to result in functional effects of positive selection in the innate 
immune related protein myeloperoxidase [Loughran et al., 2012]. Providing this 
human mouse discordance data will lead to further in vitro studies.  
 
In keeping with our computational approach we performed in silico structural 
modeling on the TLR3 protein. The difference in stability effects between human 
and mouse residues of the TLR3 protein suggests a major structural and 
functional discordance between human and mouse in their ability to detect 
double stranded RNA in viral infections. Indeed these findings for TLR3 are of 
particular interest given reports of the restricted anti-viral role of human TLR3 in 
comparison to mouse Tlr3 where LPS up-regulation of Tlr3 is seen in mouse but 
not in human macrophages [Ariffin and Sweet, 2013]. This is an important 
finding given the difficulty in modeling the human innate immune system 
[Mestas and Hughes, 2004]. This application of in silico modeling highlights its 
ability to predict molecular level signatures of species phenotypic discordance 
that warrant future in vitro study. 
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While the lineage leading to modern human and indeed Neanderthal display 
signatures of positive selection in two genes (CARD6 and IRF9), there is no 
evidence for an ongoing selective sweep in modern human in these genes 
[Tajima, 1989]. It should be mentioned that this approach is sensitive to the age 
of the adaptive event, because signatures of selective sweep are eventually lost. 
The outer limit of these analyses in human is approximately 250,000 years 
[Sabeti et al., 2006]. The conservation of these positively selected residues 
between modern human and Neanderthal may be due to shared ancestry making 
these adaptive events at minimum ~400,000 to 600,000 years old [Scally and 
Durbin, 2012]. 
 
The number of positively selected sites where the residue was variable within 
human or mouse was rare, in total 94% (in human) to 97% (in mouse) of 
positively selected sites were completely fixed in the modern human or mouse 
populations. There were a total of 8 sites where the positively selected residue 
was not fixed. All but one of these were from mouse population data and often 
encoded for ancestral residues observed in the corresponding position in other 
species (4 of 7) or that were physicochemically similar residues to those in other 
species in the alignment (2 of 7). It is important to note that the mouse 
population data is based on only 21 inbred laboratory mice strains, and likely 
does not represent true population structure due to their artificial selection 
histories [Keane et al., 2011].  
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There was a single unfixed positively selected site in our cohort of positively 
selected genes in human: position (G264E) of CARD6. This replacement SNP 
(rs61757657) is documented in only 3% of Africans and 1% of Americans (2% 
of Puerto Ricans) [Kinsella et al., 2011; 1000 Genomes Project Consortium, 
2012], suggesting that the putative positively selected residue is not completely 
fixed in these populations. Subsequent inspection of the multiple species 
alignment identified the codon of the unfixed E264 (GAA) to be homologous to 
the other great apes (chimpanzee, gorilla, and orangutan) within the alignment, 
suggesting multiple functional alternatives may be tolerated at this position. 
Disease association data would also prove valuable to determine if this 
polymorphism is slightly deleterious or neutral.  
 
The combined use of new data such as the recently completed 1000 human 
genomes and Neanderthal genomes with phylogenetic analyses of selective 
pressure, has potential for advancing our understanding of the molecular 
underpinnings of species-specific response to disease. Distinct species-specific 
selective forces are acting on components of the innate immune system, they are 
detectable at the molecular level and they align with known phenotypic 
discordance, thereby providing a predictive tool for the identification of currently 
unknown discordance cases of the immune system and beyond. 
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Chapter 4: A non-phylogenetic approach to determine gene organization 
and domain sharing within vertebrate protein coding regions 
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4.1 Chapter Aim 
Domain rearrangements in have been directly implicated in the creation of novel 
proteins, including the establishment of species-specific proteins. While 
characterizing and identifying such proteins would be highly beneficial to 
understanding functional discordance, traditional phylogenetic approaches are 
unable to fully characterize the events due to non-vertical nature of domain 
rearrangement. The primary aim of chapter four was to explore the ability of 
networks to: i) identify species-specific proteins create by domain 
rearrangements and ii) understand the properties of domain rearrangements in 
multi-domain proteins. These goals were achieved by constructing a network of 
Pfam-A domains to explore the ability of Pfam-A domains to co-occur within a 
gene. The co-occurrence network was then used to identify multi-domain 
exhibiting species-specific domain combinations. The network was also used to 
identify the governing principals of multi-domain proteins to determine if these 
principals differed in proteins exhibiting species-specific fusion events.  
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4.2 Introduction 
Phylogenetic trees have proven to be an invaluable tool for the field of 
evolutionary biology. Inferred from evidence of vertical descent, phylogenetic 
trees are commonly used to explore the evolutionary relationships among 
species, genes, and populations. While advances in phylogenetic reconstruction 
have led to complex models of evolution, this framework alone cannot fully 
explore the process of modular rearrangement in multi-domain (i.e. modular) 
proteins due to their non-vertical nature [Bapteste et al., 2013].  
 
An established view of protein modularity is the existence of functional modules 
– or domains – that are analogous to independently folding elements [Moore et 
al., 2008; Coulson and Moult, 2002]. Support for this claim has been 
documented from reports of mutations that affect the function of a particular 
domain but not the other domains of a protein [Tjoelker et al., 2000]. Domains 
are also reported to belong to domain families, which are collections of domains 
that share similar structural profiles and/or evolutionary histories [Andreeva et 
al., 2008; Finn et al., 2014]. Specific protein families, such as fibronectin III and 
kinases are widely used in the genome and found within a multitude of proteins 
[Little et al., 1994; Manning et al., 2002]. In addition, research indicates that 
several of these domain families are common to most species, indicating they 
may be ancient elements [Apic et al., 2001]. Considering the age and frequency 
of these domains families, it may not be surprising that research has shown that 
domain rearrangement have resulted in the creation of novel proteins [Bashton 
and Chothia, 2007]. As domain rearrangement may result in the creation of novel 
proteins, the identification of species-specific domain rearrangements is of 
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particular interest. For example, a number of species-specific composite genes 
(i.e. fusion of two or more genes) have been found to result in the establishment 
of unique species-specific functional properties [Thomson et al., 2000; Rogers et 
al., 2010; Molero et al., 2013]. Therefore, characterizing the governing 
characteristics of modular proteins – the domains combinations and 
rearrangements permitted – in addition to the identification of species-specific 
domain rearrangement may lead to a better understanding of protein evolution 
and the establishment of new function. 
 
In this chapter non-vertical evolution of modular proteins is explored by 
employing graph theory to accurately characterize the properties of modularity. 
In comparison to phylogenetic trees, graphs or “networks” represent biological 
data as unrestricted pairwise connections and allow genetic material to have 
multiple sources [Halary et al., 2010]. Therefore, a network considers the 
independent domains of modular proteins as individual genetic sources, and 
enables the exploration of modularity in proteins [Moore et al., 2008]. Previous 
applications of graph theory have found that biological graphs share many 
features with technological and social networks [Newman, 2003; Barabasi and 
Oltvai, 2004], highlighting the potential for universal laws of networks [Barabasi 
and Oltvai, 2004]. Beyond simply enabling the visualization of modular proteins, 
applying the concepts and techniques of network theory to biological data 
facilitates the exploration, discovery, and description of previously unknown 
properties and mechanisms of protein evolution. 
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To date, a considerable amount of research has been conducted on the modular 
rearrangements of proteins in a variety of species [Wuchty and Almaas, 2005; 
Moore et al., 2008; Kersting et al., 2012]. From these studies we have learned 
that rearrangement event such as domain fusion and fission, as well as large-
scale chromosomal events such as intragenic duplications, intergenic repeats, and 
exon relocation all play an important role in the evolution of modular proteins 
[Moore et al., 2008]. In addition, single-species networks have been successfully 
applied to understand the evolutionary impact of domain modularity [Wuchty, 
2001; Wuchty and Almaas, 2005]; nonetheless, much work remains to fully 
understand the impact of domain modularity and species-specific rearrangement 
in vertebrates.   
 
The data used in this chapter consisted of the CDSs from 30 vertebrate genomes, 
and the corresponding constructed Pfam domain co-occurrence network 
(Appendix 4.1). Here our goal is to determine the global properties of the 
domains combinations and rearrangements in the evolution of modular proteins 
in vertebrates including the discovery of species-specific domain rearrangement 
events that may result in potential functional discordance. 
 
4.3 Materials and Methods 
4.3.1 Bipartite graph and co-occurrence unipartite-projection of Pfam-A 
data: 
The profile hidden markov models (profile HMMs) of 14,831 Pfam-A domain 
families were downloaded from the Pfam website (v27.0) [Finn et al., 2014]. A 
total of 30 high-coverage genomes were downloaded from Ensembl Gene 73 on 
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Ensembl BioMart [Flicek et al., 2014] (Table 4.1). These annotated genomes 
together with the HMMscan function within standalone HMMER (v3.1b1) 
[Eddy, 1998] provided the sequence information required to identify homology 
of domains, i.e. Pfam-A motifs. Sequences homologous to Pfam-A domains were 
only reported if they passed a conservative E-value threshold of 1.0E-20. 
HMMscan homology connections were then filtered to account for the possibility 
of erroneously assigning Pfam-A domains to a gene due to the presence of either 
a composite domain or a domain family member.  
 
Composite Pfam-A domains are comprised of smaller Pfam-A domains (i.e. 
component domains) and may generate false domain combination preferences if 
component domains are not removed from the database. Domains were classified 
as component domains if they found within a larger Pfam-A domain. To account 
for the imperfect nature of determining exact alignment positions [Eddy, 2010], a 
component was allowed to have 5% of its sequence to be partially unaligned 
(either 5’ or 3’) to the composite domain. Identified components were removed 
from subsequent analysis. If multiple tiers of composites/components were 
identified only the largest overall composite was included in subsequent 
analyses, if multiple composites were found to share the largest length, the 
composite with the lowest e-value was selected.  
 
Domain families are characterized by possessing multiple Pfam-A domains with 
similar sequence motifs and may generate false domain combination preferences 
due to multiple Pfam-A domains aligning to the same position within a protein. 
To account for this potential error, if 80% of a Pfam-A domain was found to 
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overlap with another domain on a protein, only the Pfam-A domain with the 
lowest e-value was included in subsequent analyses. If multiple tiers of overlaps 
were identified only the Pfam-A domain with the lowest e-value was included in 
subsequent analyses. It should be noted that if there was evidence of domain 
families within a composite Pfam-A domain, the composite method of domain 
selection was preferred.   
 
The filtered homology connections (filtered using the program 
‘Pfam_Checker.py’ [Appendix 4.2]) were then used to construct a bipartite graph 
consisting of edges between Pfam-A domains and protein sequences (i.e. Pfam-A 
homology graph) (Appendix 4.1) using the program ‘Pfam_Checker.py’ 
(Appendix 4.2). The bipartite graph was subsequently separated into connected 
components to create Pfam-A homology sub-graph. A Pfam-A domain 
unipartite-projection was generated from the bipartite graph by removing each 
protein sequence node and inferring the connections between the Pfam-A 
domains based on the removed protein sequences (i.e. Pfam-A co-occurrence 
graph) (Appendix 4.1). Where possible Pfam-A co-occurrence sub-graphs were 
created. 
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Table 4.1: Details on the vertebrate genomes used in this study. 
 
The common name, genome assembly, fold coverage, and contig N50 are given 
for each the 30 vertebrate genomes used in this chapter. All details given were 
gathered from Ensembl [Flicek et al., 2014], NCBI Assembly, and respective 
genome publications. The contig N50 of the stickleback was not specified (n.s.). 
Species Assembly Coverage Contig N50
Anole Lizard AnoCar2.0 7 79kb
Cat Felis_catus_6.2 2 & 12 20kb
Chicken Galgal4 12 279kb
Chimpanzee CHIMP2.1.4 6 50kb
Coelacanth LatCha1 77.5 12kb
Cow UMD3.1 9 96kb
Dog CanFam3.1 7.6 267kb
Elephant loxAfr3 7 69kb
Fugu FUGU4.0 8.5 52kb
Gibbon Nleu1.0 5.6 35kb
Gorilla gorGor3.1 2.1 & 35 11kb
Guinea Pig cavPor3 6.79 80kb
Horse EquCab2 6.79 112kb
Human GRCh37.p12 High 36Mb
Macaque MMUL 1.0 5 25kb
Marmoset C_jacchus3.2.1 6.6 29kb
Microbat Myoluc2.0 7 64kb
Mouse GRCm38.p1 High 32Mb
Opossum MonDom5 7.33 108kb
Orangutan PPYG2 6 15kb
Panda ailMel1 56 39kb
Platypus OANA5 6 11kb
Platyfish Xipmac4.4.2 19.6 22kb
Rabbit OryCun2.0 7 64kb
Rat Rnor_5.0 3 & 6 52kb
Stickleback BROAD S1 11 n.s.
Turkey Turkey_2.01 17 12kb
Xenopus JGI41 7.6 22kb
Zebrafinch taeGut3.2.4 6 39kb
Zebrafish Zv9 7.5 1Mb
 164 
4.3.2 Pfam-A domain co-occurrence graph centrality: 
The following centrality measurements: degree, closeness, and betweenness, 
were calculated for each node within the Pfam-A co-occurrence sub-graphs using 
the program ‘General_Stats.py’ (Appendix 4.2). The calculation of degree 
centrality was independent of both in-degree and out-degree measurements as the 
sub-graphs were undirected. Closeness centrality values were normalized by the 
total number of remaining nodes (𝑛 − 1). Betweenness centrality values were 
normalized by maximum number of pairs of nodes not including the node of 
interest (
2
(𝑛−1)(𝑛−2)
) (as per Section 1.6.2.1).  
 
4.3.3 Node removal within unipartite-projected co-occurrence graph: 
Removing the 50 nodes with the highest degree, betweenness, or closeness 
centrality values from the Pfam-A co-occurrence sub-graphs allowed us to 
determine the role these nodes play in the structure of the graph. Using the 
program ‘node_deletion.py’ (Appendix 4.2), the impact was measured by 
calculating graph transitivity (see Section 1.5.2.4) [Luce and Perry, 1949] and 
average clustering (see Section 1.5.2.4) [Watts and Strogatz, 1998] pre- and post-
removal of nodes. Nodes were also removed at random from the graph and the 
same calculations were made. The process of selection and removal of random 
nodes from the graph was repeated 100 times.  
 
4.3.4 Pfam-A co-occurrence graph assortativity: 
Assortativity of the Pfam-A co-occurrence graph was visualized by plotting each 
edge of the graph by the degree (K) of its respective nodes. Assortativity was 
measured by: i) the linear regression of the average degree of nearest neighbors 
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for a node (<Knn>) plotted against K, and ii) the assortativity coefficient (r) 
[Newman, 2002; Newman, 2003], this was implemented in the program 
‘Network_Assortativity.py’ (Appendix 4.2). A confidence interval of the 
assortativity coefficient can be determined by creating randomized graphs that 
share the same degree distribution of the graph in question [Foster et al., 2010]. 
To determine the confidence interval, the program “Random_Assortativity” 
(Appendix 4.2) generated 10,000 randomized networks and computed the 95% 
confidence interval. 
 
4.3.5    Identification of domain co-occurrence communities: 
Pfam-A co-occurrence communities were identified from the largest Pfam-A co-
occurrence sub-graph using the NeMo plugin [Rivera et al., 2010] from the 
cytoscape package [Shannon et al., 2003]. NeMo identifies communities using a 
hierarchical method that permits the detection of internal sub-communities. The 
NeMo communities produced were evaluated as either independent (i.e. with 
sub-communities) or combined (i.e. without sub-communities). The remaining 
Pfam-A co-occurrence sub-graphs were automatically classified as independent 
communities as they lacked connections elsewhere in the graph. 
 
4.3.6 GO term associations and relevance in Pfam-A co-occurrence 
communities: 
Pfam-A co-occurrence communities were evaluated in relation to gene and 
domain GO terms to determine if community structure correlated with function. 
This was achieved using the programs ‘NeMo_Gstats.py’ (Appendix 4.2) for 
gene level analysis and ‘NeMo_Dstats.py’ (Appendix 4.2) for domains. As the 
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Pfam-A co-occurrence communities exclude gene nodes, genes were associated 
using the initial Pfam-A homology sub-graphs. Genes were only associated with 
a community if they did not possess homology outside the community. To 
circumvent potential species-based biases in GO-term annotation, only human 
genes were allowed to be associated with a community. Gene GO terms were 
downloaded from Ensembl Gene 76 on Ensembl BioMart [Flicek et al., 2014] 
and Pfam-A GO terms were downloaded from the gene ontology website 
[Ashburner et al., 2000]. GO term enrichment was evaluated using Fisher's exact 
test and chi-squared test. Where both calculations were made, Fisher's exact test 
was favored. To determine if communities were accurately displaying evidence 
of GO term enrichment (i.e. not due to due to gene- or domain-specific GO terms 
only found once in the network) we calculated the recall and precision accuracy 
of each GO term associated with a community. Recall is the ratio of the specific 
GO term displayed by community members to the remainder of the network. 
Precision is the ratio of community members with the GO term to the community 
members without. 
 
4.3.7 Enrichment of innate immunity in Pfam-A co-occurrence 
communities: 
Pfam-A communities were also evaluated for the presence of genes involved in 
innate immunity using the program ‘NeMo_IIstats.py’ (Appendix 4.2). GO terms 
associated with innate immune response were downloaded from AMIGO 
[Carbon et al., 2009] and were used to filter the previously downloaded gene GO 
terms (described in Section 4.2.6). Using similar methodologies to Section 4.2.6, 
each community was tested for enrichment of innate immune specific GO terms 
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using the Fisher's exact and chi-squared tests. The accuracy of functional 
enrichment was determined by calculating recall and precision as before (see 
Section 4.2.6.). 
 
4.3.8 Identification of species-specific domain combinations: 
Human, mouse, and dog orthologous gene families were downloaded from 
Ensembl Gene 76 on Ensembl BioMart [Flicek et al., 2014]. Orthologous gene 
families were only included if all genes were present within the same Pfam-A 
homology sub-graph. Presence or absence of the Pfam-A domain was determined 
for each gene from the bipartite similarity graph using the programs 
‘ortho_domain_networker.py’ (Appendix 4.2). Orthologous families that 
contained a member that had either a gain or loss of domain were subsequently 
aligned using PRANK [Loytynoja and Goldman, 2005]. The domain gain or loss 
events identified were then assessed at the alignment level to identify false 
positives due to sequence polymorphisms, this was achieved using the program 
‘domain_checker.py’ (Appendix 4.2). MSAs not flagged as false positives were 
confirmed using Ensembl BLAST by searching for the identified domain gain or 
loss [Flicek et al., 2014].  
 
4.4 Results 
4.4.1 Construction of the domain co-occurrence graph 
Modular proteins are typically characterized by encompassing multiple 
functional domains [Moore et al., 2008]. However, the functional domains that 
are capable of residing or co-occurring within a given modular proteins have 
been proposed to be limited, suggesting that a number of domains function 
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unaccompanied by other domains [Tordai et al., 2005]. To identify the functional 
domain combinations permitted in the evolution of vertebrate modular proteins, 
we constructed a bipartite graph (Section 1.5.1) from two independent datasets: 
the protein sequences of 30 vertebrate genomes and the HMM profiles from the 
Pfam-A domain database. Sequence homology provided connections between the 
nodes of these independent datasets. Accurate assessment of the Pfam-A domain 
database required our analysis to account for both composite domains (i.e. Pfam-
A domains that are comprised of smaller Pfam-A domains) and domain families 
(i.e. multiple Pfam-A domains with similar sequence motifs) as both categories 
bias results by creating false signatures of domain co-occurrence. See Section 
4.2.1 for details on removing biases from composite domains and domain 
families.  
 
Investigating the structure of the bipartite graph revealed 3,336 connected 
components, with a single giant connected component comprising 36.14% of all 
homology connections and 11.93% of all Pfam-A domains. The presence of this 
giant connected component in addition to other smaller components with 
multiple domains indicate that approximately 40% of all known functional 
domains are functionally promiscuous (i.e. they may co-occur alongside at least 
one other functional domain in a modular protein) and there are specific 
functional domains that reside within multiple modular proteins. The majority of 
connected components (2,816) exhibited only a single Pfam-A domain, 
indicating that the majority (60%) of known biological domains are functionally 
exclusive and therefore cannot occur within a modular protein.  
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Although the majority of vertebrate proteins are not modular in nature, an 
accurate global description of protein evolution requires us to account for those 
proteins that are modular. Protein kinases form a large gene family, they are also 
modular and frequent within our dataset, but the kinases display preferential 
functional domain combinations [Manning et al., 2002]. And so domains of high 
frequency in our dataset may not necessarily be domains that are permitted in 
many combinations in modular proteins. To determine the relationship between 
the function of a domain and its presence in modular proteins we measured the 
unbiased functional permissiveness of each domain in vertebrates. We 
constructed Pfam-A unipartite projections (Figure 4.1) by inferring connections 
between two Pfam-A domains if they co-occur on the same gene, following the 
process described in Section 1.5.1. Constructing the unipartite projections 
resulted in 520 Pfam-A unipartite graphs, with a single giant connected 
component consisting of 43.60% of all co-occurrence connections and 28.76% of 
the co-occurring Pfam-A domains. The presence of approximately a quarter of 
all co-occurring functional domains in a single component indicates that specific 
functional domains are able to co-occur in numerous combinations and therefore 
are like “glue” that holds the connected component together. In the next section 
(Section 4.3.2) we explore the properties of this component to determine if 
kinases (in addition to other domains) are representative of the “glue” pattern. 
Excluding the giant connected component, the remaining 519 components 
exhibit an average of 3 ± 2 domains. The small average of the remaining 519 
components indicates that these domains may co-occur but in limited 
combinations. 
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Figure 4.1: Visiualization of the Pfam-A co-occurrence graph. 
  
The Pfam-A co-occurrence network shows each of the 1996 Pfam-A domains found in modular proteins (i.e. nodes) as blue dots. Grey lines (i.e. 
edges) indicate that the connected Pfam-A domains are found to both reside within a single modular protein (i.e. co-occurrence). Co-occurring 
domains are separated into 520 connected components (i.e. groups of nodes connected by edges that share no edges elsewhere in the network). 
The presence of the large connected component (large circle) indicates that some domains are able to co-occur in numerous combinations and 
hold the connected component together.  
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4.4.2 Highly central Pfam-A domains are most functionally permissive  
The properties of the Pfam-A co-occurrence network are characteristic of a scale-
free graph (Figure 4.2). This is expected for biological graphs [Barabasi and 
Oltvai, 2004] and indicates that modular proteins exhibit a small number of 
functional domains that are capable of functioning in a multitude of 
combinations, i.e. the “glue” or hub nodes, whereas the majority of the functional 
domains are limited in their functional combinations [Barabasi and Oltvai, 2004]. 
To identify which of the functional domains act as hub nodes, and therefore 
which of the domains have the most influence in modular proteins we calculated 
degree, closeness, and betweenness centrality for each node in the Pfam-A co-
occurrence graph (See Section 1.5.2.1 for details on the centrality 
measurements). Calculating the centrality measurements identified several 
domains that strongly influenced (greater than expected by random chance) the 
possible functional combinations exhibited by modular proteins (Figure 4.3). Of 
these domains, Pkinase was found to have the greatest overall influence as the 
domain exhibited the highest values for degree, closeness, and betweenness 
centrality. This finding is perhaps unsurprising given the wide range of 
functional domains reported alongside kinase domains in the human genome 
[Manning et al., 2002]. Many of the other influential domains – Ank2, SH2, 
7tm_1, and RhoGAP – are motifs frequently observed in biology and found in 
proteins with a multitude of functions [Pierce et al., 2002; Mosavi et al., 2004; 
Tcherkezian and Lamarche-Vane, 2007; Filippakopoulos et al., 2008] (Table 
4.2). The observed impact of removing central domains (i.e. high degree, 
closeness, and betweenness) was measured using two graph-clustering 
measurements: average clustering and transitivity (See Sections 1.5.2.4 for 
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details on measurements). The observed decrease in average clustering upon 
removing central domains – especially domains with high degree centrality – 
indicates a decrease in individual domains displaying clique-structure with their 
nearest neighbors (including individual nodes becoming detached from the 
network altogether). In contrast, the observed increase in transitivity upon 
removing central domains indicates an increase in cliques among connected 
triplets (i.e. three nodes connected by at least two edges) (Figure 4.3). Taken 
together, these results indicate that removing central domains is resulting in 
stronger community/clique structure among the network by losing individual 
sparsely connected domains that frequently form triplets but infrequently form 
cliques. This interpretation is supported by a continuous decrease of triangles 
(i.e. triplets displaying clique structure) in the transitivity calculation after each 
deletion event, demonstrating a much greater decrease in the total number of 
triplets to result in the continuous increase in transitivity (Appendix 4.3). From a 
biological perspective, these central or “glue-like” domains are highly 
promiscuous, they are present in many different modular proteins, and without 
these central domains there would be no other relationship between these 
proteins. 
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Figure 4.2: The degree distribution of the Pfam-A co-occurrence graph is 
scale-free 
 The chart shows the proportion of domains in the co-occurrence network on the 
y-axis that exhibit the degree centrality value (i.e. the number edges possessed by 
the node) on the x-axis. The graph indicates that the majority of domains in the 
co-occurrence network exhibit low degree centrality values with approximately 
50% of domains exhibiting a degree centrality of one (i.e. only exhibit a single 
edge). Additionally, the graph shows that a much smaller number of domains 
exhibit high degree centrality values (≥10). In graph theory this degree 
distribution pattern is termed scale-free as it adheres to a power law slope 
(𝑃(𝑘) ~ 𝑘−ϒ)  (see Section 1.5.1 for details). This interpretation is supported by 
the slope of the least squares following a power law (y = 0.84x
-0.64
). Scale-free 
graphs are characterized by having a small number of nodes that possess far 
more connections than the other nodes within the network. These highly 
connected nodes are termed “hubs” and highly influential within the network.  
Slope of least squares fit: y = 0.84 x
(- 0.64)
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Figure 4.3:  Changes to average clustering and transitivity upon removal of 
domains. 
 
The impact removing nodes with high centrality on two measures of graph 
clustering: (a) average clustering, and (b) transitivity. Both (a) and (b) show their 
respective measurement on the y-axis for each domain removed (on the x-axis). 
The order in which domains were removed from the network was either based on 
centrality values (see Section 1.5.2.1) – degree (violet), closeness (green), or 
betweenness (orange) – or by random selection (red). Random selection was 
repeated 100 times for an accurate sampling of random domains. See Table 4.2 
a.
b.
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for the list of domains removed by centrality values. (a) illustrates the affect of 
node deletion on the average clustering, a measure of clique structure among 
each given node and the nearest neighbors of that given node within the network 
(see Section 1.5.2.4 for details). The chart indicates that removing domains based 
on degree or betweenness centrality decreased the average clustering of the 
network far more than expected at random. In comparison, removing domains 
based on closeness centrality decreased the average clustering only slightly more 
than expected at random. In both instances the decrease in average clustering 
shows a decrease in the number of individual domains displaying clique-
structure with their nearest neighbors within the network. (b) illustrates the affect 
of node deletion on transitivity, a measure of clique structure among connected 
triplets (i.e. three nodes connected by edges) within the network (see Section 
1.5.2.4 for details). All three centrality measurements were found to increase the 
transitivity of the network far more than expected at random. This indicates that 
the removal of central domains is increasing the number of cliques among 
connected triplets.  
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Table 4.2: The Pfam-A domains removed from the co-occurrence graph to 
measure average clustering and transitivity. 
 
#1 Node Deleted Value Node Deleted Value2 Node Deleted Value2
1 Pkinase 67 Pkinase 0.31209 Pkinase 0.56188
2 Pkinase_Tyr 43 Pkinase_Tyr 0.29145 RabGAP-TBC 0.21173
3 VWA 18 RhoGEF 0.27016 Pkinase_Tyr 0.19535
4 GVQW 18 Ank_2 0.26826 Ank_2 0.18470
5 7tm_1 17 SH2 0.26503 SNF2_N 0.12246
6 Ank_2 16 F5_F8_type_C 0.26321 Myosin_head 0.11926
7 SNF2_N 15 C2 0.26105 RhoGAP 0.11140
8 RhoGEF 15 Fz 0.26081 7tm_1 0.09532
9 Laminin_G_2 14 Myosin_head 0.26045 Filament 0.08818
10 Trypsin 14 RabGAP-TBC 0.25569 Trypsin 0.08358
11 RhoGAP 14 Kringle 0.25489 RhoGEF 0.08199
12 SPRY 13 RBD 0.25421 GVQW 0.07881
13 7tm_2 13 SH3_1 0.25376 SH2 0.07775
14 Cadherin 13 F_actin_bind 0.25376 HECT 0.07246
15 Y_phosphatase 13 I-set 0.25365 NACHT 0.07044
16 VWD 12 Inhibitor_Mig-60.25354 F5_F8_type_C 0.06922
17 FERM_M 12 Miro 0.25132 C2 0.06664
18 RabGAP-TBC 12 ANF_receptor 0.25088 Bromodomain 0.06518
19 MAM 11 OLF 0.25033 VWA 0.06453
20 CUB 11 Guanylate_cyc 0.24956 DEAD 0.06102
21 C2 11 Death 0.24902 Y_phosphatase 0.05927
22 HECT 10 CNH 0.24859 Fz 0.05354
23 Bromodomain 10 Ephrin_lbd 0.24752 SET 0.05225
24 Myosin_head 10 EphA2_TM 0.24752 PRY 0.05183
25 Fz 10 Recep_L_domain0.24741 ANF_receptor 0.05152
26 DUF3497 10 SAM_1 0.24741 Exo_endo_phos 0.04814
27 ANF_receptor 10 Furin-like 0.24741 SPRY 0.04783
28 AAA 10 GF_recep_IV 0.24741 MHC_I 0.04776
29 Kinesin 9 Sema 0.24741 PARP 0.04709
30 ABC_tran 9 DUF4071 0.24730 RVT_1 0.04522
31 NACHT 9 GTPase_binding0.24730 C1-set 0.04467
32 UCH 9 DCX 0.24720 UCH 0.04143
33 Laminin_G_1 9 ApoL 0.24720 Cadherin 0.03908
Degree	Centrality Closeness	Centrality Betweeness	Centrality
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Table 4.2: The Pfam-A domains removed from the co-occurrence graph to 
measure average clustering and transitivity. 
 
The order of removal of nodes, the functional domain removed, and centrality 
score for each of the centrality measurement assessed is given. The centrality 
scores used for selection were based on the original Pfam-A co-occurrence 
graph, the scores given for closeness and betweenness are rounded to increase 
legibility of the table. 
 
#1 Node Deleted Value Node Deleted Value2 Node Deleted Value2
34 F5_F8_type_C 9 PBD 0.24720 PH 0.03772
35 SH2 9 KSR1-SAM 0.24720 PWWP 0.03735
36 DEAD 8 POLO_box 0.24720 MAM 0.03584
37 FERM_N 8 Mst1_SARAH 0.24720 Sec7 0.03445
38 PARP 8 Focal_AT 0.24720 Transposase_22 0.03436
39 SET 8 DUF1908 0.24720 MIT 0.03435
40 RVT_1 8 PKK 0.24720 I-set 0.03241
41 NTR 8 Ig_Tie2_1 0.24720 Guanylate_kin 0.03182
42 Filament 7 PH_3 0.24720 PABP 0.03097
43 SRCR 7 Trypsin 0.24635 VWD 0.02988
44 I-set 7 Filament 0.24603 NTR 0.02923
45 FERM_C 7 MAM 0.24096 Laminin_G_2 0.02817
46 Guanylate_kin 7 Guanylate_kin 0.24076 AAA 0.02774
47 Laminin_N 7 RGS 0.24055 RRM_1 0.02773
48 RRM_1 7 MIT 0.23995 CUB 0.02750
49 A2M_recep 7 7tm_1 0.23945 OLF 0.02732
50 PWWP 7 PX 0.23895 7tm_2 0.02656
1Deletion iteration
2Rounded values
Degree	Centrality Closeness	Centrality Betweeness	Centrality
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4.4.3 Modular proteins exhibit a preference for domains with similar 
functional permissiveness  
To determine the influence of specific domain combinations on modular proteins 
we calculated the degree assortativity (i.e. preference of nodes to share edges due 
to similar degree centrality values of the respective nodes) of each co-occurrence 
connection within the Pfam-A co-occurrence graph (See Section 1.5.2.2 for 
details on calculating assortativity). The Pfam-A co-occurrence graph was 
determined to be assortative from a neighbor connectivity plot, indicating a 
preference of nodes to attach if they share exhibit degree values (Figure 4.4). It is 
possible that the large number of low degree nodes may have unrealistically 
influenced this measurement, and so we also obtained the degree assortativity 
coefficient for the network – which we calculated as 0.03301 and was 
determined to be significant using 10,000 randomized graphs with the same 
degree distribution [Foster et al., 2010] (Appendix 4.4). Together these network 
metrics indicate that Pfam-A co-occurrence is an assortative network comparable 
for example to the patterns observed in co-authorship networks, which are 
characterized by a preferential attachment of nodes with similar degree centrality 
values [Newman, 2003]. This finding is in direct contrast to the disassortative 
mixing patterns (i.e. preferential attachment of high-degree nodes with low-
degree nodes) that characterize most biological networks [Newman, 2002]. 
Therefore, in our exploration of vertebrate modular protein evolution we see that 
domains with similar domain centrality values are more likely to co-occur. For 
example, the modular protein HACE1 (HECT domain and ankyrin repeat 
containing E3 ubiquitin protein ligase 1) [Anglesio et al., 2004; Flicek et al., 
2014] contains the HECT and Ank_2 (Ankyrin 2) domains whereas TNKS2 
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(TRF1-interacting ankyrin-related ADP-ribose polymerase 2) [Lyons et al., 
2001; Flicek et al., 2014] contains the Ank_2 and PARP (Poly ADP ribose 
polymerase) domains, in both cases the pair of domains have similar degree 
centrality values. The results indicate that modular proteins are preferentially 
constructed with domains exhibiting similar co-occurrence possibilities (i.e. 
permissiveness to reside with other domains). 
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Figure 4.4: Assortativity of the Pfam-A co-occurrence graph. 
 
One method for measuring network assortativity is generating a neighbor 
connectivity plot by plotting the average degree centrality of nearest neighbors 
<Knn> on the y-axis for a node with degree K on the x-axis. As illustrated in the 
box above, <Knn> is the average degree centrality of the nodes that share an 
edge with the given node (i.e. nearest neighbors of the given node), for example, 
the <Knn> for node F is the average degree centrality of C and E (
𝐾𝐶 + 𝐾𝐸
2
 ) and 
is plotted against the K of F. The chart shows that the Pfam-A graph displays 
assortative mixing patterns as the positive slope (y = 0.2734x + 3.937) of the 
trend line (i.e. linear regression of K and <Knn>) indicates that the degree of a 
given node (K) increases alongside the degree of its nearest neighbors <Knn>. It 
should be noted that the large number of nodes with low degree values may have 
unrealistically influenced the linear regression – causing the low r-squared value 
of 0.00771 – and indicates that additional confirmation is required.   
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4.4.4 Functional domain combinations are influenced by function 
Many Pfam-A domains, such as Pkinase and Pkinase_Tyr, have been associated 
with specific biological functions [Manning et al., 2002; Scheeff and Bourne, 
2005]. Kinase domains in particular are documented to frequently co-occur with 
a variety of functional domains to construct a functional modular protein 
[Manning et al., 2002]. We wished to determine if Pfam-A domain combinations 
were associated with function at three distinct levels: i) domain functional 
enrichment (do domain combinations occur more often between domains of 
similar function?), ii) gene functional enrichment (do specific domain 
combinations occur more often in genes of similar function?), and iii) biological 
pathway functional enrichment (do domain combinations occur more frequently 
in specific pathways?). The innate immune system was selected as the set of 
biological pathways for analysis of functional enrichment.  
 
Pfam-A communities were generated from each of the 518 co-occurrence graphs 
to identify frequently connected domain combinations (see Section 1.5.2.3 for 
description of network communities). Each community was assessed for 
potential functional enrichment using GO terms associated with either the Pfam-
A domains (in the case of domain functional enrichment analysis) or the 
associated human proteins (in the case of gene and pathway functional 
enrichment analyses). Identifying functional enrichment was achieved by using a 
one-tailed (enrichment required) Fisher's exact test. In total, there were 1,376 
domains, 26,843 proteins, and 147 innate immune GO terms identified as 
significantly enriched (P < 0.05). However, this approach includes GO terms that 
are only associated with a single protein or domain and were not found elsewhere 
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in the Pfam-A network. Such GO terms do not accurately reflect enrichment due 
to their small sampling. To more accurately quantify community enrichment, two 
precision measurements (precision and recall) were also calculated. Using a 
precision threshold of 0.5 (i.e. requiring 50% of the community to possess the 
GO term) refined the results down to 243 domains, 4,363 proteins, and 20 innate 
immune genes that had GO terms that were significantly enriched (P < 0.05). 
Table 4.3 contains details on the communities that exhibited the highest precision 
and recall scores (i.e. fraction of GO term within the community vs. the entire 
network). Communities exhibiting high recall possess functional enrichment that 
is unique and not frequently observed elsewhere in the network. Indicating that 
the particular domain combination is not frequently observed in other 
combinations. Communities exhibiting higher precision possess more members 
(i.e. domains and genes) exhibiting a specific functional enrichment, indicating 
that more of the domain combination is required for the function. Therefore, 
communities exhibiting both high recall and precision indicate that the majority 
of the domain combination is required for a unique function. In summary, we 
show that modular proteins occasionally require a specific combination of 
domains to function independently or within a pathway such as innate immunity, 
or they may require a combination of functionally similar domains to function. 
For a full list of the enrichment findings see Appendix 4.5. 
 
From our analysis we found that multiple functionally enriched communities 
displayed consistently low degree centrality values with an average of 1.8 and a 
standard deviation of 1.2 (Appendix 4.6). Low centrality would indicate that 
these communities contain domain combinations that have limited functional 
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combinations. Degree centrality was also determined to be similar among 
members of the same community, with an average standard deviation across all 
communities of 0.17 (Appendix 4.6). The lack of deviation in degree that we 
observe in domains that make up the vertebrate modular proteins is also 
supported by the assortativity of the network. Therefore, it appears that 
functionally enriched domain combinations are restricted in their ability to 
operate in other combinations and favor combinations of domains with similar 
restrictions.
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Table 4.3: Community structure and gene GO-term, domain GO-term, and innate immune functional enrichment. 
 
 
 
Term
Group 
Size
Members 
w/Term
Non-group 
w/Term
Recall Precision
Fisher's Exact 
odds ratio
Fisher's 
Exact P-value
cation-transporting ATPase activity 27 27 0 1.000 1.000 inf 7.10E-85
connexon complex 22 22 0 1.000 1.000 inf 4.35E-71
neurotransmitter:sodium symporter activity 21 21 0 1.000 1.000 inf 2.82E-68
diacylglycerol kinase activity 15 15 0 1.000 1.000 inf 6.14E-51
calcium-dependent cysteine-type endopeptidase activity 15 15 0 1.000 1.000 inf 6.14E-51
protein-glutamine gamma-glutamyltransferase activity 9 9 0 1.000 1.000 inf 1.45E-32
ribose phosphate diphosphokinase activity 5 5 0 1.000 1.000 inf 2.01E-19
glucokinase activity 5 5 0 1.000 1.000 inf 2.01E-19
phosphopyruvate hydratase activity 5 5 0 1.000 1.000 inf 2.01E-19
phosphopyruvate hydratase complex 5 5 0 1.000 1.000 inf 2.01E-19
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Table 4.3 Community structure and gene GO-term, domain GO-term, and innate immune functional enrichment. 
 
 
 
Term
Group 
Size
Members 
w/Term
Non-group 
w/Term
Recall Precision
Fisher's Exact 
odds ratio
Fisher's 
Exact P-value
DNA ligase (ATP) activity 4 4 0 1.000 1.000 inf 1.52E-12
thiamine pyrophosphate binding 3 3 0 1.000 1.000 inf 7.56E-10
negative regulation of transcription, DNA-dependent 3 3 0 1.000 1.000 inf 7.56E-10
S-adenosylmethionine biosynthetic process 3 3 0 1.000 1.000 inf 7.56E-10
methionine adenosyltransferase activity 3 3 0 1.000 1.000 inf 7.56E-10
protein-arginine deiminase activity 3 3 0 1.000 1.000 inf 7.56E-10
folic acid-containing compound biosynthetic process 3 3 0 1.000 1.000 inf 7.56E-10
intramolecular transferase activity, phosphotransferases 3 3 0 1.000 1.000 inf 7.56E-10
arginyl-tRNA aminoacylation 3 3 0 1.000 1.000 inf 7.56E-10
arginine-tRNA ligase activity 3 3 0 1.000 1.000 inf 7.56E-10
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Table 4.3 Community structure and gene GO-term, domain GO-term, and innate immune functional enrichment. 
 
The 10 communities with the highest precision and recall for gene/protein, domain, and innate immune system functional enrichment. 
Calculations were determined using the size of the community (Group Size), the number of community members with the term in question 
Term
Group 
Size
Members 
w/Term
Non-group 
w/Term
Recall Precision
Fisher's Exact 
odds ratio
Fisher's 
Exact P-value
RIG-I signaling pathway 3 2 1 0.667 0.667 28598 8.80E-08
positive regulation of type I interferon-mediated signaling pathway 3 2 5 0.286 0.667 5718 6.16E-07
positive regulation of innate immune response 2 2 8 0.2 1.000 inf 4.40E-07
type I interferon-mediated signaling pathway 9 9 88 0.093 1.000 inf 2.08E-20
interferon-gamma-mediated signaling pathway 9 9 126 0.067 1.000 inf 4.54E-19
innate immune response 24 16 485 0.032 0.667 56.88247423 2.31E-18
innate immune response 17 10 491 0.02 0.588 40.13674716 3.97E-11
innate immune response 4 4 497 0.008 1.000 inf 1.49E-06
innate immune response 2 2 499 0.004 1.000 inf 1.22E-03
innate immune response 2 2 499 0.004 1.000 inf 1.22E-03
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(Members w/Term), and the number of non-community members with the term (Non-group w/Term). The results of the Fisher's exact test (odds 
ratio and P-value) are given. An odds ratio of “inf” (infinity) indicates a large difference. 
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4.4.5 Species-specific domain combinations exhibit unique properties 
Species-specific domain combinations in modular proteins may represent novel 
functional domain combinations. We wished to identify if there were species-
specific combinations present in the vertebrate modular protein network and if 
these novel combinations displayed similar characteristic to our previous 
findings of the entire network. To this end we identified species-specific domain 
combinations in the Pfam-A co-occurrence network using orthologous genes 
from human, mouse, and dog.  
 
The domains responsible for the establishment of the species-specific 
combinations were classified by protein position (5’, internal, and 3’) and most 
likely mechanism that created the event. Three creation mechanisms were 
observed within the Pfam-A network: (i) complete domain events (CDEs) 
characterized by indels that contain an entire Pfam-A domain motif, (ii) 
incomplete domain events (IDEs) characterized by indels that only contain a 
fraction of a Pfam-A domain motif, and (iii) composite gene events (CGEs) 
characterized by a single gene that contains the coding sequence of two 
nonallelic genes (Figure 4.4a).  
 
Identification of species-specific domains were limited to human and mouse to 
minimize false positives due to poor assemblies and low alternative transcript 
counts (Appendix 4.7). Analysis of human and mouse orthologs resulted in the 
identification of 122 potential species-specific domain combinations. Manual 
inspection and Ensembl BLAST [Flicek et al., 2014] identified 113 false 
positives present due to poor alignment and alternative transcripts. Of the 
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remaining 9 events there were 2 IDEs, 2 CDEs, and 5 CGEs (Table 4.4). 
Calculating the assortativity of the modular proteins exhibiting species-specific 
combinations alone (the edges of species-specific modular proteins) resulted in 
an assortativity coefficient of -0.1807 (Appendix 4.8), indicating disassortative 
mixing patterns. Therefore in this small subset of species-specific combinations 
there is a preferential attachment of high-degree nodes with low-degree nodes, 
similar to most biological networks [Newman, 2002]. This is in direct contrast to 
the assortative mixing patterns observed for the entire network that indicated a 
preference for modular proteins to incorporate domains with similar combination 
possibilities. In terms of modular proteins, the domains responsible for species-
specific combinations are frequently found in modular proteins with dissimilar 
co-occurrence ability. 
 
For each of the 9 species-specific events identified, the dog ortholog (where 
available) was used to determine the genetic mechanism behind the event and 
determine if the event was a species-specific domain gain or loss. Dog was 
selected as an output due to being the closest non-euarchontoglires mammal with 
the highest frequency of alternative transcripts (Appendix 4.7). This analysis of 
the data and additional confirmation by Ensembl BLAST (i.e verification with 
genomic DNA) provided evidence for four genetic mechanisms that have 
generated the observed species-specific combination events (Figure 4.4b). These 
mechanisms comprised: (i) the gain or loss of exons, (ii) the extension of exons 
by indels with an additional 5’ splice site, (iii) the partial gain or loss of an exon, 
and (iv), transcription readthrough events (Table 4.4). 
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Table 4.4: Details on species-specific domain combinations identified from the Pfam-A domain co-occurrence graph.  
 
The species, gene name, domain name, and proximal protein location (3’, 5’, and internal) are given for the postulated domain(s) responsible for 
the species-specific combinations. The table indicates the proposed mechanisms and genetic origin of each event. In addition, the current status 
Species	Status	
(Present	or	Absent)
Hs | Mm | Cf
Mouse Kxd1
Ribosomal_L40e,  
ubiquitin
3' CGE Readthrough −  |  +  |  −
Human FIP1L1 Pkinase_Tyr 3' CGE Readthrough +  |  −  |  −
Human PPAN-P2RY11 7tm_1 3' CGE Readthrough +  |  −  |  −
Human PRR5-ARHGAP8 HbrB 3' CGE Readthrough +  |  −  |  −
Human IQCJ-SCHIP1 IQ-like 5' CGE Readthrough +  |  −  |  −
Human AZIN2 Orn_DAP_Arg_deC Internal IDE Exon expansion +  |  −  |  +
Mouse Olfr1260 7tm_1 Internal IDE Partial exon indel −  |  +  |  +
Human MMP13 GVQW 3' CDE  Exon indel +  |  −  |  −
Human NLRP5 PYRIN Internal CDE  Exon indel +  |  −  |  +
Genetic Origin Species Gene Name Domain Name(s) Location  Mechanism  
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of the postulated domain(s) are given in the human (Hs), mouse (Mm), and dog (Cf) Ensembl genome assemblies, status of the postulated 
domain(s) are either present within assembly (+) or absent (-). 
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Figure 4.4: Schematic of the mechanisms and genetic origins of species-
specific domain combinations in the network of human, mouse and dog. 
 
 (a) The three introgressive mechanisms found by the Pfam-A co-occurrence 
network. CDEs involve the gain or loss of a complete Pfam-A domain. IDEs 
involve the gain or loss of an incomplete Pfam-A domain into a protein that 
contains sequence that completes the Pfam-A domain. CGEs involve the fusing 
of two or more non-allelic proteins to become a single protein. (b) Schematic of 
four possible genetic origins responsible for the introgressive events reported in 
the Pfam-A co-occurrence network. Exon gain or loss: In this instance, a unique 
domain combination is created by the fusion (gain) or fission (loss) of an exon 
that contained a Pfam domain. Partial exon gain or loss: In this instance, a unique 
domain combination is created by the fusion (gain) or fission (loss) of a sub-
sequence of an exon that contained a Pfam domain. Exon-expansion: In this 
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instance, a unique domain combination is created by the fusion (gain) or fission 
(loss) of a sequence that contains a splice site that either extends (gain) or 
reduces (loss) an exon sequence. Transcription readthrough: In this instance, a 
unique domain combination is created by the fusion (gain) of an entire gene by a 
readthrough event. 
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4.5 Discussion 
In this chapter, we have used graph theory to globally characterize and identify 
the species-specific domain combination events that underpin the evolution of 
modular proteins in vertebrates. In agreement with previous co-occurrence 
network analyses that used only single-species [Wuchty, 2001; Wuchty and 
Almaas, 2005], our results indicate that domain co-occurrence (i.e. the ability of 
two domains to exist on a common gene) is characteristically scale-free in 
vertebrate evolution. In biological terms, these findings indicate that only a small 
number of domains (i.e. hub nodes, see degree centrality in Table 4.2) are 
tolerated in the construction of most modular proteins, whereas the majority of 
functional domains are restricted in terms of the combinations of modular 
proteins where they are found. The topology of the network was also found to 
exhibit patterns of assortative mixing, indicating that modular proteins favour 
combinations of domains with similar degree centrality values, this is a 
previously undocumented characteristic of modular proteins. The presence of 
such preferences suggests that domains that are restricted in their functional 
combinations are incompatible with domains that have numerous functional 
combinations. 
 
Restrictions in domain combinations in modular proteins is further explained by 
the identification of graph communities, indicating that modular proteins have a 
biological preference for specific combinations of domains beyond just similar 
degree centrality values. A number of graph communities were found to display 
evidence of functional enrichment, indicating that these specific domain 
combinations may be favored for functional reasons. One community of four 
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Pfam-A domains (DNA_ligase_IV, DNA_ligase_A_C, DNA_ligase_A_M, and 
DNA_ligase_A_N) was identified as significantly enriched for DNA ligase 
activity (Table 4.3). All four domains exhibited low degree centrality values 
(Appendix 4.6) in keeping with the assortative mixing of domain co-occurrence. 
The combination of functional enrichment and low centrality was frequently 
observed in our results (Appendix 4.6) and may not be so surprising as functions 
such as DNA ligase activity and RNA polymerase activity (Appendix 4.5) are 
essential biological functions that require specialized domains and may be 
disrupted or become harmful in combinations with domains able to function in or 
interact with a wider array of modular proteins. 
 
The possible domain combinations of modular proteins are further complicated 
by the presence of species-specific domain combinations. Such events represent 
the creation of an altered modular protein due to the gain or loss of a domain 
[Bapteste et al., 2012]. The network topology for our human, mouse and dog 
comparison indicated that humans exhibits more species-specific combinations 
than mouse, but this could be partially explained by the higher frequency of 
alternative transcripts in the human genome assembly (Appendix 4.7). In 
comparison to the assortative mixing patterns of modular proteins, these species-
specific domain combinations are characterized by disassortative mixing 
patterns. The disassortative mixing patterns may be partially explained by the 
non-vertical mechanisms that generated the event, and suggests that assortativity 
could potentially enable the global identification of species-specific domain 
combinations from network topology alone.  
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The biological implication of species-specific domain combinations such as 
those identified in this chapter is the potential alteration of the function of a 
modular protein, this is plausible particularly when considering the observed 
association of functional enrichment with low centrality and the disassortative 
mixing patterns of the species-specific domain combinations. A single human-
specific combination was due to the putative binding domain GVQW [Finn et 
al., 2014]. The presence of GVQW could therefore potentially alter the binding 
capabilities of the modular protein in which it is contained. The mouse-specific 
combination between the YchF-GTPase_C domain (hypothesized to be required 
for signal transduction or ribosome function [Caldon et al., 2001]) and the Nrf1 
gene (transcription factor linked to regulating cellular growth, respiration, heme 
biosynthesis, and mtDNA transcription and replication [Pruitt et al., 2014]) could 
potentially be responsible for various species-specific functions. To properly 
investigate the biological implications of these putative species-specific domain 
combinations events, in vitro functional assessment would be essential to 
determine that the gene and protein products of these putative species-specific 
events are expressed, and if they are expressed, to characterize and compare their 
functions. 
 
In closing, network biology offers a powerful tool for studying species-specific 
domain combinations in the evolution of modular proteins. The identification of 
species-specific combinations and determining their characteristics is an 
important step to understand the causes of species-specific functions. The 
network topology and network analyses carried out in this chapter have enabled 
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us to uncover previously unknown characteristics that are unique to species-
specific events in vertebrate modular proteins.  
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Chapter 5: Discussion 
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In this thesis the innate immune system has been employed as a model system to 
better understand phenotypic discordance at the molecular level that is 
potentially governed by protein functional shift. Our approach was to use large-
scale screens for molecular signatures of positive selection between species as a 
proxy for functional discordance, an approach that has proven successful in 
previous studies of individual proteins [Sawyer et al., 2005; Loughran et al., 
2012, Moury and Simon, 2011; Farhat et al., 2013]. We identified a large 
number of genes displaying species-specific positive selection in the extant 
mouse lineage in particular. Examining these results alongside reported instances 
of functional discordance there are a number of positively selected genes 
implicated in known cases of phenotypic discordance (Section 3.4) [Wakimoto et 
al., 2002; Pumidonming et al., 2011].  
 
Using signatures of positive selection to predict potential functional discordance 
has particular relevance in deepening our understanding of the relationship 
between genotype and phenotype. In the future, this approach could direct the 
choice of model organism in which a drug will be tested, but it could also be 
used to determine which model organism will produce the closest mimic of a 
human genetic disorder. Using the software designed in this thesis, this analysis 
could easily be expanded in future projects to include lineage tests on other 
model organisms such as hamster and rat, and indeed to test non-model 
organisms that are gaining significance in biomedical research [Kim et al., 
2011]. Our findings in Chapter 3 provide a number of potential molecular 
candidates to assist in the current attempt to “humanize” the mouse model for the 
immune system [Garcia and Freitas, 2012; Ito et al., 2012].  
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Large-scale analyses of selective pressure variation is not straight-forward as 
evidenced by the complexity of the software designed in Chapter 2, and also 
there were many difficulties and limitations encountered due to data quality. The 
poor quality of sequences and assemblies resulted in unacceptably high levels of 
false positives in our analysis of the bowhead whale genome (Section 2.12) and 
spurred us to use very high quality genomes in subsequent large-scale analysis 
presented in Chapter 3.  
 
Initially there were 112 genes estimated as positively selected in the bowhead 
lineage alone, upon close inspection and following manual filtering for gene 
annotation and sequencing errors this total was adjusted to just 14 genes. The 
bowhead whale study highlighted the importance of genome and alignment 
quality for the accurate identification of positive selection [Schneider et al., 
2009]. Unfortunately this limits selective pressure analyses to species that have 
genomes of suitably high quality (at minimum  > 6X coverage) (as in Chapter 3). 
Our analysis was also limited by the absence of genome-wide population data for 
the vast majority of currently sequenced species. We implemented population 
level data analytics for the genes displaying positive selection in the human 
lineage [Tajima, 1989; Fay and Wu, 2000]. But these analyses were not possible 
for our genes displaying positive selection in the mouse lineage as we currently 
lack population data (we did attempt analyses using the 17 mouse genomes but 
these are laboratory strains and are two few in number). A greater amount of data 
on disease-associated mutations would allow us to link more precisely functional 
discordance to molecular signatures. 
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There are of course many other causes of phenotypic discordance along with 
point mutational processes studied in Chapters 2 and 3, they include but are not 
limited to: regulatory differences [Prud’homme et al., 2006; McLean et al., 2011; 
Wittkopp and Kalay, 2012], differences in gene duplication strategies/gene 
family repertoires [Blanc and Wolfe, 2004; Sullivan et al., 2009; Brown et al., 
2010; Dennis et al., 2012; Abascal et al., 2013], copy number variation [Dumas 
et al., 2007; Perry et al., 2008], and epigenomic differences [Feng and Jacobsen, 
2011; Zeng et al., 2012] between species. During the process of identifying 
protein families for analysis in Chapters 2 and 3, we noticed patterns in the 
protein coding sequences that were suggestive of introgression or gene 
remodeling (e.g. domain shuffling) playing an important role in vertebrate 
protein evolution. This observation spurred us to explore non-linear patterns that 
lead to novel protein coding genes in vertebrate evolution (Chapter 4).  
 
In Chapter 4 we applied graph theory to study the prevalence and role of 
introgressive events (gene remodeling) in the emergence of novel genes. Our 
analysis revealed not only multiple species-specific introgressive events in the 
evolution of vertebrate modular proteins, but it also determined the unique 
evolutionary principles that govern remodeling in vertebrate protein coding 
space. We discovered that vertebrate modular proteins are more likely to be 
composed of domains that share similar promiscuity levels. In addition we found 
that there was a preference for proteins exhibiting unique functions to 
incorporate domains with limited promiscuity levels (Section 4.3.3 and Section 
4.3.4). These discoveries suggest that introgressive events do not strictly adhere 
to these same principles (Section 4.3.5). It should be stated that our graph theory 
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approach was not without challenges, including the detection of false positives 
primarily due to differences in the frequency of alternative transcripts between 
species. This again demonstrates that low quality assemblies result in 
unacceptably high levels of false positives.  
 
While the application of graph theory to evolutionary biology is still in its 
infancy, this approach has already led to advances in important theoretical 
concepts such as the ortholog conjecture [Haggerty et al., 2014]. The application 
of network theory to detecting and characterizing non-linear gene remodeling is 
providing important insights into the complex nature of protein change over time 
and is contributing to theoretical advancements in the field of evolutionary 
biology [Bapteste et al., 2012; Bapteste et al., 2013; Haggerty et al., 2014]. The 
domain shuffling described in Chapter 4 generates “partially orthologous” 
sequences that are divergent in function and also are potentially lineage-specific 
[Gharib and Robinson-Rechavi, 2011; Haggerty et al., 2014]. These results 
warrant further study at the in silico and in vitro level to determine the functional 
impact of species-specific gene remodeling.    
 
Conclusion: 
The research conducted in this thesis employed the innate immune system to 
elucidate the evolution of unique protein function within vertebrates. We 
successfully developed a high throughput pipeline that greatly simplified the 
large-scale analysis of protein coding sequence datasets. Examining the human 
and mouse innate immune systems identified a number of genes with species-
specific signatures of positive selection. Our approach was found to be able to 
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accurately identify functional discordance from sequence data for known cases 
of phenotypic discordance. Our investigation of gene remodeling by domain 
shuffling revealed how frequent this mechanism of protein evolution is and what 
the rules for gene remodeling are (e.g. which domains are compatible and 
incompatible). Our analysis revealed the prevalence of species-specific gene 
remodeling events across these vertebrate species and highlighted the importance 
of domain shuffling for the introduction of novel proteins into the innate immune 
system and indeed into the vertebrate species tested.  
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